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ENGINEERING ARTICULAR CARTILAGE USING NEWLY DEVELOPED CARRAGEENAN BASED HYDROGELS  
 
ABSTRACT 
 
Articular cartilage holds specific functionality in the human body creating smooth gliding areas and 
allowing the joints to move easily without pain. However, due to its avascular nature and to the low 
metabolic activity of the constituent cells-the chondrocytes, cartilage has a low regenerative potential. 
The current surgical options to treat damaged cartilage are not long lasting and involve frequent 
revisions. Tissue engineering may provide an alternative approach for cartilage repair, involving the use 
of hydrogels which can act as a temporary artificial matrix for encapsulated cells, supporting their 
growth and inducing the extracellular matrix (ECM) production. The use of hydrogels is regarded as 
advantageous for cartilage tissue engineering because they provide similar environment to the native 
ECM where cells reside. Up to date, many different hydrogel systems based on natural polymers have 
been developed for cartilage regeneration. Among these systems, marine polysaccharides origin 
hydrogels have received increasing attention since they are seen as an inexpensive potential source of 
material with owing to their specific characteristics and composition. 
In the present PhD thesis it was investigated the potential of carrageenan, a sulphated polysaccharide 
that can be extracted from red algae, as an alternative hydrogel for cartilage regeneration. 
Carrageenans offer appealing assets for cell encapsulation/delivery, derived from their chemical 
composition and gelation process. 
Therefore, the main aims of this thesis were: 
- develop and characterize different blends of carrageenan with alginate, processed into different 
formats;  
- study the chondrogenic differentiation of stem cells loaded in κ-carrageenan hydrogels; 
- asses the viability, proliferation and chondrogenic potential of different cell types, laden in κ-
carrageenan hydrogels; 
- evaluate the effect of cryopreservation methods on the viability and chondrogenic differentiation of 
stem cells encapsulated in κ-carrageenan hydrogels; 
- study the in vitro and in vivo biocompatibility of κ-carrageenan hydrogels.  
 
In the first part of this thesis, different formulations of alginate and carrageenan hydrogels and different 
processing parameters were considered in order to determine the best conditions required to achieve 
the most adequate response in terms of the mechanical stability, cell viability and functionality of the 
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developed systems. The morphology, size and structure of the hydrogels and their degradation 
behavior and mechanical properties were evaluated as well as their cytotoxicity and ability to 
encapsulate chondrocytes. The results obtained indicated that the different formulations, both in the 
form of beads and fibers have considerable potential as cell-carrier materials for cell delivery in tissue 
engineering/regenerative medicine applications. The results obtained in this study also showed that 
κappa carrageenan is more suitable for the proposed application than ιota carrageenan. 
Subsequently, further studies were designed to assess the ability of κappa-carrageenan hydrogels to 
support the chondrogenic differentiation of human adipose derived stem cells (hASCs). Moreover, the 
chondrogenic potential of hASCs encapsulated in κ-carrageenan hydrogels was compared to hydrogels 
laden with other cell types, namely human primary (nasal) chondrocytes (hNCs) and a chondrocytic cell 
line (ATDC5). The in vitro cellular behavior of the encapsulated cells within κ-carrageenan hydrogel was 
analyzed after different culturing periods by mechanical tests and using biochemical assays as well as 
cytohistological and real time RT-PCR analysis. 
The results from the analysis of the cells encapsulated in the developed systems indicated that κ-
carrageenan hydrogels support the viability, proliferation and chondrogenic differentiation of hASCs. 
Interestingly, the mechanical analysis demonstrated an increase in stiffness and in the viscoelastic 
properties of κ-carrageenan gels with encapsulated hASCs along the time in culture with chondrogenic 
media, as compared to hydrogels without cells or cell laden hydrogels cultured in basal media.  
Furthermore, these studies have also demonstrated that the 3 types of cells encapsulated in κ-
carrageenan hydrogels showed good cellular viability and proliferation up to 21 days of culture and the 
cell laden hydrogels showed to be positive for specific cartilage markers. Nevertheless, the results also 
showed that hASCs embedded in κ-carrageenan hydrogels proliferate faster and exhibit higher 
expression levels of the typical cartilage markers analysed as compared to hNCs or ATDC5 cells. Based 
on this data, it was possible to conclude that κ-carrageenan hydrogel provides a good support for 
culture and differentiation of encapsulated cells and that hASCs may provide an advantageous 
alternative to primary chondrocytes, currently used in clinical treatments of cartilage defects/diseases. 
These bioengineered constructs are anticipated to participate in a cartilage regeneration strategy 
providing temporary habitation for cell survival, proliferation and production of extracellular matrix 
which is expected to replace the hydrogel, enhancing the regeneration of native tissues in clinical 
settings. Nevertheless, the time span needed for obtaining a functional cartilage substitute using tissue 
engineering strategies, together with the need for specific patient oriented constructs stimulated our 
interest for assessing the possibility of developing of ―off-the shelf‖ products, based on 
cryopreservation, that would provide clinical substitute available as needed and could be adapted to an 
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autologous immediate solution for the patient. Therefore, the following experiments were planned to 
examine the effects of cryopreservation on the chondrogenic differentiation characteristics of hASCs 
encapsulated in κ-carrageenan hydrogels. The results obtained show that the hydrogels withstand the 
cryopreservation with dimethyl sulfoxide, maintaining their structural integrity, while assisting cells 
proliferation and chondrogenic potential after cryopreservation. Thus, cell encapsulation systems of 
natural based hydrogels seem to be an interesting approach for the preservation of cartilage tissue 
engineered products. 
The final stage of the work developed involved studies on the in vitro and in vivo biocompatibility of κ-
carrageenan hydrogels. The in vitro cytotoxicity of the hydrogels was evaluated under standard tests 
using the L929 cell line, and chemiluminescence assays were performed using human 
polymorphonuclear cells. The in vivo study was accomplished by the subcutaneously implantation of 
carrageenan hydrogels discs in Wistar rats for up to 15 days. The obtained findings indicated that κ-
carrageenan hydrogels induced a reduced and insignificant signal concerning the detection of 
superoxide and hydroxyl anions and seems to induce a low inflammatory response and thus, can be 
further studied to be used in target biomedical applications.  
Moreover, a recent preliminary in vivo study showed that loading κ-carrageenan with cells previously 
exposed to chondrogenic medium led to higher stability of the construct in vivo (rat subcutaneous 
model) as compared  to hydrogels cultured in basal media or hydrogels without cells. Such 
accomplishment is probably related to an increase in the extracellular matrix deposition which may 
result in progressive increase of the mechanical properties, in agreement with the results obtained in 
the in vitro studies performed with κ-carrageenan. 
Overall, the work developed under this thesis allowed to conclude that κ-carrageenan hydrogels laden 
with human adipose derived stem cells show a great potential to be tailored to specific applications in 
cartilage tissue regeneration approaches. 
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Desenvolvimento de novos hidrogéis baseados em carragenina para aplicação em engenharia de 
cartilagem articular 
 
RESUMO 
 
A cartilagem articular desempenha funções específicas no corpo humano criando áreas de 
deslizamento lisas e quase sem atrito que permitem a movimentação das articulações sem causar dor. 
No entanto, devido à sua natureza avascular e a reduzida atividade metabólica das células que a 
constituem condrócitos, possui um potencial de regeneração baixo. As atuais opções cirúrgicas para o 
tratamento da cartilagem danificada não são duradouras e geralmente obrigam a repetição de 
procedimentos e/ou recorrência dos sintomas. A engenharia de tecidos proporciona uma abordagem 
alternativa na regeneração da cartilagem, envolvendo o uso de hidrogéis que atuam como uma matriz 
artificial temporária para encapsular células, suportar a sua proliferação e produção de matriz 
extracelular. O uso de hidrogéis é considerado vantajoso na engenharia de tecido cartilagíneo, uma vez 
que estes proporcionam um ambiente similar ao da matriz extracelular onde as células nativas 
residem. Até à data, foram desenvolvidos vários hidrogéis com base em polímeros naturais para 
regenerar cartilagem. Entre estes, os polissacáridos de origem marinha têm recebido atenção 
crescente já que são considerados uma fonte barata e praticamente inesgotável de material, e também 
pelas suas características e composição. 
Nesta tese de doutoramento foi investigado o potencial da carragenina, um polissacárido sulfatado 
extraído das algas vermelhas, como hidrogel alternativo para regeneração de cartilagem. As 
carrageninas possuem aributos apelativos para o encapsulamento/libertação de células, dada a sua 
composição química e processo de gelificação. 
Assim, os principais objetivos desta tese foram: 
- desenvolver e caracterizar diferentes misturas de carragenina com alginato, processadas de 
diferentes formas; 
- estudar a diferenciação condrogénica de células estaminais encapsuladas/cultivadas em hidrogéis de 
κ-carragenina; 
- avaliar a viabilidade, proliferação e potencial condrogénico de diferentes tipos celulares encpasuladas  
em hidrogéis de κ-carragenina; 
- analisar o efeito de métodos de criopreservação na viabilidade e capacidade de diferenciação 
condrogénica de células estaminais encapsuladas em hidrogéis de κ-carragenina; 
- investigar a biocompatibilidade in vitro e in vivo de hidrogéis de κ-carragenina. 
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Na primeira parte desta tese, foram consideradas diferentes formulações de hidrogéis de alginato e 
carragenina, bem como diferentes parâmetros de processamento de forma a determinar as condições 
ótimas para obter a resposta mais adequada em termos de estabilidade mecânica, viabilidade celular 
e funcionalidade dos sistemas desenvolvidos. 
A morfologia, tamanho e estrutura dos hidrogéis, a sua degradação e propriedades mecânicas foram 
avaliadas, bem como a sua citotoxicidade e capacidade de mantera viabilidade de durante o 
encapsulamento de condrócitos. Os resultados obtidos indicaram que diferentes formulações, quer sob 
a forma de esferas quer sob a forma de fibras, possuem um potencial considerável como sistemas de 
encapsulamento/libertação de células em aplicações de engenharia de tecidos/medicina regenerativa. 
Os resultados obtidos revelaram que a κapa-carragenina é mais adequada para a aplicação proposta 
do que a ιota-carragenina. 
Consequentemente, os estudos posteriores foram planeados para avaliar a capacidade dos hidrogéis 
de κ-carragenina de suportar a diferenciação condrogénica de células estaminais humanas derivadas 
de tecido adiposo (hASCs). Para além disso, o potencial condrogénico de hASCs encapsuladas em κ-
carragenina foi comparado com o de hidrogéis semeados com outros tipos celulares, nomeadamente 
condrócitos (nasais) primários humanos (hNCs) e uma linha celular condrocítica (ATDC5). O 
comportamento celular in vitro das células encapsuladas foi investigado após diferentes períodos de 
cultura,  através de testes mecânicos, ensaios bioquímicos, citohistologia e RT-PCR. 
Os resultados destes ensaios indicaram que os hidrogéis de κ-carragenina mantêm a viabilidade, 
proliferação e diferenciação condrogénica das hASCs. Interessantemente, a análise mecânica mostrou 
um aumento das propriedades mecânicas dos géis de κ-carragenina contendo hASCs encapsuladas, 
ao longo do tempo de cultura com meio condrogénico, quando comparados com os géis sem células 
ou géis com células mas em meio basal. 
Os resultados demonstraram igualmente que os três tipos celulares encapsulados em hidrogéis de κ-
carragenina mantiveram boa viabilidade celular e proliferação até aos 21 dias de cultura, e os géis 
semeados com as células expressaram positivamente marcadores específicos de cartilagem. 
No entanto, os resultados mostraram que as hASCs encapsuladas na κ-carragenina proliferaram mais 
rapidamente e exibiram níveis de expressão de marcadores típicos de cartilagem mais elevadoss do 
que os observados em hNCs e ATDC5. Com base nestes dados foi possível concluir que o hidrogel de 
κ-carragenina providencia um bom suporte para a cultura e diferenciação de células nele 
encapsuladas, e que as hASCs podem ser uma alternativa vantajosa aos condrócitos primários usados 
atualmente em tratamentos clínicos de defeitos/patologias da cartilagem. 
 xiii 
 
Antecipa-se que estes hidrogéis possam ser utilizados em estratégias de regeneração de cartilagem, 
providenciando habitat temporário para as células encapsuladas, aseegurando a sua viabilidade, 
proliferação e produção de matriz extracelular, que deverá substituir o hidrogel, intensificando a 
regeneração do tecido nativo em situações clínicas. Apesar das vantagens, é necessario um certo 
tempo para obter um substituto funcional da cartilagem com este tipo de abordagens de engenharia 
de tecidos, há uma clara necessidadede produtos "off-the-shelf", que possam ser imediatamente 
disponibilizados e adaptados a uma solução autóloga para o paciente. Isto pode ser evantualmente 
conseguido recorrendo a métodos baseados na criopreservação. Por este motivo, as experiências 
seguintes foram planeadas para examinar os efeitos da criopreservação na diferenciação condrogénica 
característica das hASCs encapsuladas em κ-carragenina. Os resultados obtidos mostraram que o 
hidrogel suporta a criopreservação com dimetilsulfóxido (DMSO) mantendo a sua integridade estrutural 
e a capacidade de manter a proliferação e diferenciações celulares. O último estádio do trabalho 
desenvolvido envolveu estudos in vitro e in vivo de biocompatibilidade dos hidrogéis de κ-carragenina. 
A citotoxicidade dos hidrogéis foi avaliada por ensaios standards utilizando uma linha celular (L929) e 
por ensaios de quimoluminescência com células polimorfonucleadas humanas. O estudo in vivo 
envolveu a implantação subcutânea de discos de κ-carragenina em ratos Wistar durante 15 dias. Os 
resultados obtidos demosntraram que os hidrogéis de κ-carragenina induziram uma resposta 
insignificante na detecção de aniões superóxido e hidroxil, bem como resposta inflamatória mínima 
podendo ser estudados para aplicações biomédicas. 
Um estudo preliminar recente, in vivo revelou que a κ-carragenina semeada com células pré-
diferenciadas em meio condrogénico apresenta maior estabilidade in vivo (modelo de implante 
subcutâneo em rato), comparando com géis previamente cultivados com meio basal ou géis sem 
células. Este facto deve-se muito provavelmente ao aumento de deposição de matriz extracelular que 
pode resultar no aumento das propriedades mecânicas, em concordância com os resultados obtidos in 
vitro. 
Resumindo, o trabalho desenvolvido e apresentado nesta tese, permitiu concluir que os hidrogéis de κ-
carragenina encapsulados com células humanas derivadas do tecido adiposo, revelam grande 
potencial para serem adaptados a aplicações específicas de terapias de  regeneração de cartilagem. 
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Chapter I* 
Polysaccharide-based hydrogels used for the regeneration of articular cartilage 
 
 
ABSTRACT 
This manuscript provides an overview of the in vitro and in vivo studies reported in literature focusing 
on seaweed polysaccharides based hydrogels that have been proposed for applications in regenerative 
medicine, particularly, in the field of cartilage tissue engineering. For a better understanding of the 
main requisites for these specific applications, the main aspects of the native cartilage structure, as 
well as recognized diseases that affect this tissue are briefly described. Current available treatments 
are also presented to emphasize the need for alternative techniques. The following part of this review is 
centered on the description of the general characteristics of algae polysaccharides, as well as relevant 
properties required for designing hydrogels for cartilage tissue engineering purposes. An in - depth 
overview of the most well known seaweed polysaccharide, namely agarose, alginate, carrageenan and 
ulvan biopolymeric gels, that have been proposed for engineering cartilage is also provided. Finally, this 
review describes and summarizes the translational aspect for the clinical application of alternative 
systems emphasizing the importance of cryopreservation and the commercial products currently 
available for cartilage treatment.  
 
 
 
 
 
 
Keywords: Polysaccharide, hydrogels, cartilage regeneration, in vitro - in vivo application, clinical and 
commercial products. 
 
 
 
* This chapter is based on the following publication: 
Popa EG, Reis RL and Gomes ME, Polysaccharides-based hydrogels used for the regeneration of 
articular cartilage, Submitted (2013) 
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I.1. INTRODUCTION  
Biological structures can be defined as open dynamic systems which interact and respond accordingly 
to changes of the environment. Therefore, to obtain a specific response from a target biological 
structure, it is necessary to create appropriate environments. A lot of work is being done to unravel the 
puzzle around structural and biochemical functions of the natural extracellular milieu that directs cell 
fate. Understanding the mechanisms of cell function, the typical response to generate matrix 
development and tissue growth, is critical for further advances in regenerating any damaged biological 
part. A great deal of research has been carried out developing biological constructs that support cell 
proliferation based on specific interactions between the biomaterial interface domains and the cell 
receptors to mimic the physiological environment. The natural extracellular matrix (ECM) is a hydrogel-
like structure itself, comprised of several different biopolymers, encompassing a wide range of 
biological, chemical, and mechanical properties [1]. Generally hydrogels are used for cells growth and 
delivery, although being expected to behave like more than simple carriers with the goal of developing 
de novo tissues and ultimately regenerating and integrating the functional engineered tissue equivalent 
within the body. In the last few years, a vast range of different hydrogels that mimic more closely the 
native ECM have been proposed for regeneration strategies, produced by different methodologies and 
materials, with varying properties and composition. These hydrogels create a microenvironment for the 
cells to survive, multiply and produce ECM to form tissue substitutes. The knowledge obtained to this 
date, indicates that there is not a single ideal hydrogel available that can meet the requirements for all 
possible applications and thus, one must select a specific matrix with unique properties akin to target 
regenerative purposes. The use of polysaccharides as supportive systems for tissue formation reveals 
an increasing tendency in the biomedical field [2]. Among all the naturally derived polymers, the 
carbohydrate based polysaccharides, composed of sugar-ring building blocks, are emerging as a front 
runner in cartilage tissue engineering (TE) applications [3]. The polysaccharides of marine algae origin, 
especially the ones of seaweed source, such as alginate, agarose and recently κ-carrageenan or ulvan, 
which will be presented in this review, play important roles in biomedical applications aimed at 
maintaining the structure of the extracellular matrix, contributing with specific properties. Hydrogels 
based on polysaccharides are certainly the most studied structure type of biomaterials to heal and 
regenerate damaged cartilage, mostly because they resemble the dynamic ECM that constitutes this 
tissue [4]. In cartilage tissue, the cells are anchored into a matrix network which a hydrogel design 
intends to mimic. Thus, once embedded in hydrogels the cells renew and specialize due to spatial 
organization maintaining the round shape that characterizes specific cartilage cells phenotype. 
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Therefore, hydrogels that are morphologically similar to the native ECM,  are commonly used as 
encapsulation systems [5], enabling the maintenance of chondrocyte phenotype similarly to the native  
tissue [6]. 
This review addresses the recent developments on the use of the above mentioned marine origin 
materials in studies envisioning the treatment and repair of cartilage defects. Several aspects are 
covered, namely the polysaccharide main characteristics/properties, in vitro and in vivo research and 
clinical/biomedical applications, with emphasis in cartilage TE (Figure 1). 
 
 
Figure  I- 1. Schematic diagram showing multidisciplinary approach of cartilage tissue engineering (BM-
bone marrow; AT-adipose tissue; MSCs-mesenchymal stem cells). 
 
I.2. CARTILAGE TISSUE 
I.2.1. Native cartilage tissue Structure and function 
In order to design adequate therapies for the regeneration of damaged cartilage tissue it is essential to 
know and understand its structure, function, properties, so as to mimic as closely as possible cartilage 
native environment. Articular cartilage, found in joints, consists of a thin viscoelastic layer, usually less 
than 3 mm thick, which provides a smooth, near frictionless articulating surface [7]. Homeostasis of 
articular cartilage and the functions of chondrocytes depend on mechanical joint loading generated 
during daily activities [8, 9]. Cartilage tissue, is a stiff, dense and inflexible connective tissue without 
blood vessels, aneural and with few cells [10]. Chondrocytes represent only 1–5% of the articular 
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cartilage volume and also participate in the formation and maintenance of the ECM typically composed 
of collagens (collagen type II), large negatively charged hydrophilic proteoglycans (aggrecan), 
glycosaminoglycans (chondroitin sulfate, keratin sulfate) and smaller glycoproteins [11]. Their specific 
characteristics include no cell-to-cell contacts, spherical shape, high individual metabolic activity and 
ability to synthesize type II collagen. Furthermore the cells in articular cartilage receive nutrition through 
a double diffusion barrier, survive on low oxygen concentration and hence depend on anaerobic 
metabolism [12]. Details about composition with the corresponding ultra-structure can be found in 
Figure 2. Compared to other connective tissues, when cartilage is damaged the functional and 
metabolic properties of the original hyaline tissue will not be easily restored [13, 14]. In fact, 
considering the low cellularity and proliferative capacity of chondrocytes and due to specific 
characteristics such as being bound in lacunae with low migrating abilities to damaged areas [15] 
cartilage tissue underlies an intrinsic inability to repair. Given the limited spontaneous repair caused by 
the lack of vascularization preventing the onset of an inflammatory response following tissue injury, 
immediate and practical repair solutions are needed.  
 
 
Figure  I- 2. Schematic representation showing the structured organization of native cartilage tissue,  as 
well as specific features of its main constituents, adapted [19]. 
 
I.2.2. Cartilage Pathologies  
Damage of cartilage can be traumatic or degenerative and emerge as a result of a wide range of 
injuries or as an effect of another treated injury, having great impact on the quality of life of thousands 
of people. Factors such as obesity, alcohol abuse, and diabetes as well as mechanical factors like 
instability, trauma, and joint misalignment are causes for articular cartilage diseases [16]. 
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Osteoarthritis and rheumatoid arthritis are examples of chronic conditions of cartilage damage. Defects 
can be associated to partial and full thickness extension to the underlying bone and, based on the 
macroscopic changes of the articular cartilage, are categorized in grade I, II, III and IV [17]. The 
increasing frequency of degenerative joint diseases caused by continuous aging and overweighted 
population and, due to high incidence of sports injuries, support the growing demands for the 
development of functional cartilage substitutes. More detail information on cartilage structure, diseases 
and treatment can be found elsewhere [18, 19]. 
 
I.2.3. Current repair strategies  
Current strategies in the clinical field of cartilage repair progressed to what might be called the 3 ―R‖ 
paradigm: reconstruction, repair, and replacement [20]. Cartilage regeneration strategies have evolved 
from marrow stimulation–based techniques to osteochondral transplantation and to cell-based repair 
techniques. Microfracture, the most common bone marrow-based technique, demonstrated positive 
short-term results. Nevertheless, after ∼2 years, low integration and poor mechanical properties were 
evidenced [21]. Other available repair techniques that follow, based on autogenic (mosaicplasty) and 
allogenic tissue transplantation principles, showed excellent results for the first 5 years, but significant 
loss of viability upon 15 years [22, 23]. The therapeutic approach consisting in the autologous 
chondrocyte implantation (ACI), which include biologic replacement using a chondral biopsy taken from 
a donor site and cultured in vitro for a determined period of time, has been successful up to 10 years 
now [24, 25]. There are four generations of ACI therapies and all ultimately intend to preserve the 
chondrogenic phenotype, maintain cellular viability and function; the 3rd generation of ACI - matrix-
induced autologous chondrocyte implantation (MACI) uses 3-dimensional (3-D) supports to achieve 
such requirements. MACI should secure the cells in the defect area, offer a more homogeneous 
chondrocyte distribution and minimize graft hypertrophy [26]. Critical issues that concern the above 
cartilage repair strategies consist of the donor tissue variability as well as the possible chondrocytes 
dedifferentiation. Alternative cell sources have been investigated, particularly allogenic adult 
mesenchymal stem cells (MSCs) [27]. A summary description of these cartilage repair techniques is 
detailed in Table I. Although these approaches offer good opportunities for the regeneration of cartilage 
defects, all current treatment options inflict some degree of tissue destruction before any therapeutic 
effect can be achieved. Consequently,  the current available treatments based on ―damage to heal 
approaches‖ [28], have limitations, which might be overcome through emerging TE strategies.  
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Table I- 1. Summary of clinical strategies for articular cartilage replacement, based on [24, 32].  
Arthroscopic techniques Cartilage 
replacement 
techniques 
Cell based therapies 
Non 
reparative 
procedures 
Reparative 
procedures – bone 
marrow stimulation  
Autologous chondrocyte 
implantation (ACI) 
Tissue 
engineering 
debridement Pridie drilling 
mosaicplasty 
First generation 
two stage procedure 
Chondrocytes/
MSCs 
chondral 
shaving 
microfracture 
technique 
Second generation 
collagen matrix 
scaffolds or 
hydrogels 
knee joint 
lavage 
 
abrasion 
chondroplasty 
osteochondra
l/chondral 
allografts 
Third generation 
MACI GF/ 
cytokines Fourth generation  
MSCs 
MACI - Matrix-induced autologous chondrocyte implantation, MSCs - mesenchymal stem cells, GF - growth factors.  
 
I.3. CARTILAGE TISSUE ENGINEERING 
As suggested above, the development of biological tissue substitutes through TE, may provide 
advantages over the current repair procedures enabling alternative therapies and hope for cartilage 
defects regeneration (Figure 1). These potential advantages include the formation of a more reliable 
hyaline cartilage tissue, through the delivery of appropriate cell types embedded in a suitable hydrogel 
[29] promoting enhanced integration with surrounding tissues [30]. However, to achieve further 
improvements, minimally invasive procedures and innovative cell carrier concepts should be refined 
[31].  
Furthermore, there is a lot of debate over which is the most suitable cell source to be used in cartilage 
cell-based therapies. Ideally, a cell source should be easily available, enable an excellent yield number, 
high proliferation capacity, stable phenotype/genotype, no issues of immunogenicity or disease 
transmission risks, and no donor site morbidity. For cartilage TE, most of the published studies refer to 
the use of primary autologous chondrocytes [32, 33] and adult stem cells [34, 35]. Although 
chondrocytes are an obvious choice as a source of cells for cartilage TE, a number of disadvantages 
[36, 37]  have led to intense interest in alternate cell types that can differentiate into the chondrogenic 
lineage. Bone marrow-derived stem cells (BMSCs) [38] and adipose tissue-derived cells (ASCs) [39, 40] 
are frequently considered top candidates for cartilage TE, due to their ability to create functional 
cartilaginous tissues. Some advantages and disadvantages of the two stem cell sources may be clearly 
identified in terms of collection procedures, cell number and proliferation capacity (Table II). Some 
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studies described a higher chondrogenic potential of BMSCs when compared to ASCs [41] likely due to 
their role in bone formation, including endochondral ossification.  
Another important issue is to determine the optimal number of cells (chondrocytes or stem cells) for a 
successful in vivo application. Although this is still under consideration, several studies suggest that 
higher cellular content induces better tissue repair [42-44]. Commercially available sources of 
chondrocyte suspensions recommend a dose between 0.5 and 2.0 × 106/cm2  and similar cell values (2 
to 3 × 106 for a 4- cm2 collagen membrane) have been used in the clinical practice [45]. Moreover, the 
chondrocytes density in native cartilage tissue is around 1.4 ×107 cells/cm3, i.e., about 5-10 %  of the 
cartilage volume, but such cell density is difficult to replicate in vitro due to slow growth rates that differ 
depending on the cell type [46]. The process of chondrogenesis is regulated by a number of growth 
factors including the members of transforming growth factor beta family (TGF-β, BMPs- bone 
morphogenetic proteins) [47]. The in vitro experiments have confirmed that growth factors 
supplementation enhance the production of cartilage in tissue-engineered constructs [48, 49]. Clearly 
chondrogenesis is a complex process which involves not only biological growth factors, but also a 
carefully controlled time dependency [50, 51]. Furthermore, this process can be dramatically 
influenced by the 2D and 3D (two and three dimensional) environment in which cells are delivered 
/cultured. The fact that hydrogels provide 3D cellular microenvironments that can be tailored to stand 
physical, chemical and biological signals, has encouraged the development of engineered functional 
tissue equivalents based on such systems.  
Several natural origin hydrogels sources including proteins (collagen, elastin, silk fibroin, fibrin), 
polysaccharides (chitosan, chondroitin sulphate, hyaluronic acid) and seaweed source (alginate, 
agarose, carrageenan, ulvan) have been extensively studied for cartilage repair [52]. According to data 
collected from the literature, the reasons for using seaweed polysaccharides in regeneration 
applications lie in their intrinsic features, such as chemical similarity with native tissue components, 
non-harsh processing, variable degrees of hydrophilicity and biocompatibility [53]. Natural materials 
obtained from algae are often preferred for biological applications since they are believed to elicit low 
immune response when choosing a potential biological application [54]. Most of them offer advantages 
concerning biocompatibility, which is of extreme importance for the integration with the surrounding 
tissues. Moreover, they are readily available, inexpensive and easy to fabricate into hydrogels, making 
them appealing choices for designing hydrogels to be used in different biomedical application [3]. In 
addition, the hydrogel structure protects the entrapped cells against the immune system of the host, 
simultaneously allowing the unhindered passage of nutrients, oxygen and secreted therapeutic factors 
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or proteins [55]. The hydrogels design can vary from injectable systems to solid structure like discs, 
fibers, cylinder, and capsules ranging from micro to macro dimensions. 
 
Table I- 2. List of supporting and opposing arguments in applying stem cells versus somatic, 
precommitted cells for cartilage tissue engineering.  
BMSCs – bone marrow mesenchymal stem cells; ASCs – adipose derived stem cells, Growth factors- GF; transforming 
growth factor β - (TGF-β); Bone Morphogenetic Proteins - (BMPs) 
 
 
CELL SOURCE 
PRIMARY CULTURE STEM CELL REF. 
CHONDROCYTES BONE MARROW (BMSCS) ADIPOSE TISSUE (ASCS)  
Collection 
procedures   
Cartilage biopsy Marrow aspirate Liposuction or 
reconstructive surgery 
[45] 
Isolation site 
influence 
donor site 
morbidity & 
contamination or 
potential infection 
more invasive, painful 
and not frequently result 
of another intervention 
performed in parallel 
with another surgery, 
safe and easy to obtain  
 
Cell yield 
(number) 
limited limited numbers, quickly 
amplified in monolayer 
high 400000 stem 
cells/ml adipose tissue 
[60] 
 
Mitotic 
potential 
slow medium high  
Self renewal 
capacity 
low limited high  
Plasticity tendency to 
dedifferentiation 
dedifferentiation is not 
an issue 
dedifferentiation is not 
an issue 
[61] 
Isolated tissue 
origin  
provoke immune 
rejection 
supportive cells for 
haematopoiesis, exists 1 
out of every 105 cells 
 not an issue  
Additional 
procedures 
no need of GF or 
can use GF to not 
dedifferentiate 
(TGF-β3) 
TGF-β1, TGF-β3, BMPs TGF-β1, TGF-β3, BMPs 
 
 
[62] 
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I.4. ALGAE POLYSACCHARIDES – DETAILED CHARACTERISTICS 
Some algae polysaccharide based hydrogels, namely alginate and agarose have already been 
extensively studied for TE applications, but others such as carrageenan and ulvan are just starting to be 
investigated. Even though hardly applied in the field of cartilage repair, these algae polysaccharide have 
recently registered an increased attention in the biomedical research field. Such consideration is owed 
to the intriguing feature of the amounts of sulphate found in their structure, whose beneficial biological 
properties prompt scientists to focus on their use in the biomedical fields [56]. Certainly the presence 
of sulphate groups in their structure/composition and the chemical affinity with mammalian 
glycosaminoglycans (GAGs) due to the similar chemical content play important roles in the antiviral, 
anticoagulant, antioxidant and anticancer activity of these polysaccharides [57]. 
The carrageenans are temperature dependent materials since they are soluble in water above 60 °C 
and gel upon cooling to temperatures between 30 and 40 °C being designated as a physical hydrogels. 
The gelation of carrageenan is induced by the reversible temperature sensitive formation of 
intermolecular hydrogen bonds and involves a coil to helix conformational transition followed by helix 
aggregation [58]. The thermoresponsive solubility behavior and the gelation promoted by monovalent 
cations such as potassium ions open perspectives to develop systems that gel at body temperature 
[59]. They are characterized as high molecular weight polysaccharides with high sulfate-ester content, 
meaning higher level of solubility and lower gel strength [60]. Ionically cross-linked hydrogels, such as 
carrageenan, normally undergo slow dissolution that can be shifted through chemical modification and 
the stiffness can be altered as well, allowing tuning of the mechanical properties [61]. Ulvan structure 
shows great complexity and variability as evidenced by the numerous oligosaccharide repeating 
structural units identified [62]. The main constituents of ulvan are sulfated rhamnose residues linked to 
uronic acids, resulting in a repeated disaccharide unit β-D-glucuronosyl-(1,4)-α-L-rhamnose 3-sulfate, 
called aldobiouronic acid [63]. In aqueous solution, ulvan tend to form microaggregates due to the 
polymeric material not fully dispersed indicating limit number of functional groups available for 
chemical modifications thus, hampering its potential versatility [64]. 
The overview on the friendly gelation mechanism induced by temperature or ions clearly demonstrates 
the relevance of the use of such biopolymers in the field of TE. In particular sulphated polysaccharides 
(carrageenan and ulvan) present a real potential for delivering products for therapeutic applications 
providing a valid alternative to mammalian glycosaminoglycans. More details regarding seaweed type, 
gelation or degradation mechanism and the interactions of alginate, agarose, carrageenan and ulvan 
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with cells are summarized in Table III. For complete description of chemical structure, gelation process 
or other characteristics of algae polysaccharide consider consulting existing publications [56, 65, 66].  
Table I- 3. Important properties of algae polysaccharide (modified from [6, 75]). 
POLYSACCHARIDE SEAWEED 
TYPE 
GELATION  
 
DEGRADATION CELL 
INTERACTION 
REF. 
Alginate 
Brown 
Seaweed 
Ionic (Ca2+) 
Ion exchange; 
others 
Low [76] 
Agarose 
Red 
Seaweed 
Thermal 
 
Non-degradable Low [77] 
Carrageenan 
Red 
Seaweed 
Thermal & Ionic 
(Ca2+ /K+) 
Ion exchange 
 
Low 
[78] 
Ulvan 
Green 
Seaweed 
Ionic (boric acid 
and divalent 
cations) 
Enzymatic 
degradation 
n.d. [79] 
n.d. – not determined 
 
However, not every characteristic comes only as an advantage. Table IV summarizes pros and cons 
features reported for the polysaccharide hydrogels. For example, the lack of manufacture 
reproducibility on a large scale, batch-to-batch variability and also the presence of impurities in the final 
processed material due to the extraction process, constitute major concerns [67]. Recent data suggests 
that contaminants during extraction processing are likely to cause an immune response but this issue 
is still being disputed, although such molecules can be removed by purification methods [68, 69]. 
These are time- and money-consuming processes and introduce variation in the biological response. 
This factor is far more important than holding mechanical properties and expecting that the synthesized 
cartilaginous tissue growth acts as reinforcement [70].  
Other associated common weakness of the seaweed based hydrogels are related to inadequate 
mechanical properties, which is a common trend [71]. Nonetheless, it is expected that a hydrogel 
structure will partially tolerate shock absorption and deformation, mimicking articular cartilage 
characteristics. Enhanced mechanical properties can be achieved by adjusting various parameters, 
including the concentration, the crosslinking density and the possibility of mixing such hydrogels with 
composite. In addition, introducing photo-crosslinkable parts, appropriate to the chemical structure of 
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the hydrogels, can modify the stiffness of the structure but simultaneously compromise the viability of 
the cells [72].  
In terms of cellular response, these natural algae polysaccharide have been investigated as potential 
delivery matrices based on encapsulation techniques, for cell transplantation [73]. Their gelatinous 
consistency enables ‗‗anchorage independent‘‘ 3D cell immobilization, namely in situ hydrogel 
formation, which facilitates subsequent cell differentiation [74]. Like in many hydrogels, there is no 
integrin interaction between cells and the hydrogels matrix, therefore, cells retain their rounded shape, 
likely to enhance chondrogenesis [75]. On the other hand, long-term integrin binding can lead to 
dedifferentiation and formation of fibrocartilage [75]. Furthermore, hydrogels being hydrophilic and 
binding to water provide few sites for the cells to attach, directly affecting cell viability and proliferation. 
 
Table I- 4. Main advantages and disadvantages of carbohydrate polysaccharide hydrogels from algae 
origin. 
POLYMER NAME ADVANTAGES DISADVANTAGES REF. 
Alginate  Low toxicity 
 Cheap 
 Easy to gel  
 Degrades through ionic 
exchange with surrounding 
media  
 Minimal cellular 
interaction 
 Protein not easily 
absorbed 
[160, 
161] 
Agarose  Easy to control pore 
sizes 
 Easy to gel 
 Larger pores ideal for 
cellular growth introduce 
structural instability 
 Low mechanical 
properties 
[162, 
163] 
Carrageenan  Thermally reversible  
 Cheap 
 Easy to gel & 
manipulate 
 Display close 
similarity with mammalian 
glycosaminoglycans 
 Degrades through ionic 
exchange with surrounding 
media 
 Influenced by 
temperature, pH and cations 
concentration 
[164-
166] 
 
Ulvan  Abundant and cheap 
source 
 Great chemical 
functionalities  
 Display close 
similarity with mammalian 
glycosaminoglycans 
 Contain proteins which 
need specific purification 
protocols 
 Formation o 
microaggregates when dissolved 
in water 
 
[64] 
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I.5. IN VITRO APPLICATIONS OF HYDROGELS BASED ON ALGAE POLYSACCHARIDE 
Considering all the above mentioned polysaccharide hydrogels characteristics, this section will review 
some of the most extensively studied algae polysaccharide-based hydrogels, such as alginate and 
agarose and some new candidates, like carrageenan and ulvan, for the culture and differentiation of 
stem cells and chondrocytes. In what follows, it will be provided an overview of different approaches 
and parameters including hydrogel concentration, different cell source and cell number, as well as the 
stimulation with various growth factors, envisioning application in cartilage regeneration. Table V 
summarizes the most recent studies concerning cartilage TE applications using algae polysaccharide 
hydrogels.  
 
I.5.1.  Alginate 
Alginate continues to be the most widely used hydrogel for in vitro studies due to its easy production, 
effectiveness and low cost (Tables III and IV). Applications of alginate in the cartilage TE field revealed 
that after an initial cell loss, chondrocyte maintained their typical chondrocyte phenotype [76]. To 
maintain the chondrocytic phenotype and the synthesis of ECM proteins, alginate has been used in 
vitro as a matrix for the three-dimensional culture of human articular chondrocytes from elderly patients 
[77]. Similar performance was reported in another study where human articular chondrocytes, 
embedded in alginate beads, showed enhanced collagen type II and aggrecan expression [78, 79]. 
Moreover, the 3D alginate culture system was proven to be efficient in keeping high viability, 
chondrogenic phenotype and promoting the redifferentiation of articular chondrocytes [80, 81]. A 
different work show that chondrocytes encapsulated in alginate maintain their viability and function due 
to the addition of microchannels to the polymeric hydrogels [82]. In another study, the supportive 
alginate-based hydrogels provided an environment and ways to deliver chondrocytes and compared 
with monolayer culture, stimulated the deposition of sulphated glycosaminoglycans (sGAG) and 
collagen type II, although without promoting redifferentiation [83]. Furthermore, alginate hydrogels have 
been used to expand and induce stem cell differentiation [84]. Human MSCs encapsulated in alginate 
beads undergo chondrogenesis, demonstrated by the cells assuming a rounded morphology with 
lacunae. Hyaline cartilage-like tissue was developed, showing to be positive for Safranin-O staining and 
immunohistochemistry of typical chondrogenic markers, namely COL2A1 and COL10A1 [85]. Human 
MSCs showed a time-dependent accumulation of sGAG, aggrecan and type II collagen in this type of 
hydrogel [86]. In other study, bone marrow-derived stem cells (BMSCs) encapsulated in alginate 
evidenced enhanced cartilaginous matrix accumulation over agarose [87]. Alginate demonstrated to 
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improve the stability of the system, supporting sGAG and collagen II production as well as chondrogenic 
gene expression, when human BMSCs were entrapped in a blend that included fibrin in addition to 
alginate [88]. Induction of chondrogenesis of stem cells isolated from adipose tissue in alginate 
hydrogels has also been achieved. After 2 weeks of in vitro culture the adipose-derived stem cells 
produced cartilage matrix proteins which show dependency of physical environment and culture 
conditions [89]. To overcome weaknesses like low mechanical and uncontrollable degradation 
properties, ionically cross-linked alginate hydrogels have been modiﬁed, with no toxic effects on the 
encapsulated MSCs, supporting chondrogenic differentiation [90]. Recently, investigators have 
produced hybrid constructs mixing alginate with other materials or tailored alginate with synthetic 
adhesion peptides as ways of improving its properties [91-93].  
 
I.5.2. Agarose  
Agarose has also been widely investigated in cartilage TE strategies (Table V). For example, 
encapsulation within agarose hydrogels has shown to support rabbit articular chondrocytes 
redifferentiation [94]. Articular chondrocytes seeded on agarose hydrogels demonstrated enhanced 
chondrogenic matrix elaboration when applied under physiological deformational loading, accelerating 
the formation of a cartilage-like tissue [95]. Compressive mechanical forces are transmitted to the 
embedded chondrocytes which respond by producing extracellular matrix proteins leading to increased 
stiffness of the newly developed engineered tissue [96]. The culture of murine chondrocytes embedded 
within agarose hydrogels has shown to maintain the chondrocytic phenotype, allowing matrix deposition 
around chondrocytes and showing that chondrocytes sense and respond to mechanical forces [97]. 
The concept of developing functional TE systems centered on the use of bioreactor enabling 
physiologic-like loading, has also reported successful results with immature bovine primary 
chondrocytes but did not produce the same outcome when using adult canine primary chondrocytes 
[98]. Moreover, studies suggest that the age of the cells plays an important role, showing that 
unpassaged cells can elaborate inferior matrix as compared to passaged mature chondrocytes. The 
continuous supplementation of TGF-β3 in combination with mechanically loading prior to implantation 
also seems to result in an improved engineered tissue substitute [99]. Agarose hydrogels have also 
been investigated in combination with mesenchymal stem cells, including human adipose-derived stem 
cells and bovine mesenchymal stem cells, for a variety of applications, including cartilage repair, as 
shown in Table V. Agarose hydrogels are noted for their ability to promote and maintain the 
chondrogenic phenotype of bone marrow stem cells (BMSCs), with deposition of cartilage-specific 
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biomacromolecules [100]. Another work showed that the chondrogenesis of the stem cells was directly 
correlated with the number of cells used, meaning that higher cell density led to enhanced expression 
of cartilage-specific gene [101]. It has also been reported that BMSCs produced an ECM with lower 
mechanical properties than that produced by differentiated articular chondrocytes embedded in 
agarose hydrogel [102, 103]. Findings reported in other publications such as the induction of 
chondrogenesis in hMSC-seeded agarose constructs without TGF-β suggest that, application of 
hydrostatic pressure may initiate chondrogenesis faster than lower pressure [104]. Although, the 
exclusion of TGF-β3 from culture conditions has been reported to have significant effect on the 
mechanical properties and also on the biochemical content, the functionality of cartilaginous tissues 
using MSCs from joint infrapatellar fat pad, encapsulated in agarose hydrogels, has resulted in robust 
chondrogenesis, as shown by another study [105].  
 
I.5.3. Carrageenan 
Carrageenan hydrogels have been mostly used as drug or growth factor delivery systems [106-108], 
immobilization of enzymes [109] and in pharmaceutical formulations [110]. However, the 
characteristics and specific properties of these natural derived hydrogels, concerning their potential for 
cartilage regeneration are poorly exploited in the literature [111]. Upon adding cations, the carrageenan 
solution rapidly forms a gel and can be used as in situ cell matrix delivery material, due to its mild 
cross-linking properties [112] which makes it extremely interesting to be applied in the biomedical field 
[113]. Nevertheless, carrageenan has been used for the encapsulation of human-adipose-derived stem 
cells (hASCs), human nasal chondrocytes (hNCs), and a chondrocytic cell line (ATDC5) showing 
potential for cartilage regeneration strategies [114]. The findings from this study showed that hASCs 
embedded in κ-carrageenan hydrogels exhibited higher expression of typical cartilage markers 
(collagen type II and aggrecan) than chondrocytes providing further evidence for the advantageous use 
of hASCs as an alternative cell source in cartilage treatments (Table V). In a subsequent study, hASCs 
encapsulated in κ-carrageenan hydrogel and cultured with medium supplemented with chondrogenic 
growth factors appeared to increase the stiffness and the viscoelastic properties of the hydrogel 
construct providing a versatile platform for cartilage TE  [115].  
 
I.5.4. Ulvan 
Ulvans are the major constituents of green seaweeds cell walls (Ulvales, Chlorophyta) and are 
composed of rhamnose, glucuronic acid, iduronic acid, xylose and sulphate [65]. These green algae 
 
____________________________________Chapter I. Polysaccharide based carrageenan hydrogels__ 
 
55 
 
can be prepared into different structure designs such as membranes [116, 117], particles [118], 
hydrogels [119] and 3D porous structures [117]. Due to the difficulties in identifying the chemical 
structure of algal sulfated polysaccharides, the relation between their structures and biological activities 
is not completely understood [120]. Despite ulvan chemical variability, biological properties have been 
frequently reported like antioxidant effects [121], antitumoral activity [122], immunostimulating ability 
[123]. Antihyperlipidemic activities [124] or antiviral effects [125] have also been studied. Subsequent 
to all of these findings, ulvan polysaccharides are considered to have great potential for biomedical 
applications (Table V). Nevertheless, relevant studies on ulvan are limited and their applicability may 
range from drug delivery [117] to wound dressing or TE [118, 126]. 
 
Table I- 5. A summary of key studies from the current literature describing polymers hydrogels, cell 
types and cell densities used in laboratory cartilage tissue engineering applications 
POLYMER 
CONCENTRATIO
N  
CELL SOURCE SIGNALING 
MOLECULES 
CELL DENSITY 
(cells/mL) 
REF. 
ALGINATE 
1.2 % (w/v) Human  
chondrocytes 
- 2 × 106  [100, 102, 146] 
20 mg/mL; 2 
% (w/v) 
Non human 
chondrocytes 
IGF-1, TGF- β1 25-50 × 106  [146-149] 
 20 mg/mL  Human bone marrow 
MSCs 
TGF-β3 20 × 106  [104, 106] 
2 % ; 1.5 % 
(w/v) 
Non human bone 
marrow MSCs 
TGF- β1 or Dex;  20 × 106;  
1-2 × 106  
[105, 150] 
2 %; 1.2 % 
(w/v) 
Human  adipose tissue 
MSCs 
TGF- β1; 
BMP-6 
10× 106;  5 × 
106  
[151, 152] 
AGAROSE 
2 % or 3 % 
(w/v) 
Non human 
chondrocytes 
 TGF- β3 30 - 60 × 106  [32, 44, 115] 
2 % (w/v) Non human bone 
marrow MSCs & 
TGF- β3 or -   10 - 60 × 106 [115, 118-120, 
153-155] 
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chondrocytes  
2 % (w/v) Human bone marrow 
MSCs 
TGF- β3 3, 6, and 9 × 
106 
[118, 120, 121] 
2 % (w/v) Human adipose tissue 
MSCs   
TGF- β1 10 × 106  [151] 
2 % (w/v) Non human bone 
marrow & adipose 
MSCs 
TGF- β1; TGF- 
β3 
10 - 15 × 106  [156], [46, 118, 
157-159] 
CARRAGEENAN 
0.8 % and 
1.2% 
Human  
chondrocytes 
- 2 × 106  [160] 
1.5 % (w/v) 
2.5 % (w/v) 
Human adipose tissue 
MSCs; Human nasal 
chondrocytes;   
TGF- β1 5 × 106  [161, 162] 
2 % (w/v) ATDC5-chondrocytic 
cell line 
-  1 × 106  [129] 
ULVAN 
5 %; 8 % 
(w/v) 
L929-mouse 
fibroblasts 
- 5 × 105 cells/ 
structure 
[145] 
GF - Growth factor; TGF - Transforming growth factor; BMP-6/ BMP-2 - Bone morphogenetic protein - BMP-6; Dex - 
dexamethasone; IGF-1 - Insulin-line growth factor; ES - embryonic stem; ATDC5 - mouse teratocarcinoma AT805 derived cell 
line  
 
I.6. IN VIVO APPLICATIONS OF HYDROGELS BASED ON ALGAE POLYSACCHARIDE 
It has been noted that even though research carried out in vitro provides high quality outcome, it 
usually serves as a precursor to more complex in vivo methods. As a first step in demonstrating the in 
vivo chondrogenic potential of tissue engineered constructs, investigators have used heterotopic animal 
models, typically consisting on the implantation of the bioengineered cartilage tissue in dorsal 
subcutaneous pouches of immunocompromised nude mice [127]. Although these experiments may 
indicate the biological construct performance under in vivo conditions, different results may be 
observed when the cartilage substitute is implanted into a cartilage defect.  
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I.6.1. Alginate 
Several in vivo studies have been conducted aiming at assessing the potential of alginate as a 
supportive matrix for different relevant cell types, including primary chondrocytes and stem cells from 
different origins, in various animal models. Alginate seems to stimulate chondrogenesis as suggested 
by studies where chondrocytes were seeded and stimulated to produce a cartilage-like matrix, being 
subsequently implanted subcutaneously in nude mice for 8 weeks [128]. The same study suggests that 
the addition of alginate provided retention of the cartilage graft shape without any influence on the 
amount of cartilage matrix proteins produced per tissue wet weigh. The implantation of alginate with 
allogenic rabbit chondrocytes, followed up until 6 months, provided complete in vivo reconstruction of a 
full-thickness articular cartilage defect [129]. After 6 months, the implantation of alginate alone 
developed only fibrous cartilage while the suspension of chondrocytes led to the recovery of a normal 
tissue structure. On the other hand, transplanted chondrocytes in an alginate gel implanted into full-
thickness osteochondral defects in rabbits didn‘t form repaired tissue and cells decreased in number 
with time [130]. The evaluation of chondrogenesis of human adipose tissue-derived stromal cells when 
cultured in alginate hydrogels and implanted subcutaneously in nude mice for up to 20 weeks [131], 
reveled significant production of cartilage matrix proteins, suggesting the beneficial use of alginate 
systems for cartilage regeneration, as they maintain stable cartilaginous phenotype with no sign of 
hypertrophy during 20 weeks. Also, using a rabbit model, full-thickness defects filled with alginate 
beads containing rabbit stromal cells remained viable, showing chondrogenic phenotype embedded in 
a positively stained proteoglycans matrix and occupying the defects within regenerated tissue [132]. 
 
I.6.2. Agarose  
Agarose hydrogels laden with different cells types have been studied to assess their ability to induce the 
in vivo development of cartilage tissue. One of these studies showed that, 18 months after the 
transplantation of allogenic chondrocytes in agarose hydrogels in rabbits, neo cartilage tissue was 
formed, exhibiting higher type II collagen, proteoglycan contents when compared with untreated 
defects. Additionally, control implants of agarose alone produced poor fibrous substitute tissue, 
insufficient healing and incomplete filling of the cartilage defects [133]. In another study, the 
implantation of chondral and osteochondral constructs based on primary or passaged (using growth 
factors) canine chondrocytes encapsulated in agarose showed no gross or histological signs of rejection 
and excellent integration with surrounding cartilage and subchondral bone [134]. However, when 
agarose constructs were seeded with stem cell and subcutaneously implanted in nude mice, they 
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showed significant decrease of sGAG content, while no significant change was observed using primary 
chondrocytes, indicating that the in vitro generated chondrocyte-like phenotype was transient [135].  
 
Table I- 6. A summary of key studies describing polymers hydrogels, cell types, densities and 
implantation time register in experimental animal models for cartilage tissue engineering applications 
POLYMER 
CONCENTRATION 
CELL TYPE FORMULATION 
CELLS DENSITY 
ANIMAL MODEL (DEFECT) FOLLOW UP 
TIME 
REF. 
ALGINATE 
2 % sodium 
alginate; 1.2 %; 
0.75 % 
Chondrocytes  10-50 × 106 
cells/mL 
subcutaneous implantation, 
mice; defect in rabbits;  
8 weeks;  
30 weeks;  
6 months 
[164, 
171] 
2% alginate; 1.2 
% alginate beads 
Chondrocytes 50 × 106 
cells/mL; 
107/ml; 4 × 
106 cells/mL 
subcutaneous implantation, 
sheep/ nude mice; defects 4 
mm diameter 
mini-pigs 
1 week; 
5 weeks; 
6 months;  
 
[172-
174] 
1.2 % ; 
2 % sodium 
alginate  
Bone marrow 
MSCs 
 
1× 106 
cells/defect 
Ø3×6 mm  
defects in rabbits; Ø4×5 mm 
defects in rabbit 
 
3 months 
[167, 
175] 
2.2 %  barium 
alginate; 1.25 % 
sodium alginate 
Human & 
mouse ESCs  
10 × 106 
cells/mL 
SCID and BALB/c nude mice  [176, 
177] 
AGAROSE 
2 % Chondrocytes - rabbit 
 
18 months [168] 
2 %  Chondrocytes 30 × 106 
cells/mL. 
canine knee 12 weeks [169] 
0.6 - 1 % Periosteum - rabbit knee 6 weeks [178] 
0.6 %  Human bone 
marrow/ 
adipose 
tissue MSCs 
10 × 106 
cells/mL 
injection, muscles of athymic 
mice 
5 weeks [179] 
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2 % Bone marrow 
MSCs 
20 × 106 
cells/mL 
subcutaneous implantation, 
nude mice 
28 days [170] 
MSCs – mesenchymal stem cells; Ø – diameter; SCID - albino mouse strain with spontaneous severe combined 
immunodeficiency mutation; BALB/c - albino, immunodeficient inbred mouse strain; ESCs – embryonic stem cells;  
 
I.7. FROM LABORATORY TO CLINICAL APPLICATION 
Although the in vivo trials involving cell laden hydrogels have registered different outcomes, mostly 
depending on the cell type used and cell number, the polymer concentration tested and the size of the 
defect treated, it is clear that overall, the use of hydrogels in cartilage regeneration strategies produces 
positive results.  
Nevertheless, there have been few clinical studies on products applicable to humans, which mean that 
engineering cartilage repair strategies still require improvements before they get into a standard clinical 
application and commercialization. The clinical approach to any cartilage repair technique should be 
customized based on both patient-specific and lesion-specific factors [20]. The engineered graft has to 
fit completely to the damaged area, providing support and biological cues to restore the tissue function. 
A well-designed clinical model to regenerate cartilage should always consider the safety, efficiency and 
simplicity of the developed system, even if it is necessary to compromise the quality of the regenerated 
tissue [13]. Additionally, to translate research-scale production into routine clinical use, biological 
cartilage substitutes will need to demonstrate cost-efficiency ratios that are beneficial over other existing 
treatments and excellent reproducible results in order to perform reliable quality control and 
standardization [136].   
One important development for the translation of TE products into the clinical/industrial scenario would 
be the production of "off the shelf" products, eliminating the waiting time and reducing patient 
incapacity period, relying on the availability of the engineered grafts upon immediate clinical need. This 
could be achieved by common cryopreservation approaches that may assure the tissue substitutes 
functionality ultimately shortening the time of developing engineered constructs set up on cell culture 
procedures [137, 138]. This would be a way to specifically design, generate and scale up, ready-to-use 
engineered tissue substitutes guaranteeing immediate accessibility for clinical applications. However, 
few studies have focused on tissue substitutes banking and storage technologies, addressing the 
impact of such process on hybrid constructs that contain a scaffold/carrier material and cells [137, 
139]. Yet, there are studies that have reported the effect of cryopreservation in cell encapsulating 
systems (hydrogels) [140, 141] using several different cryoprotectants, [142, 143] and vitrification 
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solutions [138, 144], predicting that tissue-engineered products can be cryopreserved without 
prejudice of their functionality.  
It is already possible to find several hydrogels approved or under clinical trials for cartilage treatments 
(see Table VII). The most well-known commercial product based on polysaccharides is a hybrid medical 
grade agarose-alginate hydrogel, Cartipatch® (Company/Responsible - TBF Genie Tissulaire). This 
product was tested for implantation of autologous chondrocytes in chondral and osteochondral human 
defects. After a minimum follow-up of two years, patients with lesions larger than 3 cm2 improved 
significantly more than those with smaller lesions. Also, in 8 out of 13 patients, hyaline cartilage-like 
repaired tissue was predominantly observed  [145]. In a phase III clinical trial alginate gel suspension 
(Company/Responsible - Curis, Inc.) was used injecting chondrocyte harvested from the ear cartilage of 
the patient for the treatment of pediatric patients with vesicoureteral reflux. As seen in Table VII the 
majority of commercial tissue engineering products developed for cartilage regeneration are protein 
collagen-based hydrogels, since they are a component of ECM and due to the presence of bioactive 
domains in its structure regulates important process during chondrogenesis [146]. However, other 
clinical products are being used to promote cartilage repair namely, hyaluronate (hyaluronic acid) or 
synthetic polymers. Although there is an extensive range of products for cartilage treatment, only few of 
them are approved for clinical trials, the rest are still in different phases of clinical use. 
 
Table I- 7. Commercial products in cartilage tissue engineering adapted from [190-192]. 
PRODUCT NAME COMPANY PRODUCT 
COMPOSITION 
REGULATORY 
STATUS 
FORM & USE REF. 
CARTIPATCH Tissue Bank of 
France, Lyon, 
France 
agarose- 
alginate hydrogel & 
autologous 
chondrocytes 
clinical trial 
phase is unclear 
chondral and 
osteochondral 
[189] 
CARTICEL, MACI Genzyme 
Biosurgery, 
Massachusetts, 
USA 
type I /III collagens 
(porcine) & 
autologous 
chondrocytes 
completed 
phase III clinical 
trials; product 
not available  
sheet- articular 
cartilage injury 
[193-
195] 
ATELOCOLLAGEN Koken Co. Ltd, 
Tokyo, Japan 
type I collagen 
 
clinical trial 
phase is unclear 
 [196, 
197] 
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CARES Arthro Kinetics, 
Esslingen, 
Germany 
type I collagen (rat-
tail) & autologous 
chondrocytes 
2007 Germany;  3D discs –
articular 
cartilage injury 
[198] 
NOVOCART 3D TETEC Tissue 
Engineering 
Technologies 
AG, Reutlingen, 
Germany 
collagen- 
chondroitin-sulfate 
based membrane & 
autologous 
chondrocytes 
clinical trial 
phase is unclear 
 [199]  
HYALOGRAFT® C Fidia Advanced 
Biopolymers, 
Abano Terme, 
Italy 
benzylic ester of 
hyaluronic 
acid (roosters) 
& autologous 
chondrocytes 
commercial sale 
began in 2000; 
completed 
phase III clinical 
trials 
3D discs –
articular 
cartilage injury 
[200-
202]  
BIOSEED-C Biotissue 
Technologies, 
Freiburg, 
Germany 
polymer of 
polyglycolic/ 
polylactic acid and 
polydioxanone & 
autologous 
chondrocytes 
First clinical 
trials were in 
2001; 
completed 
phase II clinical 
trials 
3D discs –
articular 
cartilage injury 
[203, 
204] 
Status and descriptions of the clinical trials are available from the web site of U.S. National Institutes of Health, 
http://clinicaltrials.gov/. 
 
I.8. SUMMARY AND FUTURE DIRECTIONS 
Research on polysaccharide-based hydrogels for TE application is continuously improving and there are 
many questions that instigate the attempts to regenerate cartilage. To mimic the structural 
(biochemical and histological characteristics) and functional (compression properties) complexity of 
native cartilage is a challenging objective to accomplish. Thereby, every attempt to achieve this aim 
brings scientists closer in the process of assembling the necessary knowledge to repair damaged 
cartilage tissue.  
The knowledge and research so far supports that natural cell-carrying matrices based on algae 
polysaccharide are suitable for engineering cartilage. Many of these hydrogels are combining well with 
the cells and can be designed as injectable systems, setting in situ and filling any shape and size of the 
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recipient defect. All of these available data needs to be compiled in order to develop clinical relevant 
solutions for cartilage regeneration, considering that the functionality of these hydrogels in the 
laboratory and animal experiments had been established.  
While in vitro the developed tissue engineered constructs show promising results, the potential value for 
in vivo treatment of cartilage defects remains uncertain, as setup parameters of the performed in vitro 
and in vivo studies vary to a great extent. Furthermore, in vitro manipulation of either chondrocytes or 
stem cells used is required in most of the currently available approaches. In fact, culturing the cells 
prior to in vivo implantation allows creating a mature cartilage and the presence of matrix around the 
cells is known to enhance donor cell retention at the repair site [21]. However, the manipulation of the 
cells in vitro increases concerns on how cells may be affected and increases the complexity of the 
treatment, compromising the safety of the procedure and the associated cost. Despite the advantages 
of using polysaccharide hydrogels in cartilage TE, some concerns remain which result mainly from 
insufficient characterization of the cell hydrogel construct or the level of repaired tissue formation and 
from too short follow up periods. Moreover, the cell culturing conditions, cell number, as well as the cell 
origin, leads to varied results and finally serious concern in estimating the potential clinical application 
of the tissue substitute (Tables V and VI). Findings have demonstrated that cell density is likely a key 
parameter to consider in TE design, since cells could not develop cell-cell contacts or express cartilage 
like tissue component without some minimal cell density which can vary with the source of cells [147]. 
Also, cells respond differently to substrate rigidity therefore the increase in polymer concentration, or 
stiffness involves consequences on the cell morphology, cytoskeletal structure, and on stem cell 
differentiation [148, 149]. Ultimately, standardized procedures for cells, media and growth factors are 
required anticipating that in the future, more detailed studies will elucidate the role of cell density or 
bioactive molecules hold in chondrogenesis. Although current cartilage TE strategies investigate a wide 
range of hydrogel materials in combination with a large variety of cell source, the existing data 
demonstrate that the optimal hydrogel type has not been determined so far, while outcomes also 
depend on the cell type - stages of differentiation, culture conditions [150]. Nevertheless, hydrogels 
based on marine origin polysaccharide are still commonly used and each individual natural polymer 
has strengths and flaws to its use and results can vary depending on the application.  
Besides these comments, consideration should be given to the lesion location and damage size, activity 
level and patient age. These are influencing parameters in choosing the right cartilage repair 
techniques and controlling the outcome of the treatment. More clinical trials are needed to find 
definitive answers and to develop procedures that relieve patient pain and produce a durable 
replacement for damaged cartilage. Up until the present day, no treatment has been shown to 
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completely regenerate or restore articular cartilage/ subchondral bone to a normal status, therefore 
articular cartilage repair remains under intense investigation and the cure is yet to be defined. The 
newer generation of repair/regeneration techniques has shown some promise, but long-term outcome 
is still unknown. 
Furthermore, the extended variety of existing polysaccharides and their inherent features opens a wide 
range of opportunities for synergistic fabrications of new multifunctional biomaterials [151, 152]. The 
development of strategies aiming to overcome hydrogels limitations is gaining increasing interest. Such 
alternative encompass the fabrication of blended systems, or chemically and/or physically modification 
of their original structure. Modifying the hydrophobic properties of the polysaccharides to self-associate, 
reducing the molecular weight by depolymerization and changing the sulfation content are ways to 
improve polysaccharide-hydrogels properties [144]. The addition of interest signaling molecules is 
another way to confer a better outcome performance to the overall tissue engineered constructs [153].  
 
I.9. FINAL REMARKS  
The purpose of this review was to detail a range of the most commonly used biomaterial hydrogels 
based on algae polysaccharide for transplantation of chondrocytes or stem cells in a cartilage 
regeneration strategy approach. The progress from the in vitro experimental cartilage TE research, 
using relevant cells types, to the in vivo scenarios was described throughout the demonstration of 
applicable results. Ultimately, some hydrogels have already been submitted through clinical trials, 
showing that it is possible to maximize the generated knowledge and attain the fabrication of medical 
products that make use of these systems. 
With regard to their prevalence in the cartilage TE field, it is easily identified that alginate is the most 
common used polysaccharide followed by agarose, whereas polysaccharide κ-carrageenan and ulvan 
have only recently been proposed, reflected by the few found published reports. It is clear that these 
biopolymers provide a versatile class of hydrogels that may found widespread application in the field of 
regenerative medicine.  
As seen throughout the studies detailed here, the type of hydrogel, concentration, cell intrinsic 
characteristics from a particular source or density and the cues incorporated play a large role in 
directing the fate of the final tissue engineered construct. Therefore, it is essential to determine and 
optimize the key regulator factors that influence cartilage regeneration.    
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CHAPTER II 
MATERIALS AND METHODS 
ABSTRACT 
 
The aim of this chapter is to provide detailed description of all materials and experimental 
methods/techniques as well as the protocols used in this PhD thesis. 
Whereas each chapter in this thesis contains the materials and methods used, herein it is intended to 
provide the reader with a more complete and comprehensive view of the detailed procedures and 
relevant information for the selection of the materials and cells, in addition to the physical and 
biological characterization assays, facilitating their use by others. 
 
II.1. MATERIALS/POLYMERS 
Hydrogels have acknowledged a widespread application in tissue engineering and regenerative 
medicine. They play important roles guiding the organization, growth, and differentiation of cells, 
granting physical support, as well as chemical and biological cues needed to form  functional tissues 
[1]. There is a vast body of knowledge on hydrogels that have been proposed for research in tissue 
engineering applications however, the ideal support is yet to be found. The work described in the scope 
of this thesis focused on carrageenan, marine origin sulphated polysaccharides that exhibit GAG-like 
biological properties and which offer potentially safer compounds than mammalian polysaccharides, to 
be applied in cartilage tissue engineering strategies. Alginate and agarose were also used in different 
studies, described in chapter III and chapter VII, respectively. 
 
II.1.1. Carrageenan 
Carrageenans are water-soluble sulfated polysaccharides widely utilized in food, pharmaceutical and 
cosmetic industries as they can form hydrogels at body temperature in the presence of gel-promoting 
salts. Gelation is still subject of debate and is affected by species of cations and concentration involving 
a coil-to-double helix conformational change, followed by aggregation of the ordered molecules in an 
infinite network [2]. These systems are novel and distinguish themselves from other hydrogels 
described in the literature by several phisico-chemical features.  For example, carrageenan holds the 
ability of to become a gel at body temperature that heated turns into fluid, thus evidencing its 
thermoreversible characteristic. Carrageenans exists in three different forms, κappa (κ-) has one 
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sulphate group, while ιota (γ-) and lambda (λ-) correspond with the presence of two and three sulphate 
groups, respectively, per disaccharide unit (Table 1). Moreover carrageenans form in situ hydrogels 
under safe and mild conditions when potassium ions are added to the systems. They have a 
straightforward scale up gelation mechanism, thus leading to thydrogels with regular and reproducible 
shape, which can be processed into different formats, according to a specific target application. 
Another importer characteristic of carrageenan is the chemical composition resembling to the galactose 
or N-acetylgalactosamine containing glycosaminoglycans (GAGs); furthermore due the enclosed 
sulphate groups, they are similar to chondroitin sulfate, dermatan sulphate and keratan sulphate 
extracellular components [3]. 
Besides the phisico-chemical features, important biological advantages of carrageenan hydrogel over 
other encapsulating matrices are: the simple and readily manipulated system for encapsulated cells; a 
delivery substance and three dimensional hydrogel for tissue engineering cartilage; the ready 
dissolution of the hydrogel by agents that remove the potassium from the 3D hydrogel network formed.  
 
Table II- 1. Structure of κappa (κ)-, ιota (ι)- and lambda (λ)- carrageenan. The disaccharides sequences 
of sulfate esters of κappa-, ιota-, and lambda-carrageenan are depicted, showing the β-1→4 and the α-
1→3 bonds. 
Types 
 
κappa (κ)- 
carrageenan 
ιota (ι)- carrageenan 
lambda (λ) –  
carrageenan 
Idealised 
chemical 
structure 
  
->3)β-D-Galactose-4-sulfate (1->4) α-D-3,6-
Anhydrogalactose (1-> 
->3)β-D-Galactose-2-sulfate (1->4) 
α-D-Galactose-2,6-disulfate (1-> 
one sulfate group two sulfate groups three sulfate groups 
R = OH R = OSO3-  
 
Iota and κappa -carrageenan used in this thesis were purchased from Sigma, Cat nº 22048 and Cat nº 
22045, respectively, and used without further purification. The molecular weight of commercial extracts 
polymer ranges from 400 - 700 kDa [4, 5]. The manufacture of carrageenan involves hot extraction, 
clarification, evaporation, precipitation and drying and due to these processes, the obtained 
carrageenans are not pure as they show impurities from one another [6]. 
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II.1.2. Alginate 
Alginate, also known as alginic acid, is obtained from brown algae has been widely used in tissue 
engineering due to the characteristics like easy and mild hydrogel formation in the presence of divalent 
cations ensuring the preservation of cell viability and function. Besides its low toxicity, alginate is 
considered a slow biodegradable polymer and unable to interact with mammalian cells. The 
degradation mechanism is based on disintegration of the material due to the gradual exchange of 
gelling calcium ions with sodium [7]. Alginate is composed of (1-4)-linked β-D-mannuronic acid and α-L-
guluronic acid units (Figure 1). 
 
Figure II- 1. Chemical structure of alginate composed of guluronic acid (G) and mannuronic acid (M) 
units. 
 
II.1.3. Agarose 
Agarose is a natural based polysaccharide obtained from agar and has a neutral charge and gelation 
occurs at temperatures below 40 °C, whereas the melting temperature appears to be 90 °C. Agarose 
is a linear polymer consisting of alternating D-galactose and 3,6-anhydro-L-galactose units (Figure 2).  
 
 
Figure II- 2. Chemical structure of agarose 
 
Agarose has been widely studied for biomedical applications and thus it was used as a control material 
in chapter VII. Agarose powder was purchased from MP Biomedicals, Cat nº 800257 
 
II.2. HYDROGELS DEVELOPMENT 
For hydrogels development an aqueous solution was prepared by dissolving κ-carrageenan powder in 
distilled water at 60 °C, with constant stirring until complete and homogeneous dispersion [8]. 
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Carrageenan solution has to be well dispersed to avoid the formation of lumps and thus to obtain a 
homogeneous hydrogel. Previous to use, all solutions were sterilized by steam power during 30 
minutes at 121 °C. The solutions were prepared just before use, in order to avoid the initial thermal 
degradation steps which might affect the biomaterial response. Potassium chloride (KCl, P5405, 
Sigma) 5 % (w/v) solutions was used as reticulation agent. Upon cooling and after addition of the salt, 
an infinite variety of gels can be efficiently produced due to development of double helices of polymeric 
chains into the building blocks of a three-dimensional network. The selection of κ-carrageenan type for 
the majority of the studies performed under this thesis was based on prelimanary experiments 
performed, comparing κ-carrageenan with ιota carrageenan. Difference between the 2 types of 
carrageenan were found  in terms of gelation, κ-carrageenan  leading to stiff, brittle gels (with 
potassium salts) and the ιota type leading to elastic and gels (with calcium salts). Furthermore, in 
chapter III, alginate was blended with the 2 types of carrageenan, κappa and ιota, producing different 
results in terms of morphology, depending on concentration. Higher concentrations of the polymer, 
namely κappa type, could not be dropped easily due to the high viscosity, while lower concentrations of 
ιota type led to unstable gels. Regarding the cell studies, the cytotoxicity assays and the loading of 
chondrocytes revealed that κappa carrageenan type enabled higher cell viability than ιota type. Given 
that carrageenans classification is based on the sulphate content, with κappa having the lowest 
sulphate groups, the biological behavior seems to be dependent on the degree of sulfation, as such, for 
further experiments it was considered the κappa type. 
 
II.2.1. Blended hydrogels based on carrageenan and alginate 
In chapter III hydrogels blends of alginate with the two types of carrageenan were prepared and tested 
in the format of beads and fibers. The purpose of developing these blends was to combine specific 
properties of each polymer and obtain better results in terms of mechanical and biological 
characteristics. 
 
II.2.1.1. PREPARATION OF BEAD FROM ALGINATE AND CARRAGEENAN MIXTURES: 
Carrageenan and alginate aqueous dispersions were prepared separately by dissolving each of the 
polymers in distilled water, heated up at 60 °C (for carrageenan) and 50 °C (for alginate) [9]. The 
tested polymers concentrations were from 2 until 3.5 % (w/v) and the ration of alginate-carrageenan 
blends were 5: 5; 7: 3 and 8: 2 (w/w). The hydrogel beads were obtained based on a droplet 
technique, which consisted in the extrusion of the liquid polymer from the tip of a syringe using a pump 
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(AL-1000, Alladin Programmable Syringe Pump) into the collecting bath of 100 mL KCl and CaCl2 
(Figure 3).  
 
II.2.1.2. PREPARATION OF FIBERS FROM ALGINATE AND CARRAGEENAN MIXTURES: 
For the preparation of fibers the same steps, as described above, were followed to obtain the polymeric 
working solutions. The fibers were formed by the wet spinning technique, an easy and reproducible 
method, which consists in immersing the needle into the precipitation solution of CaCl2*KCl. Each 
polysaccharide was ionically cross-linked with the corresponding cations, thus, alginate and ιota 
carrageenan prefer to form a stable gel with Ca2+ and κappa carrageenan with K+. Several ratios of 
alginate to carrageenan blends were tested (blend of alginate with κappa carrageenan and blend of 
alginate with ιota carrageenan), namely 8:2, 7:3 and 5:5 with concentrations varying from 2 to 3.5 % 
(w/v) (Figure 3).  
 
 
Figure II- 3. Optical microscopic images of the beads and fibres obtained from blending alginate and κ-
carrageenan. 
 
II.2.2. Carrageenan hydrogels – preparation of samples in the form of discs  
In the work described in this thesis, it was optimized/used different techniques for producing 
carrageenan hydrogels samples in the form of discs. In chapters IV and V, the hydrogels were casted 
into cylinders and then sliced into discs while in chapters VI and VII, the hydrogels were molded into 
round thick membranes and then the disc samples were punched out, obtaining a more controllable 
thickness of the disc size. Since carrageenan is a thermosensitive polymer, just by allowing the 
polymeric solution to cool down for a few minutes at room temperature is enough to form a solid gel. In 
more detail, the first method consisted in casting the carrageenan solution into cylindrical moulds and 
once it gellifies, the cylinders were immersed in KCl for 15 minutes up to 30 minutes, in order to 
stabilize the 3-dimensional structure. Subsequently, the hydrogels cylinders were washed with 
phosphate buffered saline (PBS, P4417, Sigma) to remove the excess of KCl and cut, using a sterile 
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blade, into disc samples with dimensions of Ø 5 ± 0.01 x 2.5 ± 0.46 mm height (Figure 4). The other 
method to produce discs (chapter VI and VII) consisted in casting carrageenan polymeric solution into 
sterile plastic Petri dishes and allow cooling down at room temperature for 2-5 minutes (Figure 4).  The 
hydrogel formation was further stabilized by cross linking with 5 % (w/v) potassium chloride and the 
discs were cut off from the thick membrane using a sterile punching device with various dimensions. 
 
 
Figure II- 4. Schematic illustration of carrageenan hydrogel disc preparation 
 
II.2.3. Agarose hydrogels 
Agarose is a well known hydrogel that has been proved to be biologically compatible and thus it has 
been widely used for cell encapsulation in numerous in vitro and in vivo studies, envisioning TE 
applications [10-13]. For this reason, it was selected to be used in chapter VII as a control material. 
Agarose hydrogels discs were produced by dissolving 2% (w/v) powder prepared in sterile PBS and 
heated to 70 °C for 30 seconds, until complete homogenization was observed. The solution was then 
allowed to cool at room temperature, thereby decreasing the temperature and promoting gelation, 
afterwards punching off the discs samples.  
 
II.3. CHARACTERIZATION OF THE DEVELOPED HYDROGELS 
Physical properties provide important information about the processability of the 3D hydrogel also 
allowing predicting, to a certain extent, the biological outcomes. The physical analysis of the hydrogels 
developed in this thesis were analyzed by several techniques, including light microscopy, scanning 
electron microscopy, degradation/weight loss and swelling/water uptake assays or mechanical 
properties assessed by compression tests, as described below. 
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II.3.1. Optical microscopy 
The size, shape and surface morphological characteristics of the developed hydrogels were examined 
using an inverted light microscope (Zeiss, Axiovert 40 CFL, 459306), and/or a  stereomicroscope 
(Zeiss – Stemi 2000-C KL 1500 LCD, 459315) and images were obtained using a camera PowerShot 
G6, Canon. Freeze dried samples were produced by exposing the carrageenan hydrogels discs to lower 
temperature (-80 °C) and quickly transferring them to a freeze dryer (Telstar Cryodos-80, Telstar, 
Spain) where they were lyophilized during 2-3 days (Figure 5). This characterization was performed in 
the chapter III of this thesis. 
 
II.3.2. Scanning electron microscopy (SEM) 
The scanning electron microscope (SEM) was used to evaluate the morphology, pore shape, size and 
distribution providing images of the surface and cross sections of the hydrogel samples (Figure 5). In 
chapter III, prior to the SEM analyses (performed using a Leica Cambridge S360), the hydrogels were 
washed in PBS, fixed in a solution of 2.5% glutaraldehyde (in PBS), dehydrated in a gradient series of 
ethanol solutions and allowed to dry completely at room temperature before gold sputtered (Fisons 
Instruments, model SC502, England) for 2 minutes at 15 mA. 
 
 
Figure II- 5. Macroscopic observation of the hydrogels obtained and SEM micrographs of the freeze 
dried hydrogels. 
 
 
II.3.3. Degradation studies 
Degradation behavior is an important parameter for assessing the suitability of hydrogels for a 
proposed biomedical application and was investigated in chapter III. The proposed hydrogel should 
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delivery the cells at the target site but also maintain its structure under physiological conditions 
providing a defensive role for the implanted cells for enough time to guarantee their functionality.  
The degradation studies were carried out by immersion of the hydrogels discs (Ø 7 ±0.01 x 10±0.02 
mm height, n=3) in either PBS, pH 7.4 or culturing medium (Dulbecco‘s Modified Eagle‘s medium, 
DMEM, supplemented with fetal bovine serum, FBS, Gibco, pH 7.4) at 37 0C. The hydrogels were 
lyophilized and weighed (initial weight) before being transferred to 15 ml Falcon tubes and soaked in 
10 ml PBS or DMEM under constant agitation (60 rpm). The degradation solutions were changed every 
7 days to restore the original level of ions activity. After each selected degradation time point, namely 1, 
7, 14 and 21 days, the samples were washed thoroughly with PBS to remove traces of soluble 
degradation products, salts, or other impurities and then dried until constant weight was achieved; the 
dried samples were weighed (final weight) for determination of weight loss. The extent of degradation is 
commonly determined by calculating the percentage of weight loss (eq. 1): 
 
𝑊𝑒𝑖𝑔ℎ𝑡 𝑙𝑜𝑠𝑠  % =
𝐼𝑛𝑖𝑡𝑖𝑎𝑙  𝑤𝑒𝑖𝑔 ℎ𝑡  –𝐹𝑖𝑛𝑎𝑙  𝑤𝑒𝑖𝑔 ℎ𝑡
𝐼𝑛𝑖𝑡𝑖𝑎𝑙  𝑤𝑒𝑖𝑔 ℎ𝑡
 × 100                                               (1) 
 
II.3.4. Swelling kinetics 
The swelling is an intrinsic characteristic of hydrogels, as their networks are able to retain water in 
various percentages, dependent on their chemistry. In chapter IV of this thesis, the swelling behavior of 
the developed hydrogels was studied in a PBS solution (different pH values were tested) and in culture 
medium. For this purpose, a weighed amount of each hydrogel formulation was immersed in each 
testing solution (PBS, DMEM = pH 7.4) and incubated at 37 °C under static conditions. The influence 
of the pH of the PBS solution on the water uptake of κ-carrageenan hydrogel was also assessed. The 
swelling ratio was calculated using equation 2. 
 
 % 𝐸𝑞𝑢𝑖𝑙𝑖𝑏𝑟𝑖𝑢𝑚 𝑠𝑤𝑒𝑙𝑙𝑖𝑛𝑔 𝑟𝑎𝑡𝑖𝑜  % 𝐸𝑆𝑅 =
𝑊𝑠  – 𝑊𝑑
𝑊𝑑
 × 100                                          (2) 
Ws: weight of swollen gel after reaching equilibrium value under specified environmental conditions 
(PBS or DMEM); Wd: weight of the dried gel.  
To measure Ws, the swollen hydrogels were removed from the PBS or DMEM and immediately weighed 
with a microbalance after the excess of water lying on the surfaces was absorbed with a filter paper. 
Three samples were used for each testing condition (n=3). 
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II.3.5. Static compression tests 
In chapter III, uniaxial compression tests were performed to characterize the mechanical behavior of 
the produced 2.5 % (w/v) alginate-carrageenan hydrogels discs (Ø 15±0.51 mm x 5.5±0.46 mm 
height). The tests were carried out at room temperature using an universal mechanical testing machine 
(Instron 4505 Universal Machine). Mechanical testing was performed under compression using a 
crosshead speed of 5 mm/min and the results averaged from tests conducted in at least 10 
specimens [14].  
 
II.4. IN VITRO CELL CULTURE STUDIES 
In vitro cell culture studies performed under the scope of this thesis include experiments/assays 
designed to evaluate the in vitro biocompatibility of the developed hydrogels, namely cytotoxicity and 
immune response evaluation assays, and studies concerning the encapsulation of different cells into 
the developed systems.  
 
II.4.1. Cell used in the different experiments 
In this section it is described the type of cells and their isolation/culturing methodologies, that were 
used in the biocompatibility studies and in the in vitro studies designed to assess the behavior of cells 
encapsulated in the developed hydrogels. 
 
II.4.1.1. MOUSE FIBROBLAST-LIKE CELL LINE (L929 CELLS) 
For the cytotoxicity assessment of the materials described in chapter III, IV and VII, a mouse fibroblast-
like cell line, L929 (ECACC- European Collection of Cell Cultures, UK) was used. Cells were cultured 
with Dulbecco‘s modified Eagle‘s medium (DMEM, D5523, Sigma), supplemented with 10 % fetal 
bovine serum (FBS, 10270-106, Invitrogen) and 1% antibiotic/antimycotic (A/B, 15240-062, 
Invitrogen) solution. The cell density of L929 cells used for the cytotoxicity tests was 2x104 cells/ mL, 
which was seeded in 96-well cell culture plates (4x103 cells/well plate, 200 µl/well plate), in order to 
reach 70 % confluence for 24 h of incubation at 37 °C, in a humidified atmosphere with 5% CO2.  
II.4.1.2. HUMAN POLYMORPHONUCLEAR NEUTROPHILS CELLS, (HPMNS) 
For the in vitro immunological response assay, performed in chapter VII, it was used human 
polymorphonuclear neutrophils cells (PMNs) isolated from heparinized peripheral blood collected from 
healthy volunteers (under a protocol previously established with the Portuguese Blood Institute – 
Instituto Português do Sangue - IPS), following protocols previously established [15]. 
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The biological response following implantation of a material in the body such as inflammation takes 
place triggering circulatory inflammatory cells to the injury site, first PMNs. Within 24 hours, 
macrophages and in two or three days, lymphocytes begin to migrate to the site of injury, later other 
inflammatory cells, such as mast cells and eosinophils will coordinate the continuing of the 
inflammatory response. PMNs are crucial in development of an inflammatory response dictating the 
progression of the host immune system reaction by their capacity to produce cytokines, such as 
interleukins, acting as phagocytes of foreign bodies and leading to the production of oxygen radicals, 
Reactive Oxygen Species (ROS) as a defense mechanism [16]. 
The heparinized blood was placed in 6 % Dextran (D8906, Sigma) with PBS without Ca2+ and Mg2+ for 20 
min, afterwards Histopaque® -1077 (1077, Sigma) was carefully added (Figure 6). After 25 min, the 
red pellet cells was resuspended with PBS without Ca2+ and Mg2+ and centrifuged for 25 min at 21 °C 
and 2400 rpm. In order to lyse the erythrocytes from the cell pellet, distilled water was added and 
several centrifugations were performed, before counting the cells. The hPMNs cells were kept at 4 °C 
until further use, within a maximum of 2 h. 
 
Figure II- 6. Schematic representation of the protocol used for the isolation of human 
polymorphonuclear neutrophils cells, hPMNs. 
 
II.4.2. Cells used for encapsulation experiments 
In the work described in chapters III, IV and V, cryopreserved mouse derived cells (ATDC5 cell line), 
human nasal chondrocytes (hNCs) and human adipose derived stem cells (hASCs) were used after 
thawing/expansion procedures, while in chapter VII, freshly isolated hASCs were expanded to use in 
the described encapsulation experiments. The selection of a cell source to promote efficient 
regeneration is a major issue to be considered in the design of a therapeutic strategy. Ideally, a cell 
source should allow harvesting in large amounts with minimal morbidity, enable high number of cells, 
be easy to maintain/expand in vitro, and to guarantee phenotypic stability and functional suitability, 
have no issues of immunogenicity or disease transmission risks and be of low cost. In this context it 
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was motivating to work with different cell sources and to assess their behavior in terms of proliferation 
and chondrogenic potential envisioning applications in cartilage repair. 
 
II.4.2.1. ATDC5 CELL LINE 
ATDC5 is a cell line established from chondrocytic cells of a mouse embryonal carcinoma (mouse 129 
teratocarcinoma AT805 derived, ECACC, UK). ATDC5 cells  were selected to use in chapter III and V 
since they are biologically active in a 3D environment and have been extensively studied to assess their 
role in producing, maintaining, and remodeling the cartilage ECM [17]. Cryopreserved ATDC5 were 
thawed by placing the frozen cell vial in a 37 °C water bath.  When the vial was partially thawed, the 
cells were removed from the bath and centrifuged with basic culture medium to remove the 
cryoprotectant (dimethyl sulfoxide, DMSO, 156914). The cell pellet was resuspended in culture 
medium, cultured in flasks, and allowed to attach for 24 hours prior to medium exchange. The cells 
were expanded in culture medium composed of Ham's F-12 medium (D-MEM⁄F-12 (1:1), 42400-028 
Gibco) supplemented with 10% FBS (Gibco), 2 mM L-glutamine (G854, Sigma), and 1% antibiotic 
solution, until obtaining the necessary number of cells for the experiments the encapsulation 
experiments. 
 
II.4.2.2. HUMAN NASAL CHONDROCYTES (HNCS) 
Nasal cartilage was harvested from the nasal septum of adult patients undergoing reconstructive 
surgery under a protocol established with Hospital de S. Marcos, Braga, Portugal. For the isolation of 
the hNCs, the human nasal septum cartilage tissue samples were cut into pieces, washed in a sterile 
PBS solution and incubated in 20 mL of trypsin-EDTA solution for 30 min at 37 °C with agitation. 
Then, trypsin was removed and 20 mL of filter sterilized collagenase type II solution (2 mg/mL) in 
basic medium was added, and the mixture incubated for 12 h [18]. Subsequently, the digested tissue 
and cell suspension solution was centrifuged at 200×g for 7 min and the supernatant removed. Finally, 
the cell pellet was washed with lysis buffer, centrifuged several times and resuspended in expansion 
medium consisting of Dulbecco‘s Modified Eagle‘s Medium - high glucose (DMEM, 5671, Sigma), 
containing 10 mM HEPES (H403475, Sigma) buffer pH 7.4, 1% antibiotic-antimycotic, 20 mM L-alanyl 
glutamine (G8541, Sigma), 1x MEM non-essential amino acids (MEM NEAA, 11140-035, Sigma) and 
10% (v/v) FBS supplemented with 10 ng/mL basic fibroblast growth factor (bFGF, AF100-18B, 
PeproTech). The expanded nasal chondrocytes were used in the work described on chapter V. 
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II.4.2.3. ADIPOSE DERIVED STEM CELLS (HASCS)  
Adipose-derived mesenchymal cells (hASC) are an attractive type of adult stem cells, since it is possible 
to obtain large amounts of their  source tissue with low donor site morbidity and have the ability to 
commit to a range of different lineages [19]. The chondrogenic differentiation capacity of hASCs once 
encapsulated in carrageenan hydrogel was assessed in chapters IV and V. Furthermore, in chapter VI 
the chondrogenic differentiation potential of hASCs was evaluate after cryopreservation of the cell-
hydrogels constructs. 
Adipose tissue samples were obtain under a previously established protocol with the Department of 
Plastic Surgery of the Hospital da Prelada, Porto and approved by the local Ethical Committee. The 
isolation protocol implies enzymatic digestion of the tissue samples with collagenase type II (C6885, 
Sigma) in Dulbecco's Phosphate Buffered Saline (DPBS, 21600-044, Invitrogen) for 45 min at 37 °C 
under gentle stirring. Afterwards, filtration was performed using a 100 μm filter mesh (Sigma) and after 
several centrifugations, the stromal vascular fraction (SVF) was washed with lysis buffer (155 mM 
NH4Cl, 10 mM KHCO3, 0.1 mM EDTA, pH= 7.3) to remove the red blood cells [20].  The SVF was 
plated and 2-3 days after, the remaining non-adherent cells were removed with repeated PBS 
washings. The adherent hASCs were cultured with media changes on every three days [21, 22]. hASCs 
were expanded in culture medium composed of alpha Minimum Essential Medium (α-MEM, 12000-
063 Gibco, Invitrogen) with 10 % FBS (10270-106 Gibco, Invitrogen; heat inactivated), 1 % Antibiotic-
Antimycotic (15240-062, Invitrogen) and sodium bicarbonate (S5761-NaHCO3, Sigma). Human ASCs 
were subcultured at a density of 3.5 x 103 cells/cm2 and incubated at 37 °C in a humidified 
atmosphere of 5 % CO2. Confluent cultures were passaged with 0.05 % trypsin (25300-062 Invitrogen). 
The enzymatic treatment was quenched in the presence of FBS and cell counts were done using a 
hemocytometer. Only passage 3 (P3) hASCs were used in the experiments. The hASCs used in chapter 
IV and V, were isolated from lipoaspirates, while the hASCs from chapter VI were obtain from compact 
tissue samples (Figure 7), both from subcutaneous sites. For the cell culture experiments in chapter VI, 
the adipose tissue derived stem cells were from four female donors with a mean age of 35.25 years (± 
8.55) and BMI (body mass index) of 26.26 (± 2.74). The phenotype of human adipose stem cells has 
been extensively investigated in previous studies using tissue sample from same anatomical site 
(subcutaneous), harvested with similar technique and isolation following similar procedures (digestion 
with collagenase) by [23, 24] including by our research group [25-27].  
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Figure II- 7. Harvesting sites and procedures to obtain the adipose tissue. 
 
II.4.3. Cytotoxicity screening 
In order to establish the possible toxic effects of leachable eventually released from the developed 
hydrogels, indirect cytotoxicity tests were performed, using extracts of the materials, following 
methodologies based on ISO/EN 10993 part 5 guidelines [28, 29]. Cytotoxicity screenings were 
accomplished in chapter III, IV and VII of this thesis (Figure 8).  
 
II.4.3.1. MEM EXTRACTION TEST 
The developed hydrogels were extracted in complete culture medium for 24 h at constant temperature 
(37 °C) and agitation (60 rpm) [30]. The ratio of material to extract fluid was constant and equal to 3 
cm2/mL. To assess the short-term cytotoxicity of the developed hydrogels, latex rubber was used as 
positive control for cell death due to its high cytotoxicity to cells, and culture medium was used as a 
negative control representing the ideal situation for cell growth. Extracts of the different polymers were 
filtered (filter pore size: 0.22 μm) and placed in contact with the monolayer of the L929 cell line. For 
this purpose, the culture medium from the well-plates with the L929 cells monolayers was removed 
and an identical volume (200 µl/well) of extraction fluid of study materials or rubber latex extracts 
(positive control) and negative controls (standard culture medium) was added. The MTS assay was 
performed to assess the possible cytotoxicity of hydrogels extracts determining the metabolic activity of 
the cells.  
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Figure II- 8. Schematic representation of the cytotoxicity assay 
 
II.4.3.2. METABOLIC ACTIVITY 
The metabolic activity of cells in contact with extracts of the developed hydrogels was evaluated by the 
MTS assay (Cell Titer 96® Aqueous Solution Cell Proliferation Assay, Promega), in chapter III, IV and 
VII. The absorbance of the resulting solution in each well was recorded at 490 nm using an automated 
Multi-Mode Microplate Reader (Synergy™ HT, Bio-Tek Instruments). The results presented in chapter 
III, were as percentage of cell viability as hydrogel O.D (optical density) was normalized to the negative 
control using the following equation: 
 
𝐶𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦  % =
𝑂𝐷  𝑠𝑎𝑚𝑝𝑙𝑒
𝑂𝐷 𝑐𝑜𝑛𝑡𝑟𝑜𝑙
 × 100                                                            (4), 
 
where OD sample is the optical density obtained in the cells exposed to each extract and OD control is 
the OD obtained in the cells incubated with the culture medium only (negative control). Furthermore, in 
chapters IV and VII the MTS results after cytotoxicity tests were showed as OD values of hydrogel 
material, TCPs, the cell component (negative control) and latex (positive control).  
 
II.4.4. Chemiluminescence - Reactive oxygen species quantification assay 
In vitro culture models that estimate reactive oxygen species (ROS) levels within cells and/or their 
release into the culture media provide a valuable tool in understanding the mechanisms that lead to 
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cell loss and will further explain in vivo inflammatory response. The presence of superoxide anions and 
hydroxyl radicals in cell culture with the tested hydrogels was detected by a chemiluminescence-based 
method. The isolated hPMNs, were used at a final concentration of 1.3×106 cells/mL. For the 
detection of reactive oxygen species, to each 100 µL of cells suspension with the two cell stimulants, 
namely 8 µg/mL PMA/PBS (phorbol 12-myristate 13-acetate, P8139, Sigma) and 10 µg/mL 
fMLP/PBS (formyl-methionyl-leucyl-phenylalanine, F3506, Sigma), was added 100 µL of 1.5 mM 
luminol/PBS (09253, Sigma) or 100 µL 5.4×10-5M lucigenin/PBS (B49203, Sigma) [16]. Control 
conditions were simultaneously set using no cell stimulants. Samples with or without materials were 
kept on ice until asses. The chemiluminescence was read with a microplate reader (Sinergy HT, Bio-
TeK Instruments) and the results were obtained in terms of total number of counts per time period. 
 
II.4.5. Cell encapsulation experiments 
Cell encapsulation studies were performed to assess the cellular response of the developed hydrogels 
and to further select/optimize the formulation as well as the encapsulation conditions. The 
temperature-induced gelation of carrageenan permits easy formation of hydrogels under mild 
conditions, enabling its application as an in vitro cell-carrier or as an in vivo injectable system (Figure 
9). Encapsulation studies were performed in chapter III, IV, V and VI.  
 
II.4.5.1. ENCAPSULATION OF ATDC5 CELLS INTO ALGINATE/CARRAGEENAN HYDROGELS 
In chapter III and V, ATDC5 cells were encapsulated into alginate/carrageenan hydrogels. After 
trypsinization and centrifugation, the cell suspension obtained was diluted in order to encapsulate 
1x106 cell/ml of the polymeric solution to produce the beads/fibers as previously described. The 
beads/fibers with encapsulated cells were then placed into non-adherent 24 well-plates and maintained 
in culture for several periods of time (1, 7, 14 and 21 days) at 37 °C in a CO2 incubator. At the end of 
each time of culture, the beads/fibers with the encapsulated cells were retrieved, washed with PBS 
solution and maintained at 4 0C in PBS for further characterization studies. 
 
II.4.5.2. ENCAPSULATION OF HASCS IN Κ-CARRAGEENAN HYDROGELS 
In chapters IV, V and VI, it was performed the encapsulation of hASCs cells in κ-carrageenan hydrogels. 
The κ-carrageenan aqueous dispersions were prepared just before being used and sterilized as 
described in previous sections. hASCs were detached by trypsin and centrifuged at 200×g for 7 min. 
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Cells were resuspended in sterile PBS solution, counted using a haemocytometer and finally 
centrifuged. The supernatant was discarded and κ-carrageenan 1.5 % (w/v) solution was added to the 
cells to obtain a final concentration of 5×106 cells·mL-1. The carrageenan aqueous solution and the cells 
suspension was mixed until complete homogenization (Figure 9). Hydrogel discs loaded with cell were 
prepared using sterile polystyrene cylinder moulds and allowed to rest until forming a solid gel. The 
chondrogenic induction medium was composed of Dulbecco‘s Modified Eagle‘s Medium-low glucose 
(D5523-DMEM Sigma, USA), supplemented with 1% Antibiotic-Antimycotic, ITS+1 Liquid Media 
Supplement (I2521- insulin-transferrin-selenium - liquid media supplement, Sigma, USA), 17mM L-
ascorbic acid (A4544 Sigma, USA), 0.1M sodium pyruvate (P4562 Sigma, USA), 35mM L-proline 
(P5607 Sigma, USA), 1mM dexamethasone and 10ng/ml of human TGF‐β1(Transforming Growth 
Factor‐β1, 14‐8348, eBioscience). Additional controls consisted of κ-carrageenan hydrogel samples 
without cells, were kept in the same culturing conditions for the same selected time periods. At the end 
of the pre-established culture periods (21 days), the samples were retrieved, washed with PBS solution 
and further processed according to the characterization assays to be performed, as described below. 
For the cryopreservation study performed in chapter VI, the hASCs encapsulated at a density of 5 × 106 
cells/cm3 into the carrageenan hydrogels were cultured for 14 days in either chondrogenic or basal 
medium. Two-weeks time point was selected based on previous studies on hASCs chondrogenic 
differentiation [31] that suggested that this is the period of time necessary in setting chondrogenesis 
with ECM production [32]. The overall time-frame of the encapsulation studies, namely 21 days of 
culture was selected with basis on previous works with similar aims, using encapsulated stem cell in 
hydrogel for chondrogenic differentiation [33-35]. Though it will be interesting to verify the outcomes in 
a long time experiment, envisioning the clinical application of the proposed strategy, we were mostly 
concerned with the ability of the hydrogels to promise early pre-differentiation as a long term in vitro 
culturing, before implantation, is not interesting in a clinical/industrial scenario. 
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Figure II- 9. Schematic representation of carrageenan hydrogel preparation. 
 
II.4.6. Cryopreservation studies 
One of the main prospects of cartilage tissue engineering is the possibility of developing custom-made 
regenerative medicine solutions on an individual patient basis. The establishment of efficient 
preservation and storage procedures will provide products prepared in advance, scaled up,  assuring 
immediate availability and accessibility for the clinical use which could be adapted to an autologous 
immediate solution, leading to ―out of shelf‖ tissue substitutes. With this in mind, in this thesis it was 
investigated the influence of standard cryopreservation protocols on the chondrogenic differentiation 
characteristics of human adipose derived stem cells encapsulated in κ-carrageenan hydrogels, as a 
promising tissue engineering product  to be applied in cartilage regeneration (chapter VI). The 
cryopreservation process was based on the following protocol: each sample was individually placed in a 
polypropylene cryovial (479-0821, VWR) containing a solution of 10 % (v/v) dimethyl sulphoxide 
(CryoSure DMSO, 11-32-30216, Wak-Chemie Medical GMBH) in FBS. The samples were cooled down 
to 4 ºC using an ice bath (30 minutes). Afterwards, cryovials were moved into a conventional freezer (-
20 ºC; 1-2h) and then moved into a -80 ºC freezer. After 12 hours at -80 ºC, samples were stored 
inside a liquid nitrogen tank (Statebourne Biosystem) at -196 ºC for one month.  
 
II.5. CHARACTERIZATION OF CELL-LADEN HYDROGELS SYSTEMS 
Cell-laden carrageenan hydrogel systems were characterized in terms of cellular viability and 
proliferation as well as of chondrogenic differentiation features. Furthermore, morphological 
characteristics and the production of extracellular matrix components typical to cartilage were also 
considered and are described in the following sections of this chapter. 
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II.5.1. Morphological cell evaluation and distribution  
Cell morphology and distribution throughout a 3D matrix was evaluated using optical microscopy 
techniques in chapters III and VI. The full structure and morphological characteristics of the developed 
discs with encapsulated cells was observed under inverted light microscope (Zeiss, Axiovert 40 PG-
HITEC) equipped with a digital camera (Axiocam MRc5, Zeiss). 
 
II.5.2. Water content and degradation rate  
The environment in which cells are grown influences the cellular response, affecting cell viability and 
proliferation, therefore the water content/ degradation rate of the developed hydrogels was evaluated in 
simulated physiological conditions (chapter V). Hydrogel samples (111.15 mg ± 12.66) prepared 
according to the procedure described above and accurately weighed (ws) were incubated for 7, 14 and 
21 days in fresh culture medium and PBS buffer. Simultaneously, samples of hydrogels loaded with 
hASCs, hNCs and ATDC5 (prepared as described in the section above) were immersed in specific 
culture medium for each type of cell and incubated at 37 0C for the same time periods. At the pre-
determined time intervals, the medium/PBS was removed from the samples, the hydrogels were 
lyophilized and the dry weights were measured (wd). The water content of hydrogels was calculated 
from the equation (ws – wd)/ws ×100. The degradation rate was defined as the time needed for the gel 
to degrade and for calculation we considered the equation 5. The medium was replaced twice a week 
and the studies were performed in triplicates. 
 
𝐷𝑒𝑔𝑟𝑎𝑑𝑎𝑡𝑖𝑜𝑛 𝑟𝑎𝑡𝑒   % =
𝐹𝑖𝑛𝑎𝑙  𝑤𝑒𝑖𝑔 ℎ𝑡
𝐼𝑛𝑖𝑡𝑖𝑎𝑙  𝑤𝑒𝑖𝑔 ℎ𝑡
 × 100                                                  (5) 
 
II.5.3. Dynamic Mechanical Analysis (DMA)  
Dynamic mechanical analysis is a technique used to study and characterize the viscoelastic nature of 
hydrogels, as a response to stress, temperature and frequency, and determines their time-dependent 
mechanical performance. Cells and tissues exhibit a viscoelastic behavior that an implantable hydrogel 
should match in order to be successfully applied in a tissue engineering strategy [36, 37]. In chapters 
IV and VI, dynamic mechanical analysis (DMA) was conducted to analyze the stiffness of carrageenan 
hydrogel discs with or without laden hASCs cells cultured at different time points exposed or not to 
chondrogenic differentiation supplements. The carrageenan hydrogel concentration, and the disc 
sample size used in this study, as well as the culturing time assessed are summarized in table II.2. 
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Table II- 2. Samples/conditions used in DMA analysis. 
DMA 
ANALYSIS 
HYDROGEL 
CONCENTRATION 
DISC SIZE TIME OF CULTURE 
CHAPTER IV 2 % (w/v) 8 ± 0.01 mm   x 2.5 ± 
0.38 mm height. 
21 days of culture 
CHAPTER VI 1.5 % (w/v) 5 mm  x 3 mm height. before and after 
cryopreservation 
 
The carrageenan hydrogel discs prepared (as described in the hydrogel development section),  were 
subjected to compression cycles of increasing frequencies ranging from 0.1–10 Hz with constant strain 
amplitude (50 μm) using DMA equipment (TRITEC Admin 8000B, Triton Technology). A small preload 
was applied to each sample to ensure that the entire disc surface was in contact with the compression 
plates before testing and the distance between plates was equal for all samples being tested. The 
mechanical analysis results were presented in terms of two main parameters: storage modulus (E′ - the 
in-phase, elastic component) and loss modulus (E′′ - the out-of-phase, viscous component). The values 
for the compression modulus were collected along the days of culture and damping factor was 
presented as well. 
 
II.5.4. Cell viability  
The viability of encapsulated cells was evaluated by labeling the cells with fluorescent dyes like Calcein 
AM, propidium iodide and by using the colorimetric MTS assay (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium).  
 
II.5.4.1. CELLULAR VIABILITY BY CALCEIN AM – FLUORESCENT DYE  
The fluorescent calcein AM is a cell-permeant and non-fluorescent compound which is hydrolyzed in 
live cells being the fluorescence intensity proportional to the amount of live cells. Single fluorescence 
labeling, with calcein AM only, was carried out in chapter III and IV, to assess the viability of ATDC5 
and hASCs cells encapsulated in hydrogels. For this assay, the samples were washed with PBS, placed 
in a new well plate with 1 mL of DMEM and 2 µL of a Calcein-AM solution (at 1/1000 dilution) and 
incubated for 15-30 min at 37 0C in 5 % CO2. Afterwards the hydrogels were rinsed twice in PBS and 
observed under a reflected/transmitted light microscope (Zeiss, Axiocam MRc5).  
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Live/dead assay with propidium iodide (staining for dead cells) was performed in chapter VI to assess 
the viability of hASCs cells encapsulated in κ-carrageenan hydrogels. In this case, samples were 
collected, placed in a 48-well plate, and washed with PBS. Subsequently, 500 μL of 1 mg/mL Calcein 
AM in PBS (C3099, Invitrogen) was added to each sample for 10 min at 37 0C and later washed with 
sterile PBS. Afterwards, the samples were incubated with 300 µL of 1.5 mM propidium iodide in PBS 
(PI; 1:1000, P1304MP, Invitrogen) for 5 min at room temperature, previous to microscopic analysis 
(Reflected/Transmitted light Microscope, Axioimager Z1M, Zeiss).  
 
II.5.4.2. METABOLIC ACTIVITY  
This MTS test (described previously in section 4.3 – cytotoxicity screening) was also used to evaluate 
the metabolic activity of cells encapsulated in the developed hydrogels, in chapter III and V at different 
time periods, specifically 1, 2 and 3 weeks. In this case, the cell–hydrogel constructs were washed in 
PBS and placed in a mixture containing serum-free cell culture medium DMEM (without phenol red) 
and MTS reagent at a 5:1 ratio. Incubation for 3h at 37 °C in a humidified atmosphere containing 5% 
CO2 followed, at the end of which 100 mL was transferred to 96 well plates and the OD determined at 
490 nm. Controls consisting of hydrogels without cells were also used. Thus, the alginate-carrageenan 
polymers with encapsulated ATDC5 cells were assessed for their metabolic activity in chapter III. The 
MTS compound bioreduction by metabolically active cells such as hASCs, hNCs and ATDC5 cells, into 
a brown formazan product by dehydrogenase enzymes was assessed in chapter V as well. The quantity 
of formazan product as measured by the amount of 490 nm absorbance is directly proportional to the 
number of living viable cells in culture. 
 
II.5.5. Cellular content assay (dsDNA quantification) 
The proliferation of the encapsulated cells, ATDC5, hNCs, hASCs in the κ-carrageenan hydrogels, was 
determined using a fluorimetric double-strand DNA quantification kit (Quant-iT™ PicoGreen® dsDNA 
reagent, Molecular Probes, Invitrogen). The cell proliferation assay used in this thesis (chapters III, IV, V 
and VI) is a sensitive fluorescent nucleic acid staining, measuring the fluorescence produced when 
PicoGreen dye (Molecular Probes, P-7589) is excited by UV light and bounds to double-stranded DNA 
(dsDNA) present in the tested sample.  
For this purpose, samples collected after culturing time were transferred into 1.5 mL microtubes 
containing 1mL of ultrapure water. The cell-hydrogel constructs and the hydrogel alone (without cells), 
used as control, were incubated for 1 h at 37 0C in a water bath and were then stored in a -80 0C 
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freezer until they were tested. Prior to dsDNA quantification, the cell-hydrogels were thawed and 
sonicated for 15 min. Samples and standards (ranging from 0 to 2 µg· mL-1) were prepared and mixed 
with a PicoGreen solution in a 200:1 ratio and were placed on opaque 96-well plate. The procedure 
followed was according to the manufacturer‘s instructions [38]. The plate was incubated for 10 min in 
the dark, and fluorescence was measured on a microplate reader (Synergy™ HT, BioTek Instruments) 
with an excitation of 485/20 nm and an emission of 528/20 nm. A standard curve was created, and 
sample DNA values were read from the standard graph. 
 
II.5.6. Histological characterization  
The histocytological techniques include preservation, fixation, sectioning and staining technique to allow 
for visualization using a microscope (source: MeSH - Medical Subject Headings). In chapters III, IV, V 
and VI samples of cell-laden hydrogels retrieved at different culturing time-points were processed for 
histocytological analysis. The samples were fixed with 3.7 % formalin, processed to remove water from 
tissues (spin tissue processor, Microm STP120 Inopat) and replace it with an embedding medium 
(embedding center, Microm EC350-1/EC350-2 Inopat) to allow micro sections (3-4 μm) to be cut off 
(microtome, Microm HM355S Inopat). Since most staining are aqueous solutions, deparaffinization is a 
common step prior staining described below. After all staining performed, discussed in next section, all 
slides were dehydrated through series of alcohol immersions from 30 % until 100 % alcohol. Then, 
sections were allowed to air dry overnight. The final step for all the staining performed was the 
immersion in the clearing agent Histoclear® (National Diagnostics) or xylene (1.08681.1000, VWR) for 
1-2 minutes and mounted using resinous medium, Microscopy Entellan® (Merck &Co., Inc.) for later 
observation. Stained sections were observed under a light microscope (Reflected/Transmitted light 
Microscope, Zeiss).  
 
II.5.6.1. H&E  
Hematoxylin and eosin (H&E) staining was performed to observe general cell morphology and overall 
cell/matrix distribution once in cell laden carrageenan hydrogel. Hematoxylin, a basic dye, stains nuclei 
blue due to an affinity to nucleic acids in the cell nucleus; eosin, an acidic dye, stains the cytoplasm 
pink. Other tissues such as connective tissue or decalcified bone matrix also stain pink with eosin while 
mucus and cartilage will stain a light blue color  [39].  
H&E staining was conducted in automatic staining equipment (Microm HMS 740) in chapters III, IV 
and VI. After hydration, sample sections were coloured with Papanicolaou Harris hematoxylin (05-
 
________________________________________________________________Chapter II. Materials and Methods__ 
102 
 
12011/L, Bio-optica) for 3 minutes, washed in running tap water, and afterwards a blue stain 
enhancement was performed by an immersion in 0.5 % ammonium hydroxide solution (05002, Sigma) 
for 5–10 seconds. The sections were washed in running tap water and stained in Eosin-Y (05-M10003, 
Bio-optica) for 30 seconds. Finally, slides were dehydrated through series of alcohol immersions from 
30 until 100 % (v/v) alcohol. The stained cells were visualized under a light microscope 
(Reflected/Transmitted light Microscope, Zeiss Germany) and images were taken by a digital camera 
(Axion MRc5, Zeiss).  
 
II.5.7. Typical proteoglycans staining  
Alcian blue (A3157, Sigma), Safranin O (84120, Sigma), Toluidine blue (T3260, Sigma) were used to 
evaluate cartilage ECM components deposition, namely glycosaminoglycans on samples that were 
collected at the end of the experiment.  
 
II.5.7.1. ALCIAN BLUE STAINING  
Alcian blue [40] is a cationic dye, that stains acid mucosubstances and acid glycosaminoglycans, 
which may be present in cartilaginous tissues. Alcian blue staining was performed by rinsing the 
sections or the cells monolayer in 3 % acetic acid (151785, Sigma) and incubating them in 1 % Alcian 
blue solution from 30 minutes to 18 hours. After that, the stain was poured off, and sections were 
counterstained with aqueous neutral red (861251, Sigma) for 1 min and dehydrated. The sections 
were then rinsed with distilled water and observed at the microscope. This staining was performed in 
chapters IV and V. 
 
II.5.7.2. SAFRANIN O STAINING  
Safranin O is a cationic dye frequently used as a counterstain and for the detection of mucin, cartilage 
[41] and mast cells. The Safranin O staining consisted of staining the sections with Weigert‘s iron 
hematoxylin working solution for 7 minutes, fast green (FCF, 44715, Sigma) for 5 minutes and 0.1 % 
safranin O for 5 minutes. Sections were washed after each staining step, left to air dry and then 
mounted for visualization. This staining was performed in chapters IV and V. 
 
II.5.7.3. TOLUIDINE BLUE STAINING  
Beside its many roles as heparin antagonist and an antibacterial agent, Toluidine blue [41] is a basic 
nuclear and metachromatic dye that stains mucopolysaccharides. Toluidine blue solution was prepared 
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by dissolving 1 % of toluidine blue in distilled water containing 0.5 g of sodium borate (Riedel-de-Haën), 
followed by filtering and the sections were dipped in for 2–3 s. Afterwards, the stain was poured off and 
the samples washed, dehydrated, cleared in xylene and mounted for further analysis. This staining was 
performed in chapters IV and VI. 
 
II.5.8. Immunohistochemistry analysis for collagen type II and type I 
Immunodetection of specific cartilage proteins is a very precise technique in which specific antibodies 
are used to detect proteins or other molecules present in a given sample. Sections of samples 
corresponding to all experimental conditions namely, κ-carrageenan hydrogels loaded with stem cells 
exposed or not to chondrogenic conditioned medium (described in chapters IV and VI) were obtained 
as described in the section above. Immunocytochemistry was performed according to R.T.U. Vectastain 
Universal Elite ABC kit (PK 7200) kit from VectorLabs, using R.T.U Normal Horse Serum to avoid 
unspecific reactions, a biotinilated secondary antibody (R.T.U. Biotinylated Universal Antibody) and a 
Peroxidase Substract Kit (Vector SK-4100), 3,3‘-Diaminobenzidine (DAB) was the colorimetric substrate 
used. In detail, before removing the paraffin, the slides were warmed, and the antigen retrieval was 
performed for 20 minutes at 95 ºC using 10 mM citrate buffer. Sections were washed in PBS 10 to 15 
minutes, and endogenous peroxidase activity was quenched with hydrogen peroxide (31642, Sigma) in 
50 % methanol/tap water for 5 min. Afterwards, samples were washed with PBS and blocked with 2.5% 
horse serum from R.T.U. Vectastain® Universal Elite ABC Kit (PK-7200, Vector Laboratories) for 1 h to 
avoid nonspecific staining. Sections were further incubated with primary antibodies (collagen type II 
and collagen type I; mouse antitype II collagen - MAB1330 and mouse antitype I collagen - MAB3391, 
Chemicon or rabbit anti-collagen I antibody - ab292, Abcam) overnight at 4 °C, in a humidified 
atmosphere. Then slides were washed with PBS for 10 min each and incubated with secondary 
antibody (R.T.U. Vectastain® Universal Elite ABC Kit) for 1 h at room temperature, again in a 
humidified atmosphere. The remaining protocol was performed according to that described in the in 
the DAB substrate kit for peroxidase (SK-4100, Vector Laboratories). Slides were washed in water for 5 
min and then counterstained with haematoxylin for nuclei visualization and finally, slides were 
mounted. Controls were performed using normal horse serum replacing the primary antibodies. The 
samples were visualized under a light microscope and images obtained using a camera (Axion MRc5, 
Zeiss).  
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II.5.9. RNA isolation and Gene expression analysis (RT-PCR) 
The experimental work within chapters IV, V, and VI involved the use of molecular approaches to detect 
cartilage specific markers namely Sox9, Aggrecan, Collagen X, Collagen type I, Collagen type II, on cell 
laden hydrogels upon different periods of culturing and/or different culturing conditions. Real-time PCR 
is semiquantitative/quantitative method that measures in real time the quantity of a given codifying 
molecule in a sample, enabling to determine their regulatory profile, that can be up or downregulated, 
or alternatively exhibit no significant variation.  
For this purpose, total RNA was extracted from cell-hydrogel constructs using TRI Reagent® RNA 
Isolation Reagent (T9424, Sigma) according to the provided technical data sheet. Samples of each 
condition were collected at defined time periods, washed twice with PBS, added in TRI Reagent® (800 
μL) and vigorously mixed during 10 s and stored at -80 °C until the analysis was performed. At this 
point, 160 μL of chloroform was added, incubated on ice for 15 min and centrifuged at 13.000 rpm for 
15 min at 4 °C to establish a three-phase composition in the tube. The aqueous phase was collected 
into new, clean, pre chilled tubes, where 400 μL of ice-cold isopropanol was added and samples were 
incubated at -20 °C overnight. The samples were centrifuged at 13.000 rpm for 15 min at 4 °C, the 
supernatant discarded and the pellet washed with 70 % ethanol. After a final centrifugation, the 
samples were allowed to air dry, and suspended in ultrapure water for posterior analysis. Each pellet 
was dissolved in 15 μL of RNase-free water and kept at -80 °C until use. The amount of isolated RNA 
and A260/280 nm ratio was quantified using Nanodrop ND-1000 Spectrophotometer (Bonsai 06/2008 
NanoDrop Technologies, Wilmington). First-strand complementary DNA (cDNA) was synthesized from 2 
µg of RNA of each sample reverse transcribed (qScript™ cDNA Synthesis Kit, Quanta Biosciences) in a 
40 µL reaction using thermal cycler machine.  
 
Table II- 3. Primers used for RT-PCR analysis and expected size of the PCR products. 
Target gene 
Ascension 
No. 
Primer Forward Primer Reverse Amplicons 
Tm 
[°C] 
Aggrecan 
NM_00113
5 
5′tga gtc ctc aag cct cct gt 5′cag tgg ccc tgg tac ttg tt 171 bp 60.4 
Collagen II 
NM_03315
0 
  5′ggg agt aat gca agg acc aa 5′atc atc acc agg ctt tcc ag 175 bp 57.4 
Sox9 
NM_00034
6 
  5′tac gac tac acc gac cac ca 5′ctc ctc aag gtc gag tga gc 217 bp 56.2 
Collagen X 
NM_00049
3 
  5′cag gca taa aag gcc cac ta 5′agg act tcc gta gcc tgg tt 179 bp 57.4 
Collagen I 
NM_00008
9 
  5′agc cag cag atc gag aac at 5′aca cag gtc tca ccg gtt tc <200bp 51.5 
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GAPDH 
NM_00204
6 
5′tgc acc acc aac tgc tta gc 5′ggc atg gac tgt ggt cat gag 87 bp 60.6 
bp - base pairs; GAPDH - glyceraldehyde-3-phosphate dehydrogenase. 
 
II.5.10. PCR analysis of chondrogenic markers 
In chapters IV and VI real-time qRT-PCR was performed to detect amplification variations using 
PerfeCTa® SYBR® Green FastMix®, (Quanta Biosciences, USA) on Eppendorf Mastercycler® ep 
realplex gradient S machine. The relative quantification of the gene expression was calculated using the 
2-ΔCt and 2-ΔΔCt method [42]. The mRNA expression levels of target genes were normalized to the 
average expression of endogenous housekeeping gene GAPDH (glyceraldehyde-3-phosphate 
dehydrogenase) value. The number of cycles and annealing temperature were selected according to 
the manufacturer‘s instructions. All the primer sequences were generated using Primer3 software and 
acquired from MWG Biotech. More details can be found in Table 3. 
In chapter VI conventional PCR was performed using a High- Fidelity DNA Polymerase (Finnzymes) and 
dNTP Mix (Finnzymes) as well as a primer concentration of 0.2 mM in a 35 cycle 3-step reaction. The 
PCR products were detected in a 1.3 % agarose gel (SeaKem®LE agarose, Lonza) using a 100 bp DNA 
ladder (GeneRuler™ SM024, Fermentas). Images from the gels were obtained using a UV 
Transiluminator (BioSpectrum AC Chemi HR 410, UVP). 
 
II.6. IN VIVO IMPLANTATION 
II.6.1. Preparation of κ-carrageenan hydrogel discs 
For the in vivo study, described in chapter VII, the κ-carrageenan hydrogels samples were prepared as 
follows: the polymeric powder was mixed with distilled water under constant stirring at 60 ºC to obtain 
a final concentration of 2 % (w/v). The polymer solution was then casted into a mould (plastic Petri 
dishe of 55 mm ) and kept at room temperature (RT) for 2-5 minutes, forming a solid gel and further 
stabilized by cross linking with KCl for 15 minutes. Finally the gels were washed with PBS to remove 
the excess of KCl present on the surface. Discs of Ø 8 ±0.01 mm x 2.5 ±0.46 mm height were then 
cut-off using a sterile punching device. Agarose hydrogels were used as a control material, were 
produced using a sterile agarose low gel temperature (800257, MP Biomedicals) 2 % (w/v) solution, 
heated up to 70 °C for 30 seconds, until complete dissolution. The solution was cooled at RT, 
decreasing the temperature and promoting gelation.  
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II.6.2. Preparation of cell laden κ-carrageenan hydrogel discs 
In chapter VIII, κ-carrageenan hydrogels discs for subcutaneous implantation were prepared as follows: 
the polymeric powder was mixed with distilled water under constant stirring at 60 ºC to obtain a final 
concentration of 1.5 % (w/v). The polymer solution (100 μl) was poured into 48 well plates and kept at 
room temperature (RT) for 2-5 minutes, to form gel and further stabilized with KCl for 10 minutes. 
Afterwards, discs of 11.5 ±0.01 mm x 1.8 ±0.24 mm height were washed with PBS to remove the 
excess of KCl.  
The human adipose derived stem cells (hASCs) used in this assay, were enzymatically isolated 0.2 % 
collagenase type II (C6885, Sigma) in PBS for 45 min at 37 °C under gentle stirring as previously 
described in section 4.2.3. For the cell encapsulation experiments, κ-carrageenan 1.5 % (w/v) solution 
was added to the cells to obtain a final concentration of 5x106 cells×mL-1. The discs with encapsulated 
cells were cultured in chondrogenic differentiation medium for 7 days or freshly loaded in κ-
carrageenan, just before they were subcutaneously implanted. Additional controls consisted of κ-
carrageenan hydrogel samples without cells and empty defects were created. The chondrogenic 
differentiation medium was composed of Dulbecco‘s Modified Eagle‘s Medium- low glucose (DMEM, 
D5523, Sigma), supplemented with 10 % FBS (10270-106 Gibco, Invitrogen), 1% Antibiotic-Antimycotic 
(15240-062, Gibco, Invitrogen), ITS+1 Liquid Media Supplement (I2521- insulin-transferrin-selenium - 
liquid media supplement, Sigma), 17 mM L-ascorbic acid (A4544, Sigma), 0.1 M sodium pyruvate 
(P4562, Sigma), 35 mM L-proline (P5607, Sigma), 1 mM dexamethasone (D4902, Sigma) and 10 
ng/ml of human TGF‐β1 (Transforming Growth Factor‐β1, 14‐8348, eBioscience). 
 
II.6.3. Subcutaneous implantation of κ-carrageenan hydrogel discs 
The in vivo biocompatibility was evaluated by subcutaneous implantation of the hydrogels, using a total 
of 20 rats (12-weeks-old Wistar male rat with an average weight between 260 and 300 g), 
corresponding to 10 rats / time point / condition. All animal studies were performed accordingly to the 
national guidelines and conducted in accordance with Portuguese legislation (Portaria nº1005/92) and 
international standards on animal welfare as defined by the European Communities Council Directive 
(86/609/EEC). Surgeries were performed under general anesthesia, intraperitoneal (IP) administration 
route using a combination of medetomidine (Dormitor® - 0.5mg/Kg) with ketamine (Imalgene® - 
75mg/Kg) and post-surgical pain control subcutaneous administration route with carprofen (Rimadyl®, 
2.5-5mg/Kg) was performed for each animal. κ-Carrageenan and agarose hydrogels discs (Ø 8±0.01 
mm x 2.5±0.46 mm height) were prepared as described in previous section. Under surgical sterile 
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conditions, two full thickness skin longitudinal incisions (about 1 cm) containing the subcutis and the 
panniculus carnosus (skin and smooth muscle) were performed in the dorsum of each animal (anterior 
and posterior incisions). Cranial and lateral oriented subcutaneous pockets were created by blunt 
dissection, one on each side of the incision. The hydrogel discs were inserted into these pockets (four 
discs of the same materials per animal), and the panniculus carnosus and the skin were carefully 
sutured (Figure 10). A negative control group was set for the time periods of implantation with empty 
pockets. As positive control group, rats were injected with LPS (1μg/g rat body weight, L4641, Sigma) 
24h before the collection of exudates. After each predetermined implantation time period (7 and 15 
days), each animal was induced with isofluorane and injected (IP) with an overdose of pentobarbital 
sodium (Eutasil® from Ceva Saúde Animal). 
 
 
Figure II- 10. Four individual skin longitudinal incisions (1 cm) with cranial oriented subcutaneous 
pockets were created by blunt dissection. 
 
II.6.4. Subcutaneous implantation of cell laden κ-carrageenan hydrogel discs 
The study described in chapter VIII was designed as a pilot/preliminary study to assess the stability of 
the κ-carrageenan hydrogels laden with either fresh or pre-cultured hASCs, as compared to the 
hydrogels alone, since in the previous in vivo study it was found that the hydrogels were ―dissolved‖ 
shortly after implantation. Surgeries were made on 9-week-old male Wistar rats under standard sterile 
conditions. Briefly, the rats were anesthetized with an intraperitoneal injection of a combination of 
medethomidine (30-100 μg/kg) plus ketamine (50-100mg/kg). After shaving the hair and disinfection 
with povidone-iodine (Betadine), a longitudinal incision was made on four distinct regions of the back of 
the rats. Ionic κ-carrageenan hydrogels with and without cells were implanted subcutaneously. Empty 
defects were used as controls. Then, the wounds were closed with a nonabsorbable polypropylene 
suture 4-0. All the animal experiments were performed accordingly with the National Ethical Committee 
for Laboratory Animals and conducted in accordance with Portuguese legislation (Portaria nº1005/92) 
and international standards on animal welfare as defined by the European Communities Council 
Directive (86/609/EEC). Each rat received the implantation of 4 constructs randomly placed on their 
 
________________________________________________________________Chapter II. Materials and Methods__ 
108 
 
back. Animals were placed on a heating pad under a warming light and observed until they recover 
consciousness. Animals were assessed for 30 minutes following their return to consciousness to 
assess evidence of distress and placed in cages (2/3 per cage). Animals received analgesia 
preoperatively (lidocaine) and during the post-operative period (carpofen) as needed based on evidence 
of discomfort. This was evaluated by animal behavior, feeding, and vocalization. Sutures were removed 
after 7 days postoperatively and animals were euthanized by asphyxiation with CO2. The explanted 
tissues were fixed in 4% formalin, embedded in paraffin, sectioned and processed for histological 
analysis. 
 
 
Figure II- 11. Four individual subcutaneous pockets, created by blunt dissection, were filled with 
different conditions. 
 
II.6.5. Collection of explants 
In chapter VII, at each time point, explants were retrieved from the four implantation sites of each 
animal together with the respective axillary and inguinal lymph nodes. Explants were either fixed in 3.7 
% formalin for histological evaluation, or frozen for posterior PCR analysis. 
In chapter VIII, the explants were retrieved from the implantation sites of each animal and fixed in 3.7 % 
formalin and processed under standard histological tissue processing techniques for paraffin 
embedding.  
 
II.6.6. Characterization of explants 
II.6.6.1. HISTOLOGICAL CHARACTERIZATION 
For histological analysis, explants were subjected to standard histological tissue processing for paraffin 
embedding. Sections with 4 μm thickness were obtained using a microtome (HM355S, Microm, 
Thermo scientific) and stained with haematoxylin and eosin (05-12011/L, 05-M10003, Bio-optica) in 
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an automatic stainer (HMS740, Microm, Thermo scientific). H&E staining was performed based on the 
protocol already detailed in the section with the procedures for histological characterization (5.6.1). 
In chapter VIII, sections with 4 μm thickness were obtained using a microtome and stained with 
haematoxylin and eosin and Masson Goldner Trichrome (MGT) staining. The last staining is 
recommended for connective tissue, nuclei or collagen and tree different stains were used: Weigert‘s 
iron hematoxylin for nuclei, picric acid for erythrocytes and light green for collagen. After typical 
hydration steps, Weigert‘s iron hematoxylin reagent was added to the sections and left to act for 15 
minutes. Without washing, the slides were drain and picric acid alcoholic solution was added to the 
section for 4 minutes. After quick wash in distilled water the other reagents were put on the section to 
act for a total of 15 minutes. Washing in distilled water and rapid dehydration through ascending 
alcohols, clearing in xylene and mounting was performed as last step. 
 
II.6.6.2. IMMUNOHISTOCHEMISTRY FOR CD163 AND CD25 ANTIBODY 
Immunohistochemistry was performed on histological sections to assess presence/localization of 
different cell populations and thus tissue response to the implants, namely inflammatory cells 
infiltration (chapter VII). Detection of recruited macrophages and activated lymphocytes was completed 
using an avidin-biotin alkaline phosphatase technique. The tissue sections were dewaxed, rehydrated 
and the antigen retrieval was achieved by heating at 96 °C with 10 mM citrate buffer, pH=6, for 40 
minutes. Sections were washed in PBS and endogenous peroxidase activity was blocked with 0.6 % 
hydrogen peroxide - methanol for 10 min at 22 °C. Afterwards, the permeabilization was done with 
Triton™ X-100 (X-100, Sigma) followed by incubation with protein block buffer for 20 min at 22 °C. 
Excess serum was removed by blotting and the sections were incubated overnight at 4 °C with either 
CD163 antibody (ED2, MCA342GA, AbD Serotec) to detect recruited macrophages or CD25 antibody 
(MCA494GA, AbD Serotec) to detect activated lymphocytes. After incubation, sections were rinsed with 
PBS for 5 min and incubated with polyclonal swine anti-mouse, goat, rabbit IgG antibody (Dako) for 1 h 
at room temperature. Further washes in PBS were performed prior to exposure of the sections to 
Vectastain elite ABC reagent (PK-6200, Vector Laboratories Ltd.) for 30 minutes at 22 °C and the 
substrate reaction was developed using the the 3,3′-diaminobenzidine (DAB) peroxidase substrate 
solution (SK-4100, Vector Laboratories Ltd.). Finally sections were counterstained with haematoxylin for 
1 minute and mounted with Entellan® (4111, Inopat). Stained sections were observed under a light 
microscope (Reflected/Transmitted light Microscope, Zeiss Germany) and images obtained with Axion 
MRc5; Zeiss, camera.  
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II.6.6.3. PCR ANALYSIS OF INFLAMMATORY MARKERS 
RT-PCR analysis was used to detect at the molecular level, the expression of inflammatory markers, 
namely IL-1 alpha, IL-4, and IFN- gamma. The housekeeping gene was glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) chosen as an endogenous control for the experiments. The detailed 
description of the sequence of the primers used is presented in Table II.4. The explanted tissue was 
transferred to eppendorfs tubes with 1 mL TRI Reagent® RNA Isolation Reagent (T9424, Sigma) and 
stored at -80 °C until processing. The homogenization of the biologic tissue was achieved using a 
mortar and pestle. Total RNA was extracted from samples following the manufacturer‘s guidelines (TRI 
Reagent®). The amounts of isolated RNA from samples with A260/280 ratio between 1.6 and 2.0 were 
determined using Nanodrop ND-1000 Spectrophotometer (Bonsai 06/2008 NanoDrop Technologies). 
A predetermined amount of RNA from each sample was reverse transcribed into cDNA using qScript™ 
cDNA Synthesis Kit (Quanta Biosciences) using a MJ Mini™ Personal Thermal Cycler (Bio-Rad 
Laboratories) machine. Amplification of the sequences of interest was performed using a GoTaq® 
Green Master Mix (M7112, Promega) and the primers were used at a concentration of 10 μM in a 30 
cycle 3-step reaction. The PCR products were visualized in a 1.7 % agarose gel (SeaKem ®LE agarose, 
Lonza) with a DNA marker pBR322 - Hae III (A5229, AppliChem). Images from the gels were taken 
using a UV Transilluminator (BioSpectrum AC Chemi HR 410, UVP). 
 
Table II- 4. Primer pair sequences and annealing temperatures for the genes analyzed by RT-PCR on 
samples retrieved from in vivo experiments performed in a rat model. 
II.7. STATISTICAL ANALYSIS 
Statistical analysis was carried out by mean  standard error of mean. Several statistical methods were 
used in this thesis, accordingly to the experimental assay requirements. First, an F-test was used to 
ascertain about the data normality to determine equality of variance, or the data was inspected with 
Shapiro-Wilk test. The null hypothesis, that the means of each set were equal, was evaluated with a 
95% confidence level (α=0.05). If the null hypothesis was found to be false, indicating that the means 
Target 
gene 
Sequences Tm  
[ºC] 
Bp 
Sense Antisense 
IL-1α GCAAAGCCTAGTGGAACCAG GCAGAAGGTGCACAGTGAGA 59.4 244 
IL-4 TTTTGAACCAGGTCAACACCA GTGAGTTCAGACCGCTGACA 57.4 - 
IFN-γ GCCCTCTCTGGCTGTTACTG CTGATGGCCTGGTTGTCTTT 59.4 221 
GAPDH GGTGATGCTGGTGCTGAGTA GGATGCAGGGATGATGTTCT 58.4 81 
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of the different experimental treatment sets were not equal, then multiple comparison tests was 
performed [43]. 
The results indicated that at the 0.05 level, the data was significantly drawn from a normally distributed 
population and analysis of variance (ANOVA one way) followed by Tukey test was used to determine 
significant differences between groups and conditions using with OriginPro 8 program or GraphPad 
Prism statistic software. The difference was considered significant when p < 0.05 [44].  
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CHAPTER III* 
CELL DELIVERY SYSTEMS USING ALGINATE-CARRAGEENAN HYDROGEL BEADS AND FIBERS FOR REGENERATIVE MEDICINE 
APPLICATIONS 
 
ABSTRACT 
 
 
The present work was focused on the development and characterization of new hydrogel systems 
based on natural origin polymers, namely alginate and carrageenan, into different formats and with 
adequate properties to sustain the viability of encapsulated cells, envisioning their application as cell 
delivery vehicles for tissues regeneration. Different formulations of alginate and carrageenan hydrogels 
and different processing parameters were considered in order to determine the best conditions 
required to achieve the most adequate response in terms of the mechanical stability, cell viability and 
functionality of the developed systems. The morphology, size and structure of the hydrogels and their 
degradation behavior and mechanical properties were evaluated during this study. In addition to 
cytotoxicity studies, preliminary experiments were carried out to investigate the ability of alginate-
carrageenan beads/fibers to encapsulate chondrocytes. The results obtained indicated that the 
different formulations, both in the form of beads and fibers have considerable potential as cell-carrier 
materials for cell delivery in tissue engineering/regenerative medicine applications.  
 
 
 
 
Keywords: Natural hydrogels, Encapsulation, Carrageenan, Cell delivery, Chondrocytes, Cell viability. 
 
 
 
 
* This chapter is based on the following publication: 
Popa E. G., Gomes M. E., and Reis R. L., "Cell Delivery Systems Using Alginate–Carrageenan Hydrogel 
Beads and Fibers for Regenerative Medicine Applications", Biomacromolecules, vol. 12, issue 11, pp. 
3952-3961, 2011. 
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III.1. INTRODUCTION 
Hydrogels are the basis for cell encapsulation/delivery systems, one of the most promising approaches 
for the delivery of cells and therapeutic agents to the site of interest, allowing a wide range of 
application in the regenerative medicine field [1]. During the last decade, several different hydrogels, 
particularly algal polysaccharides, have been used as cell-delivery matrices [2, 3]. Naturally derived 
hydrogels have frequently been employed because they are either composed of components or have 
macromolecular properties similar to the natural extracellular matrix of human tissues [4, 5]. With 
today‘s interest in novel renewable polymers, the underexploited marine red algae family belonging to 
carrageenan seaweeds stimulated our interest as a source of polysaccharides with innovative structure 
and functional properties. Many different hydrogels have been previously studied for biomedical 
applications, but carrageenan displays a unique potential in this field and has been very little explored 
until the present time. Carrageenan is a naturally occurring polysaccharide used far more widely than 
agar as emulsifier, gelling, thickening and stabilizing agent in pharmaceutical [6] and industrial 
formulations. Their relatively low cost promoted their use in environmental and commercial 
applications as well [7]. This hydrophilic polysaccharides resemble to some extent to the naturally 
occurring glycosaminoglycans (GAG's) owing to their backbone composition of sulphated disaccharides 
[8]. There are three main commercial classes of carrageenan namely: κappa, that has only one 
negative charge per disaccharide and produces strong, rigid gels (extracted from Kappaphycus 
cottonii), the ιota type which has intermediate sulphate content and produces soft gels that provide 
excellent freeze/thaw stability (extracted from Eucheuma spinosum) and lambda, which is highly 
sulphated, less likely to form a gel structure, but forming gels when mixed with proteins rather than 
water [9]. Potassium salts are essential for κ-carrageenan hydrogel in order to form this firm gel 
structure. As the level of potassium is increased, the resulting gel structure becomes tightly aggregated 
and may cause syneresis (moisture on the gel surface - the separation of liquid from a gel) [10]. Ιota-
carrageenan forms elastic, dry gels especially in the presence of calcium salts. The 2-sulfate groups on 
the outside of the ιota carrageenan molecule do not allow the helices to aggregate to the same extent 
as κappa carrageenan, but form additional bonds through calcium interactions.  Because of the ionic 
nature of carrageenan, the gelling and melting temperatures are dependent almost solely on the 
concentration of the ions and gelation is strongly influenced by the presence of electrolytes [11]. This 
hydrophilic polysaccharide forms a gel with potassium and calcium ions, but also shows gelation under 
salt-free conditions helped by physical bonds being a thermosensitive hydrogel [12]. Thermoreversible 
gels, such as carrageenan, melt at elevated temperature and the gelation of the biopolymer is obtained 
by lowering the temperature. The temperature-induced gelation allows for an easy formation of gels 
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with different shapes emphasizing the versatility of the carrageenan. Contrarily to carrageenan, 
alginates are probably the most extensively studied and characterized hydrogels for cell 
encapsulation/delivery [13-15]. Besides that, alginate has a similar gelation mechanism to 
carrageenan and thus, in this study we have focused on the development of hydrogels composed of 
mixtures of alginate with different types of carrageenan. The mixture of gelled hydrocolloids, in this 
case alginate and carrageenan, acts synergistically as a result of the similarity in the type of the 
polysaccharide gelling mechanism and is expected that carrageenan favors the final properties of the 
mixture, providing better mechanical properties and tailored degradation profiles. The gelation reaction 
is produced when cations diffuse into hydrocolloid solution and specific segments of the alginate and 
carrageenan polymers interact with K+ and Ca2+ ions [16]. In this study several methodologies were 
tested in order to produce a wide range of systems based on carrageenan-alginate mixtures, with 
different properties in terms of biological and mechanical performance. The processing methodologies 
used were based on ionotropic gelation and wet spinning to produce different formats like beads and 
polymeric fibers [17, 18]. The morphology and structure were analyzed by scanning electron 
microscopy (SEM), the size, shape and membrane thickness were observed by light microscopy and 
the mechanical properties of the obtained hydrogels were evaluated by compression tests. 
Furthermore, the effect of several parameters, such as pH and different ionic compositions of 
immersion solution, on the in vitro degradation of the prepared hydrogels was evaluated. The 
biocompatibility of the developed systems was assessed by standard cytotoxicity assays. Chondrocytes 
were encapsulated and cultured into the developed beads/fibres and characterized in terms of cell 
viability (MTS assay), cell proliferation (DNA quantification) and by histological staining. In summary, 
the main goal of this work consisted in the development of an efficient cell delivery system based on 
combining properties of two natural polymers alginate and carrageenan.  
 
III.2. MATERIALS AND METHODS 
III.2.1. Materials 
Alginic acid sodium salt from brown algae (71238, Sigma, USA), κappa-carrageenan (22048, Sigma 
Fluka, USA), ιota-carrageenan (22045, Sigma Fluka, USA) and phosphate buffer saline (P4417-PBS 
Sigma, USA) were used without further purification. Calcein-AM (acetoxymethyl ester of calcein-C3099) 
was purchased from Invitrogen (Portugal).  
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III.2.1.1. DEVELOPMENT OF ALGINATE-CARRAGEENAN BEADS 
The hydrogel beads were obtained based on a droplet technique, which consists in the extrusion of the 
liquid polymer from the tip of a capillary tube continuously until it achieves a critical mass and then 
detaches and falls into a receiving solution [19]. Alginate and carrageenan aqueous dispersions were 
prepared separately by dissolving each of the biopolymers in distilled water, heated up at 50 0C (for 
alginate) and 60 0C (for carrageenan) under constant stirring from 30 min to 2 hours until complete 
dissolution [20]. The mixtures/blends composed of 8.0 g alginate solution and 2.0 g carrageenan 
solution with concentrations varying from 2 to 3.5 % (blend of alginate  with κappa carrageenan are 
herein designated by AK and blends of alginate with ιota carrageenan  by AI ), were prepared by mixing 
under constant stirring at 30 0C for 30 min. Previous to use, all solutions were sterilized by steam 
power during 30 minutes at 120 0C. The solutions were prepared just before use, in order to avoid the 
initial thermal degradation steps which might affect the biomaterial response. Briefly, the beads were 
prepared by dropping the mixture using a pump (AL-1000, Alladin Programmable Syringe Pump) from 
a 5-mL disposable syringe equipped with a needle of 25G inner diameter into the aqueous salt 
solutions stirred magnetically. The precipitating solution was composed of 100 mL of 2 % (w/v) KCl 
and CaCl2 and the pH of the solution was previously adjusted to 7.4. After gelation at fixed conditions 
(30 drops/min, agitation rate 50 rpm, hardening time 30 min, 25G inner diameter of the needle) the 
formed beads were separated, washed and stored at 4 0C, until use. The compositions of the different 
formulations studied and the different parameters used for their preparation are described in Table 1.  
 
III.2.1.2. DEVELOPMENT OF ALGINATE-CARRAGEENAN FIBRES 
For the preparation of the polymeric fibers, it was used the same working solutions as described in the 
previous section for preparing the beads. The fibers were obtained by wet spinning, an easy and 
reproducible method, which consists in immersing the needle into the cross-linking solution. Each 
polysaccharide is ionically cross-linked with the corresponding cations, thus, alginate and carrageenan 
prefer to form a stable gel with Ca2+ and K+, respectively. Alginate-carrageenan fibers were produced 
using a coagulation bath of CaCl2*KCl 2%, aiming at producing 3D fiber meshes. Both κappa and ιota 
carrageenan can shape hydrogels with potassium and calcium salts. They have the ability to form, 
upon cooling and after addition of the salt, an infinite variety of gels due to development of double 
helices of polymeric chains into the building blocks of a three-dimensional network. The shape and 
stability of the hydrogels formed by extrusion techniques are determined by numerous physico-
chemical factors. Experimental conditions were optimized, such as the distance between the syringe 
and gelation media, several inner diameters of the needle (21G, 25G and 29G); the flow rate of the 
 
___________________Chapter III. Cell delivery systems using alginate-carrageenan hydrogels__ 
123 
 
polymeric solution falling into gelation bath, the cross linker concentration and also the temperature of 
the system (Table 1).  
 
Table III- 1. Conditions studied referring to the alginate- carrageenan ratio, polymeric concentration, the 
salts used to crosslink the gels and their concentration, different types of carrageenan (κappa or ιota), 
and processing parameters for obtaining the hydrogels such as hardening time, flow rate and inner 
diameters of the needle.  
Materials 
Alginate-
Carrageenan 
ratio 
Polymeric 
Concentrat
ion (%) 
Salt 
type 
Salt 
Concentr
ation (%) 
Hardening 
time (min) 
Flow rate 
(drops/
min) 
Inner 
diameters 
Alginate -
κappa 
Carrageenan 
5 : 5 
7 : 3 
8 : 2 
2 
CaCl2 
*KCl 
2 
15 
30 
60 
15 
30 
60 
21G 
25G 
29G 
2.5 2.5 
3 3 
3.5 3.5 
Alginate –
ιota 
Carrageenan 
5 : 5 
7 : 3 
8 : 2 
2 
CaCl2 
*KCl 
2 
2.5 2.5 
3 3 
3.5 3.5 
 
III.2.2. Physico-chemical characterization of the developed hydrogels 
III.2.2.1. MORPHOLOGICAL CHARACTERIZATION 
In this work, the size, shape and surface characteristics of the developed hydrogels were examined 
using a stereomicroscope (Zeiss, Stemi 1000 PG-HITEC) and the images were obtained using a 
camera PowerShot G6, Canon. Scanning Electron Microscope (SEM - Leica Cambridge S-360, UK) was 
used to observe the surface and the cross section morphology of the hydrogels. For SEM analysis, 
samples of each condition were washed in PBS, dehydrated in a gradient series of ethanol solutions 
and allowed to dry completely at room temperature before sputter coating with gold (Fisons 
Instruments, Sputter Coater SC502, UK).  
 
III.2.2.2. DEGRADATION BEHAVIOUR OF THE PREPARED HYDROGELS 
Degradation studies were carried out by immersion of the hydrogels discs (Ø 7 ±0.01 x 10±0.02 mm 
height, n=3) in phosphate buffered saline (PBS, pH 7.4) and culturing medium (DMEM, pH 7.4) at 37 
0C. The hydrogel were lyophilized, weighed (initial weight) before being transferred to 15 ml Falcon 
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tubes and soaked in 10 ml PBS or DMEM under constant agitation (60 rpm). After each selected 
degradation time point (final weight), namely 1, 7, 14 and 21 days, the samples were washed 
thoroughly with PBS to remove traces of soluble degradation products, salts, or other impurities and 
then dried until constant weight was achieved. The degradation solutions were changed every 7 days to 
restore the original level of ions activity. At the end of each degradation period, the dried samples were 
weighed for determination of weight loss. The extent of degradation is commonly determined by 
calculating the percentage of weight loss (eq 1).  
 
𝑊𝑒𝑖𝑔ℎ𝑡 𝑙𝑜𝑠𝑠  % =
𝐼𝑛𝑖𝑡𝑖𝑎𝑙  𝑤𝑒𝑖𝑔 ℎ𝑡  –𝐹𝑖𝑛𝑎𝑙  𝑤𝑒𝑖𝑔 ℎ𝑡
𝐼𝑛𝑖𝑡𝑖𝑎𝑙  𝑤𝑒𝑖𝑔 ℎ𝑡
 × 100         (1) 
 
III.2.2.3. MECHANICAL TESTING 
Uniaxial compression tests were performed to characterize the mechanical behavior of the produced 
2.5 % (w/v) alginate/κ-carrageenan hydrogels discs (Ø 15 ± 0.51 mm x 5.5 ± 0.46 mm height). The 
hydrogels discs of blends with ιota carrageenan type were not tested since it was nearly impossible to 
achieve samples with precise dimensions and thus difficult to obtain results after mechanical tests. The 
tests were carried out at room temperature conditions using a universal mechanical testing machine 
(Instron, 4505 Universal Machine). Mechanical testing was performed under compression using a 
crosshead speed of 5 mm/min and the results from tests conducted for at least 10 specimens. The 
details regarding these methods are presented elsewhere [21].  
 
III.2.3. Biological characterization of the developed hydrogels 
III.2.3.1. CYTOTOXICITY EVALUATION 
The cytotoxicity of the constituent‘s released from the materials was evaluated using cell culture 
methods, namely MEM extraction test (72 h) in order to select the most promising and/or reject any 
possible systems that are cytotoxic. In all cytotoxicity tests performed, latex rubber and tissue culture 
plastic were used as positive and negative controls, respectively. These assays are particularly aimed at 
establishing the possible toxic effects of leachable released from medical polymers during extraction. 
The objectives of the MEM extraction test are to evaluate changes in cell morphology and growth 
inhibition, whereas the MTS (3-(4,5-dimethylthiazol-2-yl)-5(3-carboxymethoxyphenyl)-2(4-sulfofenyl)-2H-
tetrazolium) assay determines whether cells are metabolically active [22]. The detailed method is 
presented elsewhere [23]. Briefly, for biocompatibility assessment of the different formulations of the 
developed hydrogels a mouse fibroblast-like cell line, L929 (ECACC- European Collection of Cell 
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Cultures, UK) was used. Cells were feed with Dulbecco‘s modified Eagle‘s medium (DMEM, Sigma-
Aldrich), supplemented with 10% fetal bovine serum (FBS, Gibco, UK) and 1% antibiotic/antimycotic 
(A/B, Gibco, UK) solution. L929 cells were incubated at 37 0C in an atmosphere containing 5 % CO2 
until 90 % confluence was achieved. Then, a cell suspension with a concentration of 2x104 cells/ mL 
(4000 cells/well) was prepared and seeded onto 96-well plates. Extract of the developed materials 
were prepared by incubating the hydrogels with media containing serum at an extraction ratio of 
3cm2/ml for 24 h at 37 0C. One hundred microliter of the extracts of the hydrogel, negative control 
(standard culture medium), and positive control (latex rubber) were placed on 80 % confluent 
monolayer of cells. The absorbance of the resulting solution in each well was recorded immediately at 
490 nm using an automated Multi-Mode Microplate Reader (Synergy™ HT, Bio-Tek Instruments, USA). 
Results were presented as OD (optical density) after extraction of the blank value (i.e; medium only) 
and we conducted all cytotoxicity screening tests by using six replicates. The results were expressed as 
percentage of cell viability calculated using the following equation: 
 
𝐶𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦  % =
𝑂𝐷  𝑠𝑎𝑚𝑝𝑙𝑒
𝑂𝐷  𝑐𝑜𝑛𝑡𝑟𝑜𝑙
 × 100           (2), 
where OD sample is the optical density obtained in the cells exposed to each extract and OD control is 
the OD obtained in the cells incubated with the culture medium only (negative control). 
 
Table III- 2. Results obtained from cytotoxicity tests performed using extracts of AK and AI hydrogels 
with different concentrations. The results are based on the MTS test performed after 1, 3, and 7 days 
of culture. 
Samplesa Day 1 Day 3 Day 7 
AK2.5% 74.13 ± 0.72 40.57 ± 2.68 54.39 ± 0.78 
AK3% 128.26 ± 6.89 123.00 ± 1.73 98.77 ± 4.88 
AK3.5% 106.89 ± 0.62 96.23 ± 3.22 90.26 ± 5.40 
AI2.5% 55.99 ± 5.39 28.59 ± 2.03 35.89 ± 0.31 
AI3% 91.26 ± 5.50 86.56 ± 2.16 75.24 ± 0.89 
AI3.5% 106.89 ± 0.62 96.23 ± 3.22 90.26 ± 5.40 
aWe determined the values by taking into account the fact that TCPs (negative control) corresponded to 100 %. Latex was 
used as a positive control of cell death and produced cell viability values that were considered to be negligible. 
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III.2.4. Encapsulation of ATDC5 cells into alginate/carrageenan hydrogels 
Cell encapsulation experiments were performed to assess the viability of cells incorporated in the 
developed hydrogels and to further select/optimize the developed formulations as well as the 
encapsulation conditions. ATDC5 cells, a cell line established from chondrocytic cells of a mouse 
embryonal carcinoma (mouse 129 teratocarcinoma AT805 derived, ECACC, UK) was selected for this 
work, since these cells are more biologically active in a 3D environment and have been extensively 
studied to assess their role in producing, maintaining, and remodeling the cartilage ECM [24]. As 
previous experiments revealed that the shape of the hydrogel didn‘t affect differently the viability or 
proliferation of the cells herein it was decided to present results based on hydrogels with fibers shape. 
Prior to cell culture studies, alginate/carrageenan solutions were sterilized by heat for 30 min at 120 
0C. The cells were expanded in cell culture medium (Ham's F-12 medium (DMEM-F12, Gibco, UK) 
supplemented with 10 % FBS (Gibco, UK), 2mM L-glutamine (Sigma), and 1% A/B antibiotic solution 
(Gibco, UK) at 37 0C in CO2 incubator, until obtaining the necessary number of cells for the 
experiments. After trypsinization and centrifugation, the cell suspension obtained was diluted in order to 
encapsulate 1x106 cell/ml of the polymeric solution to produce the beads/fibers as previously 
described. The beads/fibers with encapsulated cells were then placed into non-adherent 24 well-plates 
and maintained in culture for several periods of time (1, 7, 14 and 21 days) at 37 0C in a CO2 
incubator. At the end of each time of culture, the beads/fibers with the encapsulated cells were 
retrieved, washed with PBS solution and maintained at 4 °C in PBS for further characterization studies. 
 
III.2.4.1. LIGHT OPTICAL MICROSCOPY AND FLUORESCENCE STAINING WITH CALCEIN-AM  
ATDC5 cell morphology after encapsulation in beads and fibers was observed under inverted light 
microscope (Zeiss, Axiovert 40 PG-HITEC). The viability of ATDC5 cell line was investigated using 
Calcein AM fluorescence labeling after 21 days in culture. For this assay, the samples were washed 
with PBS, placed in a new well plate with 1 mL of DMEM and 2 µL of a Calcein-AM solution (at 1/1000 
dilution) and incubated for 15-30 min at 37 0C in 5 % CO2. The fluorescence staining was washed and 
replaced by 500 µL of formalin (10 %) for 10 min at room temperature to fix the cells. Afterwards the 
formalin was removed and the beads and fibers were rinsed twice in PBS and observed under a 
reflected/transmitted light microscope (Zeiss, Axiocam MRc5).  
 
III.2.4.2. ASSESSING THE METABOLIC ACTIVITY (MTS ASSAY) 
The alginate-carrageenan polymers with encapsulated ATDC5 cells were cultured for 1, 7, 14 and 21 
days; cell free hydrogel samples were kept in the same conditions to be used as experimental controls. 
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After each of the selected time points of culture, the medium was removed; samples were washed with 
PBS and assessed for their metabolic activity using the CellTiter 96® AQueous One Solution Cell 
Proliferation Assay (MTS, Promega). Briefly, cell–hydrogel constructs (n=3) were washed in PBS and 
placed in a mixture containing serum-free cell culture medium DMEM (without phenol red) and MTS 
reagent at a 5:1 ratio and incubated for 3 h at 37 0C in a humidified atmosphere containing 5 % CO2, 
at the end of which 100 mL (n=6) was transferred to 96 well plates and the OD determined at 490 nm.  
 
III.2.4.3. CELL PROLIFERATION BY DNA QUANTIFICATION 
ATDC5 cell proliferation in the hydrogels was determined using a fluorimetric double-strand DNA 
quantification kit (Quant-iT™ PicoGreen® dsDNA reagent, Molecular Probes, Invitrogen). For this 
purpose, samples that were collected at 1, 7, 14 and 21 days of culturing were transferred into 1.5 mL 
microtubes containing 1mL of ultrapure water. ATDC5 cell-hydrogel constructs and the hydrogel alone 
(without cells), used as control, were incubated for 1 h at 37 0C in a water bath and were then stored in 
a -80 0C freezer until they were tested. Prior to dsDNA quantification, constructs were thawed and 
sonicated for 15 min. Samples and standards (ranging from 0 to 2 µg/mL) were prepared and mixed 
with a PicoGreen solution in a 200:1 ratio and were placed on opaque 96-well plate. Each sample or 
standard was made in triplicate. The plate was incubated for 10 min in the dark, and fluorescence was 
measured on a microplate reader (Synergy™ HT, BioTek Instruments) with an excitation of 485/20 nm 
and an emission of 528/20 nm. A standard curve was created, and sample DNA values were read 
from the standard graph. 
 
III.2.4.4. HISTOLOGICAL ANALYSIS (H&E STAINING) 
Hydrogels fibers samples were collected at each time point of the study and previously fixed with 10 % 
formalin were processed by a series of dehydration steps, embedded in paraffin and sectioned at 4 µm 
(HM355S Rotary Microtome, Thermo Scientific). Haematoxylin and eosin (H&E) staining was conducted 
in automatic staining equipment (Microm HMS 740) and then cleared in xylene (VWR) and mounted for 
further analysis.  
 
III.2.5. Statistical analysis 
Data of compression, degradation, MTS and DNA assay are presented as means ± standard deviations, 
with n=6 for each group. For statistic analysis multiple pair‘s comparison has been performed using 
One-Way ANOVA, Tukey method with a significance level of 0.05, using OriginPro 8 program. First an F-
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test was used to ascertain about the data normality of the results, namely to determine the equality of 
variance.  
 
III.3. RESULTS  
III.3.1. Development of carrageenan-alginate hydrogel beads and fibers  
This study has focused on the development of novel hydrogels based on natural-origin polymers, 
namely alginate and carrageenan. In order to obtain the optimum hydrogel formulation several aspects 
were considered, such as, the use of different types of carrageenan, ιota and κappa, different 
concentrations of the polymers and various concentrations of the salts were evaluated (Table 1). 
Parameters related to the processing method, such as flow rate and needle diameter show a direct 
influence in the size of the produced beads; increasing the flow rate of the polymeric solution resulted 
in larger bead diameter and using needles with small diameter resulted in smaller droplets. The 
concentration and molecular structure of carrageenan and alginate, as well as the concentrations of 
calcium and potassium chloride have an important effect in the gelation process. Other aspects related 
to the ionotropic gelation method by droplet formation, namely, droplet rates, flow rate of the viscous 
solution, hardening time, needle distance, needle diameter and pH of the solution were taken into 
account for the optimization of the gel formation. Contrary to κ-carrageenan, no spherical beads were 
formed with formulations based on ι-carrageenan using the selected salt solutions (Table 1). The 
optimum concentration of the reactants was determined using empirically classical methods. 
Experiments with κ-carrageenan type showed that the best bead formation were obtained by dropping 
2.5 % κappa carrageenan polymer into 5 % potassium chloride solution while for ιota carrageenan type 
the best spheres were obtained with 3.5 % dispersion and 2 % calcium chloride. Higher concentrations 
of the polymer dispersion used in this study could not be dropped so easily from the needle due to the 
high viscosity. The same difficulty was observed with lower concentrations, which led to non-stable gels 
in terms of shape and structure. Alginate/κ-carrageenan hydrogels blends were formed faster than κ-
carrageenan alone, due to the quick and strong reaction of alginate with Ca2+ ions. In addition, 
carrageenan basically formed softer beads with less spherical shape than the alginate-based beads. 
Alginate/carrageenan fibers produced by immersion of the polymeric solutions inside the chemical 
bath containing potassium and\or calcium ions presented the same gelling properties as in the case of 
beads formation.  
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Figure III- 1. SEM micrographs of alginate-carrageenan blends surface (8:2) of beads A1 - AK 2.5 %, B1 
- AI 3.5 % and fibres A2 - AK 2.5 %, B2 - AI 3.5 %; embedded images correspond to  light microscopy 
pictures of the same samples in wet state, precipitated in 2 % (w/v) CaCl2*KCl and hardening time of 
30 min. 
 
III.3.2. Morphologic characteristics of alginate/carrageenan hydrogels 
SEM micrographs of the hydrogels namely AK 2.5 % (Fig. 1 A1 -beads and A2 -fibers) and AI 3.5 % (Fig. 
1, B1 –beads and B2 -fibers) showed no significant differences regarding the surface morphology. 
Nevertheless, blends with κappa carrageenan 2.5 % concentration and blends with 3.5 % concentration 
for the ιota carrageenan type led to the formation of the most stable and well defined shapes. From the 
light microscopy images of the beads (Fig. 1, A1 - AK 2.5 %, B1 - AI 3.5 %) and fibers (Fig. 1, A2 - AK 2.5 
%, B2 - AI 3.5 %) in wet state one can observe the smooth and homogeneous surface and the well 
defined and stable shapes. The mean beads dimension for the AK 2.5% (8:2) formulation using 21 G 
needle was 2.76 ±  0.14 mm, using the 25 G diameter needle the mean dimensions was 2.16 ± 0.13 
mm and when applying the needle of 29 G was 1.08 ± 0.07 mm. The mean fibres dimensions for the 
AK 2.5% (8:2) formulation were typically lower and ranging from 1.1 ± 0.08 mm (21 G), 0.9 ± 0.08 
mm (25 G) and 0.56 ± 0.08 mm (29 G). Various complexes of hydrogels were prepared from different 
(5:5 and 8:2) alginate/carrageenan ratios and variations of carrageenan type namely; κappa and ιota 
were assessed (Fig. 2). The hydrogels were cross-linked in reaction with CaCl2 and KCl and SEM 
(Scanning Electron Microscopy) images of cross linked and non-cross-linked hydrogels were compared. 
These images show that the pore size was homogenously distributed and increased with increasing 
carrageenan content. More than 60 % of the hydrogel volume or greater, presented porosity, indicating 
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that the carrageenan content is a key factor for controlling the pore size. Two different pore 
morphologies are obvious in the non-cross-linked, mainly due to the type of carrageenan used, κappa 
hydrogels exhibiting round porosity, small and circular cavities and ιota presenting longitudinal pores, 
large and elongated cavities. Regardless of the hydrogel composition, the pore size (ranging from 100 
~ 200 µm) of cross-linked hydrogels was smaller than the pore size of non-cross-linked ones and many 
pores in cross linked hydrogels were deformed by cross-linking (Fig. 2). The cross-linked hydrogel 
prepared from an 8:2 alginate/carrageenan mixture using κappa type, followed by reaction with 
CaCl2*KCl, enabled the formation of an uniform hydrogel provided by a good miscibility and thus was 
found to be the most suitable hydrogels formulation.  
 
 
Figure III- 2. Scanning Electron Microscopy images of freeze-dried cross sections presenting the 
morphology and porosity of AK 2.5% and AI 2.5% hydrogel blends (5:5, 8:2 polymeric ratio, with cross-
linking agent and without cross-linking, CaCl2*KCl) at 100x magnifications and 200µm. 
 
III.3.3. In vitro degradation studies 
The aim of the degradation studies was to evaluate the behavior of the developed materials in 
simulated physiological conditions. Therefore, the degradation of the hydrogels was monitored as a 
function of incubation time in PBS and DMEM at 37°C, as shown in Fig. 3. During the degradation 
time, most of the formulations based on ιota-carrageenan with a low concentration showed to be very 
unstable, disintegrating after a few days in the degradation media and therefore, only the κappa 
formulation was further analyzed. Moreover, it was found that the hydrogels obtained with higher 
polymeric concentration and a polymeric ratio of 8:2 had acceptable stability and therefore these were 
selected for further and detailed characterization. The polymeric concentration of the hydrogel blend 
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had a significant influence on the weight loss. In the first days of the experiment, the hydrogel blends 
with lower concentrations presented the highest weight loss rate. The hydrogels with 2 % and 2.5 % 
polymer concentrations lost about 35 to 45 % of their weight in the first 7 days of the experiment (Fig. 3 
A). The blended hydrogels with higher concentration (3 % and 3.5 %), showed a lower weight loss rate. 
At day 21, the AK 2.5% formulation presents the highest weight loss. Therefore, this formulation was 
selected for further characterization of the degradation behavior and thus immersed in PBS and DMEM 
medium for up to 21 days. The results obtained from these experiments are presented in figure 3 B. 
Weight loss results showed fast degradation behavior in PBS solution as compared to DMEM medium.  
 
 
Figure III- 3. Representation of weight loss percentage vs. time of alginate/κ-carrageenan discs with 
different polymeric concentrations immersed in medium (A) and measurements after immersion in 
PBS and DMEM solutions at 37°C for AK 2.5% hydrogel blend (B). Values reported correspond to 
averages (n=3) ± standard deviation. 
 
III.3.4. Mechanical characterization by compression tests 
The mechanical properties of the blend consisting of alginate and κ-carrageenan 2.5 % (w/v, ratio 8:2) 
were examined in compression experiments. The Young‘s modulus for AK 2.5% (8:2) in compression 
was found to be 0.7 ± 0.25 MPa. 
 
III.3.5. Biological Studies - Cytotoxicity Assays 
The cytotoxicity of the components that leach out of the developed hydrogels was evaluated by a 
viability assay (the MTS test). Table 3 shows the results of the cellular metabolic activity obtained using 
extracts of the materials under study. The results obtained revealed that the extracts from the samples 
with a higher polymeric concentration did not affect the viability of the cell line L929. This test 
demonstrates the extremely low cytotoxicity levels of the alginate-carrageenan blend when using higher 
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concentrations of the polymers. On the other hand, the hydrogels with the lower polymeric 
concentrations presented a higher cytotoxicity.  
 
III.3.6. Optical microscopy and fluorescence staining with Calcein-AM 
The cells were encapsulated within the 2.5 % (w/v) alginate/κ-carrageenan hydrogel blend in beads 
and fibers. The light microscopic images presenting ATDC5 encapsulated in beads and fibers show a 
uniform cell distribution after 21 days in culture, a homogeneous cell density and smooth, well 
delimited shape of the hydrogels. Calcein AM fluorescence staining was conducted to assess the 
ATDC5 cells viability and distribution within the hydrogels. The majority of the cells were positive for 
calcein AM, which indicates a dominance of viable cells over a period of 21 days in culture. Three 
weeks post encapsulation, ATDC5 chondrocytes cells exhibited round shapes, uniform cells distribution 
into the hydrogel and a high cellular density (Fig. 4). These results show that both shape conditions of 
the hydrogels blend are not cytotoxic and that the temperature cycle used to promote the sol-gel 
transition does not affect cell viability.  
 
 
Figure III- 4. Inverted light microscopic images of ATDC5 cell encapsulated in beads and fibres (1A and 
1B) and fluorescence staining, Calcein-AM (green, 2A and 2B) images depicting viable cells stained at 
day 21 of culture. 
 
III.3.7. Viability and proliferation of cells encapsulated in the developed hydrogels 
In this study the influence of two parameters on the viability and cell proliferation were analyzed, 
namely the ratio of the two types of carrageenan, κappa and ιota and also the concentration of the 
cross linker used for the formation of the 3D construct. Generally, from the MTS and DNA results, it 
was found that the ATDC5 cells remain viable and proliferate for up to 21 days of 
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encapsulation/culture in the 3D hydrogels developed. From the MTS assay results (Fig.5 A) we can 
observe that the formulations based on κappa-carrageenan enabled higher cell viability as compared to 
those based on ιota-carrageenan. This difference in terms of cellular response could be related to the 
chemical composition of ιota-carrageenan which presents more sulphated groups that κappa 
carrageenan, and thus the lower strength of its network [25], enables an easier leach out of cells from 
the tested samples. Analyzing the importance of the polymers ratio used, we can notice an increase in 
the metabolic activity obtained for the ATDC5 cells encapsulated in the formulation with higher alginate 
content, corresponding to the ratio 8:2 but not significantly different. For further biological 
characterization it was selected the blend with 2.5 % (w/v) alginate and κ-carrageenan with a ratio of 
8:2. The influence of several concentrations of the reticulation agent (CaCl2*KCl) and their biological 
response were investigated (Fig. 5 B and C). The results obtained from the MTS assay showed that a 
lower concentration of the reticulation agent has a positive effect in the cellular response especially for 
AK 2.5% formulation. Moreover, we can observe a higher cell proliferation with the formulation exposed 
to lower concentration of CaCl2*KCl precipitation bath complementary to the MTS assay results (Fig. 5 
C) 
 
Figure III- 5. A. Metabolic activity of ATDC5 cells encapsulated in the 2.5% alginate-carrageenan with 
different polymeric ratio. Figure 5B present the hydrogels exposed to different concentration of the 
CaCl2*KCl coagulation bath. The results are based on the MTS test performed after 1, 7, 14 and 21 
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days of culture. Figure 5C shows cell proliferation of ATDC5 cells entrapped in hydrogels blend using 
the two types of carrageenan with different concentration of the precipitation bath (CaCl2*KCl). The 
results are based on the DNA quantification test performed at 7, 14 and 21 days of culture. The 
symbols * indicates statistical significance of the formulation AK 2.5% and AI 2.5% (ratio 8:2). 
 
III.3.8. Histological analysis (H&E) 
The morphology of the cells residing in the hydrogel blends containing one of the two types of 
carrageenan and with different polymeric concentration was further observed by H&E staining. 
Histological analysis of samples taken after 21 days of culture was performed using hematoxylin-eosin 
(H&E) for regular morphological cellular analysis (Fig. 6). In a typical tissue, nuclei are stained blue, 
whereas the cytoplasm and extracellular matrix have varying degrees of pink staining. From the 
histological results we observed that the cells are viable, presenting homogeneous distribution and 
exhibit a clearly delimited nucleus over the culturing period. Encapsulated ATDC5 cells exhibit a normal 
morphology, some presenting small nuclei mostly in the initial culturing period, others large 
proliferating nuclei by 21 days of culture and in some cases, one can notice cell clustered formation in 
general in κappa condition. Additionally, after encapsulating ATDC5 chondrocytic cells, we observed 
that they were able to proliferate and maintain their typical chondrocytes morphology, namely, the 
lacunae aspect.  
 
 
Figure III- 6. Haematoxylin Eosin staining of ATDC5 chondrocytes encapsulated in alginate/κ-
carrageenan and alginate/ι-carrageenan type. The ATDC5 chondrocytes exhibited vacuoles morphology 
and cell clusters in κ-carrageenan formulation during the experiment, scale bars have 100 µm and 
images are taken at 20x magnification. 
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III.4. DISCUSSION 
Hydrogels can be used for cell delivery [26], as well as growth factor or drug delivery [27]. Hydrogels 
derived from naturally occurring polysaccharides mimic many features of extracellular matrix (ECM) 
and thus have the potential to direct the migration, growth and organization of encapsulated and 
transplanted cells during tissue regeneration [28]. In this study, a new forming biodegradable hydrogel 
system was developed, which may be used as a carrier for cell delivery purpose. Alginate hydrogels are 
fast gelation systems, hard to control, often the resulting structure is not uniform and mechanically 
strong and thus is difficult to achieve complex-shaped 3-D structures [29]. We expected that adding 
carrageenan hydrogel to the system could overcome some of these disadvantages. The hydrogels were 
obtained by the cross-linking of alginate and κ-carrageenan with Ca2+, K+ ions at a stable physiological 
pH. Different volume ratios of the hydrogel blend were prepared for assessing the best formulation in 
terms of degradation profile, mechanical stability and cell behavior. It was possible to process alginate-
carrageenan in different ways, enabling to obtain various structures/shapes, such as beads and fibers 
which can be used in different approaches/strategies for the delivery of cells. The smooth appearance 
of the hydrogels is clearly observed from the microscopic images of the beads and fibers in dry and wet 
state (Fig. 1). This demonstrates that the rigid, glassy alginate polymer can be blended with the highly 
flexible, amorphous κ-carrageenan polymer creating smooth morphologies and enhance the thermal 
stability [20, 30]. The images obtained from the cross sections of the hydrogels suggest that the 
morphology of the blends depends on the type of carrageenan used and this may result from the fact 
that κ-carrageenan gives harder gels than ι-carrageenan with CaCl2 (The United States Pharmacopeia 
XXIII, 1995). The SEM images of the freeze-dried hydrogels also demonstrated that a higher content of 
κ-carrageenan results in the formation of smaller, more round pores and tighter network structure in 
the blend hydrogels (Fig. 2). A similar behavior was register in blends made with carrageenan and 
gelatin where the average pore size and porosity decreased with increasing κappa-carrageenan content 
as well, owing to the high molecular weight and viscosity of the κappa-carrageenan solution [31]. 
Moreover, the morphology and porosity is highly affected by the gelling agents, as compared to the 
degree of cross-linking with ions. However, our results showed that the type of carrageenan used in the 
blend composition and the alginate/carrageenan ratio are both important parameters for pore size 
control and shape of the hydrogel [32]. To promote the regeneration of tissues, it is important that the 
proposed hydrogels can delivery cells at the target site, but also maintain its structure under 
physiological conditions, similar to those found in vivo, for enough time so that they can perform a 
protective role for the implanted cells and thus assure their functionality [33]. In engineered hydrogel 
for cell encapsulation/delivery degradation can alter the diffusion of nutrients, waste and cell-material 
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interactions. The performed degradation studies allowed characterizing the developed hydrogels in 
simulated physiological conditions like PBS and DMEM immersion mediums at 37 °C by mimicking the 
behavior in the in vivo scenario. As mentioned before, it was found significant differences and 
systematic variation in the formation and stability of the hydrogel depending on the polysaccharide 
used, with κ-carrageenan being firm and rigid and ι-carrageenan being soft, elastic. Having in mind 
these physicochemical differences between κappa and ιota carrageenan type on the blend formation 
only κ-carrageenan polymer has been taken into account for degradation characterization. The hydrogel 
blend with low concentration revealed less stability, consequently increasing the exposure of polymer 
chains to water molecules, and significantly leading to water absorption enhancement and faster weight 
loss (Fig. 3). Also, the carrageenan component of blend would be expected to have a greater 
preference for water sorption than alginate because of the presence of highly polar sulfate groups in 
the structure [30]. Polymeric concentration influences many properties of the resulting hydrogels. In 
general, an increase in the polymer concentration results in a decrease in water content and mass 
weight loss. In other words, the hydrogels with lower concentrations present a faster degradation rate, 
losing almost 45 % of their weight by the end of the study. Similar degradation behavior was found for 
example, for hyaluronic acid hydrogel [34]. The 2.5 % alginate-κ-carrageenan hydrogels showed a 
slower degradation rate in DMEM medium than hydrogels exposed to PBS solution at 37 0C (Fig. 3).The 
divalent cations used to keep hydrogels cross-linked will be exchanged by monovalent ones, leading to 
the formation of less cross-linked networks, as described elsewhere [35]. This might be explained 
further by the higher content of ions in DMEM which interact with the hydrogels of ionic nature and also 
related to the possible interaction of κ-carrageenan with the proteins presented in the DMEM medium 
composition [36]. Concerning the mechanical properties it was found that the mechanical strength of 
the blends system (alginate/κ-carrageenan) presented values around 0.7 ± 0.25 MPa. Interestingly, 
the mechanical properties exhibited by the hydrogels in the wet state fall within the normal ranges of 
those reported for cartilage native tissue [37] and are higher than the typical values presented for 
hydrogels like alginate [38], chitosan [39, 40], hyaluronic acid [41]. The tensile strength of gels made 
from alginates reported in the literature appeared to be around 150 to 240 and 250 to 280 kPa [42]. 
These results clearly suggest that the compressive modulus of the developed hydrogels was improved 
by adding κ-carrageenan to the blends. It has been reported that the decreased sulfate content of 
carrageenan increases the strength of the hydrogel thus κappa carrageenan, which has less sulfated 
groups is expected to have better properties than ιota carrageenan [25]. Another important aspect for 
assessing the potential of these hydrogels for regenerative medicine applications is to evaluate their 
biocompatibility and their ability to sustain viability and proliferation of encapsulated cells. Since the 
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microstructure and high water content are very similar to that of the extracellular matrix of natural 
cartilage, hydrogels are expected to preserve the viability of the cells. All hydrogels produced showed a 
non-cytotoxic behavior. Nevertheless, lower polymeric concentrations and consequently less cross-
linked networks, led to lower cell viability results, as a consequence of easier components release to 
the extraction medium. With increasing polymeric concentration the viscosity of the hydrogel also 
increases making it more stable when compared with the formulations with lower concentration, which 
lose their stability more easily due to the lower viscosity and cross linking. Light and live cell imaging 
provided a wealth of information about the biophysics and biochemistry of cells encapsulated in the 
hydrogels. Figure 4 presents ATDC5 cells encapsulated in beads and fibers observed under light and 
fluorescence microscopy. Results from samples collected after 3 weeks of culture showed the presence 
of viable cells in both hydrogels formats as indicated by the positive staining with Calcein AM 
fluorescent dye. Three formulations (5:5, 7:3 and 8:2) corresponding to the two types of carrageenan, 
ιota and κappa, in the blend with alginate were considered for the cell encapsulation assay. The results 
showed that the different ratio of alginate-carrageenan in the blend didn‘t affect significantly the viability 
of the encapsulated ATDC5 chondrocytes. From the data presented in figure 5A we can easily observe 
higher viability for the formulations with the κ-carrageenan type compared with the metabolic activity 
register for the blends made with ιota type. This cell behavior could be related to the higher sulphate 
composition of the ιota carrageenan type [43] . The influence of CaCl2*KCl different concentration over 
the metabolic activity and proliferation of ATDC5 encapsulated cells showed that low concentration 
have higher cell viability (Fig. 5B). The DNA quantification results complemented the data obtain from 
the MTS test (Fig. 5C). After evaluating the influence of the polymeric concentration and the influence 
of the cross-linker over ATDC5 chondrocytes viability, it results clear that the first parameter is more 
important compared to the second. HE staining presented ATDC5 chondrocytes encapsulated within 
the hydrogel with typical cartilage spherical morphology (Fig. 6) predicting a potential application of the 
hydrogel as an injectable scaffold in cartilage tissue engineering. These results further confirmed the 
biocompatibility of the developed hydrogels for cell encapsulation and delivery applications. Evaluation 
of these properties contributed to a further understanding of the formation mechanism of hydrogels 
and the biological applicability of these systems. As this process of the blend hydrogel formation is 
simple, feasible, and usually performed under mild conditions without employing any extraneous toxic 
cross-linking agents, we believe that such a matrix will have potential applications as cell delivery 
systems, wound management, drug delivery, cartilage tissue engineering and other related biomedical 
fields.  
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III.5. CONCLUSIONS 
We report herein the development of alginate-carrageenan hydrogels by a mild, friendly technique 
yielding on using these carriers as cell delivery systems. The morphology, degradation and mechanical 
behavior showed highly tunable properties, without affecting their biocompatibility. Finally the cell 
encapsulation assays revealed that alginate/κ-carrageenan hydrogels presented a positive cellular 
response, supporting the viability and proliferation during long term cell culturing. The thermo-gelling 
properties of such materials may be also used in new injectable systems that could be used to deliver 
cells, through minimally invasive procedures. In fact, all the results obtain demonstrated that 
alginate/κ-carrageenan can be an innovative and adequate alternative for the development of carrier 
systems to encapsulate cells or other bioactive agents of relevance in tissue engineering applications.  
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CHAPTER IV* 
 
CHONDROGENIC POTENTIAL OF INJECTABLE Κ-CARRAGEENAN HYDROGEL WITH ENCAPSULATED ADIPOSE STEM CELLS FOR 
CARTILAGE TISSUE ENGINEERING APPLICATIONS 
 
ABSTRACT 
 
Due to the cartilage limited self-repair capacity, regenerative medicine therapies for the treatment of 
cartilage defects must use a significant amount of cells, preferably applied using a hydrogel system that 
can promise their delivery and functionality at the specific site. This paper discusses the potential use 
of κ-carrageenan hydrogels for the delivery of stem cells obtained from adipose tissue in the treatment 
of cartilage tissue defects. The developed hydrogels were produced by an ionotropic gelation method 
and human adipose stem cells (hASCs) were encapsulated in 1.5 % (w/v) κ-carrageenan solution at a 
cell density of 5x106 cells/mL-1. The results from the analysis of the cell encapsulated hydrogels, 
cultured up to 21 days, indicated that κ-carrageenan hydrogels support the viability, proliferation and 
chondrogenic differentiation of hASCs. Additionally, the mechanical analysis demonstrated an increase 
in stiffness and in viscoelastic properties of κ-carrageenan gels with the encapsulated cells along the 
time in culture with chondrogenic media. These results obtained allowed to conclude that κ-
carrageenan exhibit adequate properties that enable the functionality of encapsulated hASCs and thus 
may provide the basis for new successful approaches for the treatment of cartilage defects. 
 
 
Keywords: adipose derived stem cells; cartilage; chondrogenic differentiation; hydrogels; κ-carrageenan; 
mechanical properties 
 
 
 
* This chapter is based on the following publication: 
Popa E. G., Caridade S. G., Mano J. F., Reis R. L., and Gomes M. E., "Chondrogenic potential of 
injectable κ-carrageenan hydrogel with encapsulated adipose stem cells for cartilage tissue-engineering 
applications", Journal of Tissue Engineering and Regenerative Medicine, doi:10.1002/term.1683, 
2013. 
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IV.1. INTRODUCTION 
The need for tissue-engineered cartilage constructs is immense and of great clinical significance 
because no existing medication or surgical procedures substantially promotes the healing process of 
articular cartilage.  Compared to other connective tissues, cartilage is avascular, aneural tissue, 
consisting of relatively few cells, proteoglycans and proteins and thus, when damaged due to a 
degenerative disease or trauma, the functional and the metabolic properties of the original hyaline 
tissue will hardly ever be restored [1]. Cartilage tissue engineering approaches, adopting the delivery of 
an appropriate type and amount of cells, with or without signaling factors, offer considerable promise 
as regeneration strategies [2, 3]. However, for further improvement, minimally invasive approaches and 
innovative cell carrier concepts should be refined, using the right biomaterials and cells sources [4]. 
Stem cells are the best chance for human cartilage regeneration given their ability to differentiate in 
vitro in different lineage, availability and expansion [5]. Particularly, adipose tissue has generated 
significant interest in cartilage tissue engineering as an abundant source of multipotent progenitor cells, 
which are easily acquired at high yields and can be obtained from the patient by minimally invasive 
procedures such as liposuction [6-8]. Hydrogels are the basis of cell encapsulation systems, one of the 
most promising approaches for the delivery of cells and therapeutic agents to the site of interest [9-11]. 
Different hydrogels have been previously studied for biomedical applications like alginate, agarose [8, 
12]. In the present work we evaluated the potential use of κ-carrageenan hydrogel extracted from red 
algae, as a cell carrier system. κ-Carrageenan is an ionic natural polysaccharide that displays unique 
properties that may provide advantageous features for application in the tissue engineering field. 
Carrageenan is composed of large, highly flexible molecules which curl forming helical structures [13, 
14], rendering them the ability to form a variety of different gels at room temperature and thus enabling 
a great versatility. The fully carbohydrate-based hydrogels of alternating copolymers of α-(1-3)-D-
galactose and β-(1-4)-3,6-anhydro-D- or L-galactose [15] are expected to be biologically compatible, 
biodegradable and non-toxic. κ-Carrageenan has only one negative charge per disaccharide with a 
tendency to form a strong and rigid gel. Carrageenan gels in the presence of potassium ions, but has 
also the ability  to form gels  under salt-free conditions, being a thermosensitive hydrogel [16]. The 
mechanism of gel formation is still under discussion; nevertheless, the first step may well be double 
helix stabilization when K+ is the counterion [17]. Because of the ionic nature of the polymer, the gelling 
and melting temperatures of κ-carrageenan are almost solely dependent on the concentration of 
potassium ions [18]. Thermoreversible gels, such as κ-carrageenan, melt at elevated temperature and 
by lowering the temperature results the gelation of the biopolymer. The temperature-induced gelation 
allows for the easy formation of gels in different shapes. The negative charge permits ionic interactions 
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with molecules like water or protein and allows a large osmotic swelling pressure. To some extent κ-
carrageenan resemble to the naturally occurring glycosaminoglycans owing to their backbone 
composition of sulphated disaccharides [19]. At the present, there is little information about the 
potential use of κ-carrageenan as a new natural material in biomedical applications. Nevertheless, the 
results published up to date suggest that κ-carrageenan hydrogels exhibit comparable biological 
behavior, yet higher mechanical properties over similar hydrogels extensively used for tissue 
engineering purposes [20-22]. The objective of this study was to develop κ-carrageenan hydrogel aimed 
at application in cartilage tissue engineering. Therefore, the swelling and cytotoxicity of the hydrogels 
were studied, as well as their ability to sustain the proliferation and chondrogenic differentiation of 
hASCs Furthermore, the mechanical properties of the hydrogels with encapsulated hASCs, after 
different culturing time points were also evaluated. The results obtained demonstrated that κ-
carrageenan hydrogels are non cytotoxic and support the proliferation and chondrogenic differentiation 
of encapsulated hASCs. Additionally, the mechanical properties of the cell-loaded hydrogels are 
maintained and even increased along culturing time, suggesting that the proposed systems provides a 
promising alternative to current approaches for cartilage tissue engineering.  
 
IV.2. MATERIALS AND METHODS 
IV.2.1. κ-Carrageenan hydrogel preparation 
An aqueous solution was prepared by dissolving the κ-carrageenan powder (22048, Sigma Fluka) in 
distilled water, and heating at 60 °C while stirring constantly for 2 hours until complete and 
homogeneous dispersion of the material was obtained. Previous to use, the κ-carrageenan solution was 
autoclaved during 30 minutes at 120 °C and prepared just before use. κ-Carrageenan hydrogel 
samples were produced using the sterilized polymeric solution with a final concentration of 1.5 % (w/v) 
and 5 % (w/v) potassium chloride (KCl, P5405, Sigma) as a cross linker reagent. The samples were 
shaped in the form of discs using cylindrical moulds and a complete gelation carried out for 2-5 
minutes at room temperature to form a solid gel. After gelation, the moulds ends were cut and the 
cylinder hydrogel was pushed out and immersed in KCl for 15 up to 30 minutes, in order to stabilize 
the 3-dimensional structure. Afterwards, the gels were washed with phosphate buffered saline (PBS, 
D5652, Sigma) to remove the excess of KCl present in the materials. Sample discs were then sliced off 
from the hydrogel cylinder with a thin sterile blade into discs with dimensions of Ø 5 ± 0.01 x 2.5 ± 
0.46 mm height. These samples were used for evaluating the swelling kinetics and cytotoxicity of the 
hydrogel. 
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IV.2.2. Swelling kinetics 
The swelling kinetics of the developed hydrogels was studied in a PBS solution (different pH values 
were tested) and in culture medium (Dulbecco‘s Modified Eagle‘s medium, DMEM, supplemented with 
fetal bovine serum, FBS, Gibco). For this purpose, a weighed amount of each hydrogel formulation was 
immersed in each testing solution (PBS, DMEM = pH 7.4) and incubated at 37 °C under static 
conditions. The influence of the pH of the PBS solution on the water uptake of κ-carrageenan hydrogel 
was also analyzed. The swelling ratio was calculated using equation 1.  
 
% 𝐸𝑞𝑢𝑖𝑙𝑖𝑏𝑟𝑖𝑢𝑚 𝑠𝑤𝑒𝑙𝑙𝑖𝑛𝑔 𝑟𝑎𝑡𝑖𝑜  % 𝐸𝑆𝑅 =
𝑊𝑠  – 𝑊𝑑
𝑊𝑑
 × 100                                               (1) 
Ws: weight of swollen gel after reaching equilibrium value under specified environmental conditions 
(PBS or DMEM); Wd: weight of the dried gel 
  
To measure Ws, the swollen hydrogels were removed from the PBS or DMEM and immediately weighed 
with a microbalance after the excess of water lying on the surfaces was absorbed with a filter paper. 
Three samples were used for each testing condition (n=3).  
 
IV.2.3. Cytotoxicity screening 
The cytotoxicity of the hydrogels leachable was evaluated using L929 mouse fibroblast cells (ECACC- 
European Collection of Cell Cultures, UK) as described elsewhere [23]. Extracts of the study materials 
were prepared and placed in contact with a L929 cells monolayer. Briefly the extracts were obtained 
after 24 hours incubation of the hydrogels in complete culture medium at 37 °C and under constant 
agitation (60 rpm). The ratio of the hydrogel to extract fluid was equal to 3 cm2/ml and the L929 cell 
seeding density was 4x103 cells/well plate. In all cytotoxicity tests performed, latex rubber was used as 
positive control for cell death and standard tissue culture polystyrene was used as a negative control. 
The objective of the extraction test was to evaluate changes in cell morphology and growth inhibition, 
whereas the MTS (CellTiter 96® AQueous One Solution Cell Proliferation Assay, G3580, Promega) test 
determines whether cells are metabolically active [24]. The optical density (OD) was read at 490 nm on 
a multi well microplate reader (Synergie Ht Izasa, Bio-Tek Instruments) and all cytotoxicity screening 
tests used six replicates. 
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IV.2.4. Human adipose derived stem cells isolation and expansion 
Human liposuction aspirate samples were obtained upon patient informed consent from donors 
undergoing lipoaspiration procedures under a protocol established with the Department of Plastic 
Surgery of the Hospital da Prelada, Porto, and approved by the local Ethical Committee. All the 
samples were processed within 24 hours after collection. The human adipose derived stem cells 
(hASCs) were enzymatically isolated as previously described [25]. Briefly, the adipose tissue samples 
were digested with 0.2 % collagenase type II (C6885, Sigma) in PBS for 45 min at 37 °C under gentle 
stirring. The digested tissue was filtered with a 100 μm filter mesh (Sigma) centrifuged at 1200 rpm for 
10 min at 20 °C and the cell suspension solution washed 5 min with lysis buffer to remove erytrocytes. 
Cells were again centrifuged; the supernatant removed and resuspended in alpha Minimum Essential 
Medium (α-MEM, 12000-063 Gibco, Invitrogen) with 10 % FBS (10270-106 Gibco, Invitrogen; heat 
inactivated), 1 % Antibiotic-Antimycotic (15240-062, Invitrogen) and sodium bicarbonate (S5761-
NaHCO3, Sigma). Human ASCs were plated at a density of 3.5 x 103 cells/cm2 and incubated at 37 °C 
in a humidified atmosphere of 5 % CO2. The unattached cells were removed after 2-3 days with 
repeated PBS washings. The adherent hASCs were cultured with media changes on every three days. 
Confluent cultures were passaged with 0.05 % trypsin (25300-062 Invitrogen). The enzymatic 
treatment was quenched in the presence of FBS and cell counts were done using a hemocytometer. 
Only passage 3 (P3) hASCs were used in the experiments.  
For the cell culture experiments it was performed the isolation of adipose derived stem cells from one 
patient (women 31 years old) and cryopreserve them at passage 1, to avoid patient cells variability. 
Afterwards the cells were expanded and used until passage 3 performing three independent 
experiments using the same batch of cells, with the same passage. The phenotype of human adipose 
stem cells has been extensively investigated in previous studies using tissue sample from same 
anatomical site (subcutaneous), harvested with similar technique (such as lipoaspiration) and isolation 
following similar procedures (digestion with collagenase) by [26, 27] and also by our research group 
[28-30].  
 
IV.2.5. Encapsulation of hASCs in κ-carrageenan hydrogels and in vitro cell culturing 
κ-Carrageenan aqueous dispersions were prepared just before being used by dissolving the biopolymer 
in distilled water and then sterilized, as described in previous section. Human ASCs were detached by 
trypsin and centrifuged at 200 g for 7 min. Cells were resuspended in sterile PBS solution, counted 
using a haemocytometer and finally centrifuged. The supernatant was discarded and κ-carrageenan 
 
___________________Chapter IV. Chondrogenic potential of injectable κ-carrageenan hydrogel __ 
148 
 
1.5 % (w/v) solution was added to the cells to obtain a final concentration of 5x106 cells·mL-1. The 
mixture was resuspended for complete homogenization of the cells within the matrix. Hydrogel samples 
containing human ASCs were prepared using sterile cylindrical moulds and allowing to rest at room 
temperature for 1–2 min to form a solid gel. Discs of 5 ± 0.01 mm diameter and 2.5 ± 0.46 mm 
height were cut using a sterile blade. The discs with encapsulated cells were cultured either in basal or 
chondrogenic differentiation medium for 1, 7, 14 and 21 days, which was replaced every 3–4 days. 
Additional controls consisted of κ-carrageenan hydrogel samples without cells, kept in the same 
culturing conditions for the selected time periods. The chondrogenic differentiation medium was 
composed of Dulbecco‘s Modified Eagle‘s Medium- low glucose (DMEM, D5523, Sigma), 
supplemented with 10 % FBS (10270-106 Gibco, Invitrogen), 1% Antibiotic-Antimycotic (15240-062, 
Gibco, Invitrogen), ITS+1 Liquid Media Supplement (I2521- insulin-transferrin-selenium - liquid media 
supplement, Sigma), 17 mM L-ascorbic acid (A4544, Sigma), 0.1 M sodium pyruvate (P4562, Sigma), 
35 mM L-proline (P5607, Sigma), 1 mM dexamethasone (D4902, Sigma) and 10 ng/ml of human 
TGF‐β1 (Transforming Growth Factor‐β1, 14‐8348, eBioscience).  
 
IV.2.5.1. CELL VIABILITY AND PROLIFERATION ASSESSMENT  
At the end of each time point of the study, the κ-carrageenan samples with encapsulated hASCs were 
collected from the culturing plates and incubated in a Calcein AM (C3099, Invitrogen) solution of 
1/1000 in culture medium for 15–30 min at 37 °C and afterward washed in sterile PBS. The stained 
samples were placed on a microscope slide and observed under a fluorescent microscopy 
(Reflected/Transmitted light Microscope, Zeiss). The proliferation of the hASCs encapsulated in the κ-
carrageenan hydrogels was assessed using a fluorimetric double-strand DNA quantification kit (P7589-
PicoGreen, Molecular Probes, Invitrogen). For this purpose, samples collected at 1, 7, 14 and 21 days 
of culturing, were washed in PBS and then transferred into 1.5 mL microtubes containing 1 mL of 
ultrapure water. Prior to dsDNA quantification, hASCs cell-hydrogel constructs and the sample controls 
(hydrogel samples without cells), were sonicated for 15 min to release all DNA from the hydrogel. 
Samples and standards (ranging from 0 to 2 µg· mL-1) were prepared and mixed with a PicoGreen 
solution in a 200:1 ratio and were added to a 96-well opaque white plate. For each study material and 
standards, 3 samples were used for DNA assays, and triplicates of each sample were measured. The 
procedure followed can be found elsewhere [31]  and was based on manufacture instructions. The 
plate was incubated for 10 min in the dark, and fluorescence was measured on a microplate ELISA 
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reader (Bio-Tek, Synergie HT) with an excitation of 485/20 nm and an emission of 528/20 nm. A 
standard curve was created, and sample DNA values were read from the standard graph.  
IV.2.5.2. HISTOLOGICAL ANALYSIS 
Samples were collected at the end of the experiment (21 days of culture) fixed, dehydrated with the 
Spin Tissue Processor (Microm STP120 Inopat) and embedded in paraffin  using embedding center 
(Microm EC350-1/EC350-2 Inopat). Sections were cut at 4 µm with the microtome (Microm HM355S 
Inopat) and placed on microscopy slides. Alcian blue (A3157, Sigma), Safranin O (84120, Sigma), 
Toluidine blue (T3260, Sigma) and Hematoxylin-eosin (H&E, MHS16, Sigma) staining were performed 
using the Automatic Stainer equipment (Microm HMS740 Inopat). Alcian blue, Safranin O and 
Toluidine blue staining were used to evaluate cartilage ECM components deposition, namely 
glycosaminoglycans. Alcian blue staining was performed by rinsing the sections in 3 % acetic acid 
(151785, Sigma) and incubating them in 1 % Alcian blue solution for 30 minutes. After that, the stain 
was poured off, and sections were counterstained with aqueous neutral red (861251, Sigma) for 1 min 
and dehydrated. The Safranin O staining consisted of staining the sections with Weigert‘s iron 
hematoxylin working solution for 7 minutes, fast green (FCF, 44715, Sigma) for 5 minutes and 0.1 % 
safranin O for 5 minutes.  Sections were washed after each staining step, left to air dry and then rinsed 
in absolute alcohol. Toluidine blue staining solution was prepared by dissolving 1 % of Toluidine blue in 
distilled water containing 0.5 g of sodium borate (Riedel-de-Haën), followed by filtering and the sections 
were dipped in for 2–3 s. For H&E staining, after hydration the sample sections were colored with 
Papanicolaou Harris hematoxylin (05-12011/L, Bio-optica) for 3 minutes, washed in running tap water 
and afterwards a blue stain enhancement was performed by an immersion in 0.5 % ammonia (05002, 
Sigma) for 5–10 seconds. The sections were washed in running tap water and stained in Eosin-Y (05-
M10003, Bio-optica) for 30 seconds. Finally all slides were dehydrated through series of alcohol 
immersions from 30 % until 100 % alcohol. The final step for all the staining performed was the 
immersion in the clearing agent Histoclear® (National Diagnostics) or xylene substitute for 1-2 minutes 
and mounted using Microscopy Entellan® (Merck &Co., Inc.) for later observation. Stained sections 
were observed under a light microscope (Reflected/Transmitted light Microscope, Zeiss).  
 
IV.2.5.3. IMMUNOHISTOCHEMICAL ANALYSIS  
Sections of samples corresponding to all experimental conditions were obtained as described above in 
the histological part. Before removing the paraffin, the slides were warmed, and the antigen retrieval 
was performed for 20 minutes at 95 °C using 10 mM citrate buffer. Sections were washed in PBS, 10 
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to 15 minutes, and endogenous peroxidase activity was quenched with 3 % hydrogen peroxide (31642, 
Sigma) in 50 % methanol/tap water for 5 min. Afterwards, samples were washed with PBS and blocked 
with 3 % bovine serum albumin (A2153, Sigma) for 1 h to avoid nonspecific staining. Sections were 
further incubated with primary antibodies (collagen type II and collagen type I; mouse antitype II 
collagen - MAB1330 and mouse antitype I collagen - MAB3391, Chemicon) overnight at 4 °C, in a 
humidified atmosphere. Then slides were washed with PBS for 10 min each and incubated with 
secondary antibody from Vectastain Elite ABC Kit PK-6105 (Vector Laboratories Ltd, Peterborough) for 
1 h at room temperature, again in a humidified atmosphere. The remaining protocol was performed 
according to that described in the in the Vector DAB Kit (Vector Laboratories Ltd). Slides were washed 
in water for 5 min and then counterstained with haematoxylin for nuclei visualization and finally, slides 
were mounted. Controls were performed using normal horse serum replacing the primary antibodies, 
which was also included in the kit. The samples were visualized under a light microscope and images 
obtained using a camera (Axion MRc5, Zeiss).  
 
IV.2.5.4. RNA ISOLATION AND REAL TIME QUANTITATIVE RT-PCR  
Real-time qRT-PCR analysis was used to assess the expression profile of typical markers for 
chondrogenic differentiation, namely Sox9, Aggrecan, Collagen X, Collagen type I, Collagen type II and 
thereby evaluate the ability of hASCs to undergo differentiation when encapsulated in κ-carrageenan 
and cultured with either basal or chondrogenic medium. For this purpose, total RNA was extracted from 
cell-hydrogel constructs using TRI Reagent® RNA Isolation Reagent (T9424, Sigma) according to the 
provided technical data sheet. Briefly, three samples of each condition were collected at defined time 
periods, washed twice with PBS, added in TRI Reagent® (800 μL) and vigorously mixed during 10 s 
and stored at -80 °C until the analysis was performed. At this point, 160 μL of chloroform was added, 
incubated on ice for 15 min and centrifuged at 13.000 rpm for 15 min at 4 °C to establish a three-
phase composition in the tube. The aqueous phase was collected into new, clean, pre chilled tubes, 
where 400 μL of ice-cold isopropanol was added and samples were incubated at -20 °C overnight. The 
samples were centrifuged at 13.000 rpm for 15 min at 4 °C, the supernatant discarded and the pellet 
washed with 70 % ethanol. After a final centrifugation, the samples were allowed to air dry, and 
suspended in ultrapure water for posterior analysis. Each pellet was dissolved in 15 μL of RNase-free 
water and kept at -80 °C until use. The amount of isolated RNA and A260/280 nm ratio was quantified 
using Nanodrop ND-1000 Spectrophotometer (Bonsai 06/2008 NanoDrop Technologies, Wilmington). 
After these determinations, 2 µg of RNA of each sample was reverse transcribed with qScript™ cDNA 
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Synthesis Kit (Quanta Biosciences) in a 40 µL reaction using a MJ Mini™ Personal Thermal Cycler (Bio-
Rad Laboratories) machine. Real-Time qRT-PCR was performed to detect amplification variations using 
PerfeCTa® SYBR® Green FastMix®, (Quanta Biosciences) on Eppendorf Mastercycler® ep realplex 
gradient S machine. The analysis of the results was performed with realplex software (Eppendorf 
Mastercycler, Applied Biosystems). The reaction composition was the following: 10 µl of SYBR Green 
PCR FastMix, 2.5 µl of each forward and reverse primer asses (see Table 1) and 5 µl of diluted 
template with RNase-free water. The number of cycles and annealing temperature were selected 
according to the manufacturer‘s instructions. All the primer sequences were generated using Primer3 
software (v 0.4.0) and acquired from Eurofins MWG Operon (Ebersberg). More details can be found in 
Table 1. Each gene was processed in triplicate. Human ASCs encapsulated in κ-carrageenan hydrogel 
cultured in basal medium were used as control cell sample. In each sample the mRNA level expression 
of each gene was normalized to the average expression of GAPDH value. The relative gene expression 
quantification was performed using the 2-ΔCt and 2-ΔΔCt method [32]. Three samples of each 
material/conditions under study were analyzed.  
 
Table IV- 1. List of genes under evaluation, primers and annealing temperature used in the analysis of 
samples corresponding to encapsulated hASCs in κ-carrageenan and cultured in vitro for different time 
points. 
Target genea) Forward sequence Reverse sequence Tm [ºC] 
SOX9 5'- tacgactacaccgaccacca -3' 5'- ttaggatcatctcggccatc -3' 58.4 
Aggrecan 5'- tgagtcctcaagcctcctgt -3' 5'- tggtctgcagcagttgattc -3' 58.4 
Collagen X 5'- ccaggtctcgatggtcctaa -3' 5'- gtcctccaactccaggatca -3' 59.4 
Collagen I 5'- catctccccttcgtttttga -3' 5'- ccaaatccgatgtttctgct -3' 55.3 
Collagen II 5'- gacaatctggctcccaac -3' 5'- acagtcttgccccacttac -3' 56.4 
GAPDH 5'- acagtcagccgcatcttctt -3' 5'- acgaccaaatccgttgactc -3' 57.3 
a)Real time qRT-PCR thermal cycles corresponds to the following periods: 2 minutes at 95 ºC (hot start) followed by 45 
cycles of 95 ºC for 30 seconds, corresponding annealing temperature (noted in the table) for 30 seconds and an extension 
step at 68 ºC for 30 seconds. A melting curve of 21 minutes and a hold step at 5 ºC was performed at the end. 
 
IV.2.5.5. MECHANICAL PROPERTIES OF Κ-CARRAGEENAN HYDROGELS WITH ENCAPSULATED HASCS  
Dynamic mechanical analysis (DMA, Tritec 2000 Triton) was conducted to characterize the mechanical 
properties under compression load, of κ-carrageenan hydrogel samples and hydrogels samples with 
encapsulated hASCs, after culturing in either chondrogenic or basal media for different time points. The 
samples were prepared as described above, into discs with 8 ± 0.01 mm of diameter and 2.5 ± 0.38 
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mm height. The study samples (n=5) were subjected to compression cycles of increasing frequencies 
ranging from 0.1 to 10 Hz with constant amplitude displacements of 0.1 mm using DMA equipment 
(Triton Technology, Nottinghamshire). Experiments were performed in simulated physiological 
conditions, at 37 °C in PBS medium. The frequency scans with acquisitions of 15 points per decade 
were performed at 37 °C with heat rate of 2 °C/min. The mechanical analysis results were presented 
in terms of two main parameters: storage modulus (E′- the in-phase, elastic component) and loss 
modulus (E′′ - the out-of-phase, viscous component). The values for the compression modulus were 
collected at a frequency between 0.1 and 10 Hz along the 21 days of culture and damping factor is 
expressed for the samples cultured in chondrogenic medium.  
 
IV.2.6. Statistical analysis 
Data obtained from DNA and real time qRT-PCR analysis is presented as means  standard deviations 
(n=3). Firstly, a Shapiro-Wilk test was used to ascertain about the data normality. DMA data was first 
inspected with an F-test for treatments, to determine equality of variance [33]. The results indicated 
that at the 0.05 level, the data was significantly drawn from a normally distributed population and 
ANOVA one way followed by Tukey test was used to determine significant differences between groups 
and conditions using with OriginPro 8 program.  
 
IV.3. RESULTS AND DISCUSSION 
IV.3.1. Swelling kinetics of κ-carrageenan hydrogel 
The κ-carrageenan hydrogels were obtained by a mild cross linking reaction with K+ ions at a stable 
physiological pH. It was analyzed the influence of the phosphate buffer solution pH on the swelling 
properties of κ-carrageenan hydrogels, determining the equilibrium swelling at pH= 1, pH= 4, pH= 7.4 
and pH= 11 as a function of time (Figure 1). These results showed that swelling increases with time, 
reaching a maximum constant value after 48 hours. In general, it was observed that the swelling ratio 
was increasing with increasing pH values of the PBS solution, except for the pH= 11, which registered 
the lowest value for the first 28 hours post immersion. The amount of absorbed water during the first 7 
hours in PBS at pH= 7.4 registered the highest values, showing that the developed hydrogels exhibit 
the highest water uptake at physiological pH. It was also investigated the swelling kinetics of κ-
carrageenan hydrogels when immersed in cell culture medium (DMEM, pH= 7.4, at 37 °C) 
supplemented with 10 % serum (FBS) and compared with PBS (pH= 7.4, at 37 °C), as the hydrogels 
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will be eventually exposed to this media during cell encapsulation and culturing (Figure 1). It can be 
observed that the swelling ratio in DMEM / 10 % FBS media was lower than in PBS solution.  
It is known that, upon implantation of a biomaterial in the body, typically occurs a response 
characterized by a decrease in the local pH. Thus it was thought it would be important to know the 
behavior of the hydrogel at various pHs in order to predict and eventually tailor its response upon 
implantation, envisioning in vivo studies and possible future clinical applications. When increasing the 
pH values of the immersion solutions from 1 to values equal to the physiological pH, it was observed a 
significant increase of swelling ratio leading to high water absorption (Figure 1). The κ-carrageenan 
hydrogels soaked in medium with pH=11 presented lower water uptake revealing that the equilibrium 
swelling was dependent upon pH and ionic composition of the immersion mediums. As the pH of the 
PBS solution was above 4, the ionization of the sulphated groups of κ-carrageenan gel occurred and 
led to ionic repulsion. This resulted in a more hydrophilic polymer network and contributed to higher 
water absorption. In summary, the swelling results demonstrated that the hydrogels exhibited a pH-
dependent pattern in the range of the pH that was studied. Furthermore, these results support that the 
amount of ions present in the medium significantly affects the hydrogels swelling properties, as 
confirmed by the different results obtained upon immersion in PBS and DMEM mediums [34]. It is 
important to note that ionically cross linked κ-carrageenan loses the stability over time in vitro, most 
probably due to an outward flux of cross linking ions into the surrounding medium [35]. 
 
 
Figure IV- 1. Equilibrium swelling ratio of κ-carrageenan hydrogels as a function of time, registered after 
immersion in PBS solution at different pH (1, 4, 7.4, 11) and after immersion in DMEM/ 10%FBS at 
pH=7.4 and 37 °C. Values reported as averages (n=3) ± standard deviation. 
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IV.3.2. Cytotoxicity assessment 
The cell behavior of hydrogel extracts was carried out as a preliminary approach to test the in vitro 
toxicity of the developed κ-carrageenan hydrogels. The cytotoxicity of κ-carrageenan hydrogels was 
evaluated by culturing L929 cells for 1 and 3 days with the extracts of the developed material. Figure 2 
shows the results of the cell metabolic activity assessed by the MTS test performed with the hydrogel 
extracts. It is possible to observe that the viability levels are similar to the values obtained for the 
negative control (TCPs), evidencing that κ-carrageenan and possible leachable products do not exert 
any cytotoxicity effect on L929 cells. A significant increase in cell viability was observed from day 1 to 
the last time point of the assay (*p < 0.05). The cytotoxicity assessment of κ-carrageenan extracts was 
carried out as a preliminary approach to assess the potentially harmful effect of the developed 
hydrogels. The cytotoxicity results (Figure 2) indicate that cells were viable in the presence of hydrogel 
extracts for all the time points assessed. The cells in contact with the hydrogel extracts record levels of 
metabolic activity similar to those which were in contact with culture medium, showing extremely low 
cytotoxicity levels, even after long time exposure. 
 
Figure IV- 2. Graphical representation of L929 cells metabolic activity after incubation with the extracts 
of 1.5 % (w/v) κ-carrageenan hydrogel, TCP (negative control) and latex (positive control) evaluated by 
MTS assay. * denotes a significantly higher metabolic activity at day 3 as compared to values obtained 
at day 1 of culture. Statistical analyses were conducted using one-way ANOVA for n=6 and error bars 
represent means ± SD. 
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IV.3.3. Fluorescence staining and DNA Quantification 
Fluorescence staining was conducted to analyze the viability of the cells after encapsulation/culture on 
1.5 % (w/v) κ-carrageenan hydrogels (Figure 3A). Calcein AM confirmed hASCs viability after in vitro 
culture, establishing that the cells were viable and homogeneously distributed inside the hydrogels. 
Three weeks post encapsulation, high cellular density is observed and cells are viable exhibiting round 
shape within the hydrogel matrix. These results confirm the temperature cycle used to promote the sol-
gel transition of κ-carrageenan does not affect cell viability.  
Complementary to the viability analysis along the course of the experiment, the cell content was 
quantified based on the dsDNA quantification (Figure 3B). Analysis of obtained DNA values sustain that 
from day 1 to day 7 the cell number slightly decreased for the two conditions followed by a significant 
increase from day 14 to day 21 (*p < 0.05 for basal medium and **p < 0.05 for chondrogenic 
medium). These results are also in agreement with the fluorescence viability assay (Figure 3A) showing 
that the κ-carrageenan hydrogel enables the viability and proliferation of encapsulated hASCs.  
An important aspect for hydrogels aimed at being used as cell carriers is how the encapsulation 
process affects the target cells. These hydrogels have been used to encapsulate enzymes, proteins or 
drugs and then release them through the dissolution of the hydrogel structure [36-38] but the use of κ-
carrageenan for cell delivery is still poorly exploited in the literature. It seems that a significant drop in 
cell proliferation from the initial time could be noticed and this behavior could be due to the fact that 
cells are being released from the hydrogels cell loaded systems during culturing time owing to 
degradation of the hydrogels. Gelation of κ-carrageenan hydrogel was induced by KCl treatment, which 
might initially affect the cell viability, as for fast hydrogel formation, high KCl concentration was used 
and the remaining KCl may influence the viability. Moreover, decreased cell viability upon cell 
encapsulation in hydrogels is a quite common finding, confirmed in several works reported in literature 
[20, 39, 40].  
From the DNA assay data (Figure 3B) it was possible to sustain that until the 14 days of culture, the 
different culture conditions induce significant changes over hASCs proliferation. Usually stem cells 
proliferation decreases when the differentiation process is activated, thus the decrease in cell content 
could be attributed to this characteristics. The results obtained regarding the rate of proliferation of the 
hASCs cells, along the period that where submitted to chondrogenic differentiation medium, indicate 
that from day 14 to day 21 of culture, cells proliferation rate increased significantly (**p< 0.05). 
Furthermore, hydrogels loaded with hASCs cultured in basal medium presented significant lower 
proliferation as compared to hASCs cultured under chondrogenic differentiation medium condition. 
Similar studies using other hydrogels, like collagen, alginate or agarose, using either BMSCs [21] or 
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ASCs [20], showed similar cell behavior. All together, these results prove that κ-carrageenan enables 
the viability and proliferation of encapsulated human ASCs. The chemical composition of κ-carrageenan 
hydrogels, similar to that of the native ECM, directly affects the water content of the developed carriers 
which is expected to support the phenotype of chondrocytes.  
In this work human adipose stem cells were encapsulated given that are of particular interest for ease 
way of harvest and their potential in therapies to promote cartilage repair and since there are 
numerous studies demonstrating that cells isolated from fat tissue can undergo chondrogenic 
differentiation when cultured in adequate in vitro conditions [41, 42]. Studies indicated that bone 
marrow-derived MSCs exhibit better chondrogenesis than MSCs of adipose origin, but advantages like 
high availability and high cell number makes adipose tissue a highly advantageous stem cell source to 
work with [43]. 
 
 
Figure IV- 3. Calcein AM staining and cell content of human adipose stem cells (hASCs) encapsulated 
in κ-carrageenan hydrogels and cultured for different time points in basal and chondrogenic medium. 
Fluorescent images showing the viability and distribution of encapsulated hASCs after 21 days of 
culture, magnification 5x, with 100 μm scale bar (A). Cellular content results based on the dsDNA 
quantification test performed after 1, 7, 14 and 21 days of culture (B). Error bars represent means ± 
SD. The statistics indicates that the cell number is statistically significantly higher at 21 day as 
compared to 14 day, for both basal and chondrogenic conditions (p < 0.05). 
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IV.3.4. Hematoxylin–eosin, Alcian blue, Safranin-O and Toluidine blue staining 
Chondrogenesis occurring in the hASCs laden hydrogels can be proved by the detection of GAGs 
deposition and proteoglycans protein production (Figure 4) with the metachromatic staining for Alcian 
blue, Safranin O, and Toluidine blue. Figure 4 depicts the positive staining of hASCs encapsulated in κ-
carrageenan for Alcian blue, Safranin-O, and Toluidine Blue staining, demonstrating starting deposition 
of proteoglycans (glycosaminoglycans, GAGs) which is commonly found in native articular cartilage 
ECM. The staining with Alcian Blue (Figure 4A-D) indicated concentration of acidic sulphated 
proteoglycans and cells appeared round with lacunae which are a distinct morphological appearance 
and structural characteristics specific to cartilage. For Safranin O staining we can note the similarity in 
the intensity of the color between nucleolus and cytoplasmic substance for the initial period of culture 
and the difference in color between these two for the later days in culture (Figure 4E-H). An increase in 
the intensity of the staining that evolved from a more orthochromatic (blue) in the initial periods of 
culture, to a more pronounced metachromatic (purple) staining in the later periods was noticed for 
Toluidine Blue staining (Figure 4I-L) similarly to  mast cells found in the connective tissue. This effect 
was more evident in the regions where cell clusters formed in comparison to individual cells present in 
the hydrogels. These results show that κ-carrageenan hydrogel is not only a laden system for the cell, 
but is supporting cells functionality, namely the chondrogenic differentiation, mimicking ECM properties 
observed by the interaction and cell spreading within the hydrogel. By the end of the culturing time, 
setting and partial chondrogenesis is taking place and longer time in culture will promise the fully 
differentiation of the human derived adipose stem cells. κ-carrageenan hydrogels maintain the 
chondrocyte phenotype and promote cartilage-specific ECM deposition even without growth factor 
stimulation as subsequently it was detect chondrogenic features of the cell laden hydrogel cultured in 
basal medium, concluding that the chondrogenic induction was hydrogel dependent.  
H&E stained sections, corresponding to Figure 4M-P, picture the typical tissue morphology, cell nuclei 
are stained dark blue, whereas the cytoplasm and ECM have varying degrees of pink staining. At the 
end of the first week of culture it is possible to observe a homogenous distribution of the cells with 
smaller size basophilic nucleus (blue) when in the following weeks cells assumed a more rounded 
morphology with cytoplasmic eosinophilic substance (pink) around the nucleus.  
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Figure IV- 4. Optical microscopy images of histological sections obtained from κ-carrageenan hydrogels 
with encapsulated hASCs culture in chondrogenic medium collected after several periods of culture and 
stained with Alcian Blue (A-D), Safranin O (E-H), Toluidine Blue (I-L), and with hematoxylin-eosin (M-P). 
The scale bar corresponds to 100 μm and the magnification used was 40x magnifications. 
 
IV.3.5. Immunohistochemistry and real time qRT-PCR 
To further evaluate the chondrogenic differentiation of hASCs encapsulated in 1.5 % (w/v) κ-
carrageenan hydrogels, immunohistochemical analysis of specific proteins like type II collagen and type 
I collagen was carried out. Figure 5A-D and Figure 5E-H show that the cells were positive for collagen 
type II and type I during the studied culture times and show that the staining intensity increased with 
increasing days of culture, in particular for collagen type II. Differences were found at the 
histostructural level between the two proteins evaluated, with collagen type I being detected at early 
culture times, whereas positive staining for collagen type II was detected for the latest culture times. 
However, chondrogenesis is typically a progressing process, from a morphogenetic phase to a 
cytodifferentiation phase of development via a number of precursor stages to the mature chondrocytes 
[44]. Since a heterogeneous population was used it is expected to have also positive staining for 
collagen type I. With time, the cells enlarged and secreted a dense organization around the nucleus. On 
close inspection, cells from 21 day culture were spherical in shape with cytoplasmic depositions. 
Although most of the cells had retained the round shape typically expressed by chondrocytes that 
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populate the deeper layers of articular cartilage [45], cells lying closer to the surface were flattened. No 
positive labeling was found in the negative control sections given the absence of the key protein 
markers (Figure 5I-L). The presence of a metachromatic-staining matrix, the chondrocytes like 
appearance of the cells and the detection of type II collagen suggest that the tissue generated by these 
cells is similar to the native cartilage. 
 
 
Figure IV- 5. Light microscopy images obtained from immunohistochemical staining of hASCS 
encapsulated in κ-carrageenan hydrogels after 21 days of culture for collagen type II (A-D) and for 
collagen type I (E-H) and negative controls (I-L). Scale bar corresponds to 100 µm and 40x 
magnification. 
 
The chondrogenic differentiation of encapsulated hASCs was additionally evidenced by the results 
obtained from real time qRT-PCR analysis. The analysis allowed assessing the expression, at a 
molecular level, of several important typical chondrogenic markers for the hASCS encapsulated in the 
κ-carrageenan hydrogels (Figure 6). Sustained gene expression levels were registered for Sox9 (*p < 
0.05) and Aggrecan (#p < 0.05) increasing significantly with time from day 14 until the end of 
experiment. Actually, Sox9 was up regulated to values close to 30 folds from 1 to 21 days. Collagen 
type II and Aggrecan are considered to be the two major and most important constituents of hyaline 
cartilage ECM since the functionality of this tissue relies mostly on the presence of these components 
(Figure 6). Collagen type II gene expression decreased from day 7 to day 14 of culture, but is 
significantly increased from day 14 today 21 (**p < 0.05). The expression of Collagen type I, unlike 
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Collagen type II, register an increase between 7 and 21 day of culture with 2 folds values (&p < 0.05). 
At the end of culture it was possible to notice that the mRNA expression of Sox9 gene remains highly, 
as well as the gene expression of Aggrecan and of Collagen type II. It might be mentioned that Collagen 
type X, related to the hypertrophic stage of chondrogenic differentiation, register a slight increased 
expression over the culturing time studied. In general, from the analysis of genes expression after 3 
weeks of culture, different stages in the cell life can be distinguished. Several works reported in 
literature [46, 47] investigating the chondrogenic differentiation of stem cells, state that the starting of 
chondrogenesis is around day 14, when the cells start to express chondrogenic markers as we 
reported in this study as well. The time-frame of the study, namely 21 days of culture was selected with 
basis on previous works with similar aims, using encapsulated stem cell in hydrogel for chondrogenic 
differentiation [21, 48, 49]. Though it will be interesting to verify the outcomes in a long time 
experiment, envisioning the clinical application of the proposed strategy, we are mostly concerned with 
the ability of the hydrogels to guarantee early pre-differentiation as a long term in vitro culturing before 
implantation is not interesting in a clinical/industrial scenario. 
Sox9 gene expression was prematurely up regulated, which indicates early onset of chondrogenesis 
[50]. Sox9 is an important regulator of the chondrocyte phenotype [51] and controls the expression of 
collagen II, a well known marker of the ECM of cartilage, which is usually expressed in the end stage of 
chondrogenic process of differentiation [52]. In this system, hASCs were likely stimulated down the 
chondrogenic pathway by TGF-β1 growth factor present in the chondrogenic medium. These findings 
indicated that hASCs can be successfully differentiated into chondrocytes when encapsulated in κ-
carrageenan. 
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Figure IV- 6. Relative expression of chondrogenic specific genes, namely, SOX9, aggrecan, collagen X, 
collagen type I and collagen type II, based on the mRNA produced by the encapsulated human ASCs 
after 7, 14 and 21 days of culture. The expression of these genes was normalized against the 
housekeeping gene GAPDH and calculated by the ΔCT method. Statistical analyses were conducted 
using one way ANOVA for n=3; p < 0.05. Error bars represent means ± SD. 
 
IV.3.6. Dynamic mechanical analysis (DMA) 
Compressive modulus is a particularly important parameter to consider in cartilage tissue engineering 
as native cartilage is subjected to movement (i.e., walking, running), loading and unloading are 
transient events, occurring in <1s. Hence, the mechanical response of cartilage should be measured 
under dynamic cyclic conditions at a functionally relevant frequency, i.e., in the range of 0.5–3 Hz [53, 
54]. The investigation of the viscoelastic properties of biodegradable hydrogels systems may be of great 
interest because one can not only simulate the physiological dynamical loading, but can also access 
relevant fundamental information at the molecular level, both from a structural and dynamic 
perspective [55]. Moreover, because of its complex structure and interactions of its biochemical 
constituents and due primarily to fluid flow through the solid matrix, cartilage behaves mechanically as 
a viscoelastic solid [56].  
DMA allowed determining the mechanical properties of κ-carrageenan hydrogels with encapsulated 
hASCs after different culturing times (1, 7, 14 and 21 days) in either basal or chondrogenic medium 
(as compared to κ-carrageenan hydrogels without cells), while immersed in a PBS solution at 37 °C 
and throughout a physiological relevant range of frequencies. Storage (elastic) and loss (viscous) 
components of the complex modulus were determined and are presented in Figure 7. The elastic 
modulus (E') curve shows how the stiffness of the polymeric material changes with time in culture 
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(Figure 7A). At a frequency of 1 Hz, the storage modulus of the hydrogels was estimated to be 0.23 
MPa for hASCs in basal medium, 0.22 MPa for cells cultured in chondrogenic medium and 0.17 MPa 
in κ-carrageenan gels alone by day 21, revealing the elastic nature of these gels. In this work the 
storage modulus (E') and phase angle or damping (tan δ) were monitored as a function of the 
frequency for the different hydrogels. The storage modulus curves present how the stiffness of the 
polymeric material changes with frequency (Figure 7B-D). Increase in E' is observed for increasing 
frequencies from 0.1 and 10 Hz, which suggests that the hydrogels exhibit stiffer behavior for higher 
frequencies. With the application of high frequencies to the hydrogel, the material becomes glassy and 
solid-like; at very low frequencies, the polymer exhibits a more liquid-like or rubbery response. The 
storage modulus of the hydrogel without cells presented variation between initial to final time points, 
suggesting that the hydrogels become softer, possibly due to a loss of the cross-linking ions or to a loss 
in gel stability due to thermal factors, as it is a thermoreversible and ionic hydrogel. The elastic 
modulus of κ-carrageenan hydrogels was improved with encapsulation of hASCs and along the time in 
culture (Figure 7A). Similar behavior was found for agarose or alginate hydrogels with the same type of 
cells and similar culturing conditions [20]. Nevertheless, κ-carrageenan with encapsulated hASCs 
exhibits a compression modulus approximately 10 x higher than that reported for agarose and alginate 
hydrogels in that study [20]. Hydrogels possesses also damping capability that may be useful to 
dissipate cyclic mechanical energy that is imposed in an implantation scenario. Damping is the term 
used for the general tendency of vibrating materials or structures to lose some elastic energy to internal 
heating or external friction, it tell us how good a material will be at absorbing energy [57]. The 
corresponding graphs are shown in Figure 7E. An increase in tan δ is observed from 0.1 to 10 Hz for 
day 1 for chondrogenic medium condition, suggesting a higher dissipation capability of κ-carrageenan 
hydrogels at higher frequencies (Figure 7E). At the beginning of culture we can notice an increase in 
tan δ values but after 21 days in culture, we can observe a decrease for increasing frequencies, which 
is related to higher viscous component of hydrogel biomaterial. 
During the 21 days in culture, DMA analysis indicated an increase in storage modulus and in 
viscoelastic properties of κ-carrageenan gels with encapsulated cells suggesting an increase in the 
stiffness possible due to the ECM production. It is believed that the subsequent deposition of ECM 
components within the gel constructs was facilitated by the gradual degradation of the gels. At day 21 
the statistical analysis indicated that the means difference is significant at the 0.05 level between the 
cell encapsulating hydrogels compared to the cell-free hydrogel control. The mechanism behind 
increasing the stiffness of the hydrogels laden with cells, likely involves more than the cell load as it is a 
result of the cell-mediated interactions and deposition of matrix with time. In addition, stem cells can 
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proliferate as well as differentiate but as cells differentiate their rate of replication usually decreases 
and by the end of 21 days there isn't any difference in terms of elastic modulus values between the 
cells exposed or not to the differentiation media. It has been proved that the biomechanical properties 
of articular cartilage greatly depends on composition, density of its ECM and interstitial fluid flow (water 
and solutes) [58]. So, cells encapsulation and ECM deposition may result in progressive increase of the 
mechanical properties of the 3D structures, as shown before for the cell-hydrogel construct [59].  
 
Figure IV- 7. Storage modulus (E') obtained from dynamic mechanical analysis upon compression of 
plain hydrogels and hydrogels with encapsulated hASCs, cultured in basal and chondrogenic medium, 
tested at a frequency of 1 Hz (A). The frequency sweep test presents the storage modulus in a 
logarithm scale at frequencies between 0.1 to 10 Hz of κ-carrageenan hydrogels with hASCs cultured 
in basal medium (B), hydrogels with hASCs exposed to chondrogenic medium (C) and hydrogels 
control (D). The damping factor (tan δ) is displayed upon compression over a period of 21 days for 
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chondrogenic condition (E). Values reported correspond to an average of five test samples (n=5), ± 
standard deviation. 
 
The characterization at the molecular level correlates with the mechanical properties developed by 
these systems as at day 14 we observe a decrease in Collagen type II chondrogenic marker 
(responsible for the tensile property), at the same time point there is an upregulation of Aggrecan gene 
expression (responsible for the compressive properties of the hydrogel), as these markers are 
interplaying together and are being expressed differently during the chondrogenic differentiation. These 
values mimic the mechanical properties found in articular cartilage and they are higher or within the 
range of values found for other hydrogels used in similar cartilage regenerative approaches [60, 61]. 
Human articular cartilage possesses significant mechanical properties, with a compressive modulus of 
0.79 MPa, a shear modulus of 0.69 MPa, and a tensile modulus varying between 0.3 and 10.2 MPa 
[62]. Evaluation of these properties contributed to a further understanding of the potential of these 
hydrogels for the target application.  
Considering the suitable mechanical properties, together with the simplicity and reproducibility of the 
preparation process for the κ-carrageenan hydrogel formation, which is performed under mild 
conditions without employing any extraneous toxic cross linking agents, it is possible to conclude that 
such matrix has potential applications in cartilage tissue engineering applications. To further enhance 
the quality of engineered cartilage tissues formed from encapsulating hASCs within this system, one 
may optimize the release rates of supplemental growth factors incorporated in the hydrogels.  It is also 
possible that host cells could be recruited to the gel, by release of the growth factors, participated in 
cartilage formation. 
 
IV.4. CONCLUSIONS 
This work presents κ-carrageenan as a potential hydrogel for cell delivery with application in the 
regeneration of cartilage. In summary, the results obtained using κ-carrageenan hydrogels as cell 
loading matrix, prepared via ionic cross linking reaction, demonstrate that this system could be an 
alternative cell delivery hydrogel systems. Human adipose stem cells encapsulated in κ-carrageenan 
hydrogels remain viable, proliferate and differentiate into the chondrogenic lineage. Furthermore, κ-
carrageenan hydrogels with encapsulated hASCs were able to achieve mechanical properties, under 
compressions, in the range of those reported for native cartilage. These promising in vitro results 
 
___________________Chapter IV. Chondrogenic potential of injectable κ-carrageenan hydrogel __ 
165 
 
should be further analyzed in animal model experiments designed to address fundamental questions 
concerning the in vivo degradation of the hydrogel and the possible in vivo differentiation of 
encapsulated cells. 
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CHAPTER V* 
 
CHONDROGENIC PHENOTYPE OF DIFFERENT CELLS ENCAPSULATED IN Κ-CARRAGEENAN HYDROGELS FOR CARTILAGE 
REGENERATION STRATEGIES 
 
ABSTRACT 
 
Engineering articular cartilage substitutes using hydrogels with encapsulated cells is an approach that 
has received increasing attention in recent years. Hydrogels based on κ-carrageenan, a 
thermoreversible natural origin polymer has been recently proposed as a new cell/growth factors 
delivery vehicle for regenerative medicine. In this work we report the potential of such hydrogels  
encapsulating either human adipose derived stem cells (hASCs) or human primary (nasal) 
chondrocytes (hNCs) or a chondrocytic cell line (ATDC5) for cartilage regeneration strategies. The in 
vitro cellular behavior of the encapsulated cells within κ-carrageenan hydrogel was analyzed after 
different culturing periods using biochemical assays, histological and real time RT-PCR analysis. The 3 
types of cells encapsulated in κ-carrageenan hydrogels showed good cellular viability and proliferation 
up to 21 days of culture and the cell laden hydrogels showed to be positive for specific cartilage 
markers. In summary the results demonstrate that hASCs embedded in κ-carrageenan hydrogels 
proliferate faster and exhibit higher expression levels of typical cartilage markers as compared to hNCs 
or ATDC5 cells. Based on this data, it is possible to conclude that κ-carrageenan hydrogel provides a 
good support for culture and differentiation of encapsulated cells and that hASCs may provide an 
advantageous alternative to primary chondrocytes, currently used in clinical treatments of cartilage 
defects/diseases. 
 
 
Keywords: Adipose stem cell, Cartilage, Cell encapsulation, Chondrocytes, κ-carrageenan, hydrogels 
 
 
* This chapter is based on the following publication: 
Popa E. G., Reis R. L., and Gomes M. E., "Chondrogenic phenotype of different cells encapsulated in κ-
carrageenan hydrogels for cartilage regeneration strategies", Biotechnology and Applied Biochemistry, 
vol. 59, issue 2, pp. 132-141, 2012.  
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V.1. INTRODUCTION 
The limited capacity of adult articular cartilage for self-repair is well recognized and is explained by 
being an avascular and aneural tissue that consists of relatively few cells which cannot migrate, 
specially mesenchymal stem cells cannot be recruit or get easy access to damaged areas [1, 2]. 
Currently, clinically used therapies involve either surgical technique or autologous chondrocytes 
transplantation which are generally successful in terms of pain relief and improved function but do not 
restore completely the articular cartilage function [3]. Although the use of autologous chondrocytes 
have the advantages of avoiding possible immune rejection or disease transmission, their wider 
application presents several limitations associated with the harvesting and in vitro proliferation 
procedures. The isolation of autologous chondrocytes requires an additional surgical intervention to 
harvest cartilage tissue, which often results in donor site morbidity. Moreover the amount of articular 
cartilage tissue is limited, even if retrieved from a different site location, such as the nasal septum [4]. 
In addition, the in vitro chondrocyte proliferation must be narrowed since these cells easily 
dedifferentiate in monolayer cultures and because of their low capacity to produce stable cartilage upon 
in vivo implantation with a tendency to form fibrous cartilage [5]. Since adult stem cells can be isolated 
from various tissue sources, having the ability to proliferate and differentiate along multiple lineage 
pathways in a reproducible manner, they have received great attention as an alternative resource to 
autologous chondrocytes, overcoming the limited number of primary chondrocytes and proliferation 
capacity [6, 7]. Thus, many studies have been conducted to evaluate the use of adult stem cells in 
cartilage tissue engineering, most of them focusing on the use of bone marrow stem cells (BMSCs). 
Recently, adipose derived stem cells (ASCs) have been regarded as good candidates for the repair and 
regeneration of articular hyaline cartilage due to their availability, long term cell viability and 
multilineage differentiation potential, including into the chondrogenic phenotype [8]. In fact, estimated 
yields of stem cell are in the range of 400,000 stem cells per milliliter of adipose tissue [9], resulting in 
an up to a 300-fold increase in cell number from 100 grams of adipose tissue as compared to 100 mL 
of bone marrow aspirate [10]. Nevertheless, in approaches consisting on the  direct implantation of 
cells  into the injured cartilage area, there are some challenging issues such as the leakage of 
transplanted cells from the cartilage defects leading to a low cell retention, and donor site morbidity 
[11]. Thus, three-dimensional vehicles like hydrogels have been proposed to deliver high amounts of 
cells with a well-maintained phenotype, to facilitate cell retention and assist mechanical stability of the 
transplantation site [12]. In addition, the use of a hydrogels might provide important features for cells 
functionality due to their high tissue-like water content, closely mimicking the natural environment in 
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the body, enabling efficient transport of nutrients and waste [13] and the possibility to control the 
release pattern of signaling molecules by incorporating them into the hydrogel by physical and/or 
chemical means. Various studies have demonstrated the successful use of natural polymeric hydrogels 
for cell encapsulation and in vitro culture purposes such as hyaluronic acid [14], agarose [15], 
collagen, alginate [16, 17] and chitosan [18]. However, their mechanical properties are often 
insufficient for the stability of the tissue-like construct transplantation.  Furthermore, hyaluronic acid 
promotes early inflammation which then is rapidly metabolized in vivo by free radicals and 
hyaluronidase [19]. Alginate has high molecular weight and therefore cannot be readily eliminated by 
the body  [20], and chitosan induce rapid bone regeneration at initial stages [21]. κ-Carrageenan, an 
ionic hydrogel proposed recently for cartilage regeneration approaches, which forms a gel with 
potassium ions, but also shows gelation under salt-free conditions, has demonstrated advantageous 
properties compared to other systems currently proposed for cartilage tissue repair. In this study, we 
evaluated the ability of κ-carrageenan hydrogels to support cellular functionalities, comparing 
simultaneously the potential of using human derived adipose stem cells (hASCs) versus primary human 
chondrocytes, in cartilage regeneration strategies. Additionally, ATDC5, a murine well-characterized 
chondrogenic cell line, routinely used as a model system to study the chondrogenic process, was used 
as a control. The three different cell types were encapsulated in κ-carrageenan hydrogels and cultured 
for up to 21 days. The cells response was evaluated in terms of metabolic activity (MTS assay), 
proliferation (DNA), presence of glycosaminoglycans (typical histological staining, Alcian blue and 
Safranin O) and by the expression of specific cartilage markers (namely, Sox9, aggrecan, collagen type 
I, collagen type II and collagen type X) using real time qRT-PCR analysis. The results obtained suggest 
that, κ-carrageenan hydrogel enables beneficial cellular response supporting extracellular formation 
and sustaining the chondrogenic phenotype. Moreover, encapsulated hASCs exhibit the highest 
proliferation rates and highest levels of chondrogenic markers expression, encouraging the use of these 
cells and the κ-carrageenan hydrogels as cell delivery carriers for applications in the regeneration of 
articular cartilage defects. 
 
V.2. MATERIALS AND METHODS 
V.2.1. Materials 
κ-Carrageenan powder (22048), potassium chloride (KCl, P5405), phosphate buffered saline tablets 
(PBS, P4417), Dulbecco‘s Phosphate Buffered Saline (D5652), Dulbecco‘s Modified Eagle‘s Medium-
low glucose (D5523), sodium bicarbonate (NAHCO3, S5761), dexamethasone (D8893) were purchased 
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from Sigma Aldrich (Germany). Fetal Bovine Serum (FBS, 10270-106), Antibiotic-Antimycotic (A/B, 
15240-062) was purchased from Invitrogen (Germany). (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) MTS reagent was purchased from Promega 
(UK).  
  
V.2.2. κ-Carrageenan hydrogel preparation 
An aqueous solution was prepared by dissolving the κ-carrageenan powder (herein referred as κC) in 
distilled water and heating at 60 0C while stirring constantly from 30 min until complete and 
homogeneous dispersion of the material was observed. The 1.5 % (w/v) hydrogel solution was sterilized 
by steam power during 30 minutes at 120 0C. The samples were produced in the form of discs using 
cylinder moulds and a complete gelation was achieved with KCl immersion for 10-15 minutes at room 
temperature in order to stabilize the 3-dimensional structure. Afterwards, the gels were washed with 
PBS to remove the excess of ions. Water content, degradation rate and cell culture experiments were 
all performed using hydrogels discs with Ø 5±0.01 mm x 2.5±0.46 mm height. 
 
V.2.3. Cells isolation and expansion  
Human adipose derived stem cells (hASCs) were obtained from liposuction procedures, under 
protocols established with Plastic Surgery Dept- Hospital da Prelada, Portugal and isolated by 
enzymatic digestion as previously described [22]. Briefly, the adipose tissue samples were digested 
with 0.2 % collagenase type II (C6885, Sigma Aldrich, Germany) in PBS for 45 min at 37 0C under 
gentle stirring. The digested tissue was filtered with a 100 μm filter mesh (Sigma Aldrich, Germany) 
centrifuged at 1200 rpm for 10 min at 20 0C and the cell suspension solution washed 5 min with lysis 
buffer to remove the erythrocytes. The adherent hASCs were expanded in Minimum Essential Medium 
(MEM) alpha Medium (12000-063, Invitrogen USA) with 10% (v/v) FBS, 1% antibiotic-antimycotic and 
sodium bicarbonate with media changes every three days. Nasal cartilage was harvested from the 
nasal septum of adult patients undergoing reconstructive surgery under a protocol established with 
Hospital de S. Marcos, Braga, Portugal. The chondrocytes isolation procedure followed a protocol 
presented elsewhere [23]. Briefly, the human nasal septum cartilage tissue was cut into pieces, 
washed in sterile PBS solution and incubated in 20 mL of trypsin-EDTA solution for 30 min at 37 0C on 
agitation. Then, trypsin was removed and 20 mL of filter sterilized collagenase type II solution (2 
mg/mL) in basic medium was added, and the mixture incubated for 12 h. The digested tissue and cell 
suspension solution was centrifuged at 200g for 7 min and the supernatant removed. The cell pellet 
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was washed with lysis buffer, centrifuged several times  and finally resuspended in expansion medium 
consisting of Dulbecco‘s Modified Eagle‘s Medium - high glucose (DMEM, 5671, Sigma), containing 10 
mM HEPES (H403475, Sigma) buffer pH 7.4, 1% antibiotic-antimycotic, 20 mM L-alanyl glutamine 
(G8541, Sigma), 1x MEM non-essential amino acids (MEM NEAA, 11140-035, Sigma) and 10% (v/v) 
FBS supplemented with 10 ng/ml basic fibroblast growth factor (bFGF, AF100-18B, PeproTech, UK). 
ATDC5 (cell line mouse 129 teratocarcinoma AT805 derived, ECACC, UK) cells were expanded in 
Ham's F-12 cell culture medium (D-MEM⁄F-12 (1:1), 42400-028 Gibco, UK) supplemented with 10% 
FBS (Gibco, UK), 2 mM L-glutamine (G854, Sigma), and 1% antibiotic solution, until obtaining the 
necessary number of cells for the experiments.  
 
V.2.4. Hydrogel characterization 
V.2.4.1. WATER CONTENT AND DEGRADATION RATE  
Hydrogel samples (111.15 mg ± 12.66) prepared according to the procedure described above and 
accurately weighed (ws) were incubated for 7, 14 and 21 days in fresh culture medium and PBS buffer. 
Simultaneously, samples of hydrogels loaded with hASCs, hNCs and ATDC5 (prepared as described in 
the section bellow) were immersed in specific culture medium for each type of cell and incubated at 37 
0C for the same time periods. At the pre-determined time intervals, the medium/PBS was removed 
from the samples, the hydrogels were lyophilized and the dry weights were measured (wd). The water 
content of hydrogels was calculated from the equation (ws – wd)/ws ×100. The degradation rate was 
defined as the time needed for the gel to degrade and for calculation we considered the equation 1. 
The medium was replaced twice a week and the studies were performed in triplicates. 
 
𝐷𝑒𝑔𝑟𝑎𝑑𝑎𝑡𝑖𝑜𝑛 𝑟𝑎𝑡𝑒   % =
𝐹𝑖𝑛𝑎𝑙  𝑤𝑒𝑖𝑔 ℎ𝑡
𝐼𝑛𝑖𝑡𝑖𝑎𝑙  𝑤𝑒𝑖𝑔 ℎ𝑡
 × 100                                                      (1) 
 
V.2.5. Cell encapsulation into κ-carrageenan hydrogels 
The κ-carrageenan hydrogels were produced using the ionotropic gelation method described above and 
cells, namely ATDC5, hNCs and hASCs, were encapsulated at a density of 5 × 106 cells/ml and 
cultured for 7, 14 and 21 days. The mixture composed of the κ-carrageenan aqueous solution and the 
cells suspension was resuspended until complete homogenization. Hydrogel samples loaded with 
different cell types were prepared using sterile polystyrene cylinder moulds. Discs with encapsulated 
hASCs were cultured in chondrogenic differentiation medium composed of Dulbecco‘s Modified Eagle‘s 
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Medium-low glucose (D5523-DMEM Sigma, USA), supplemented with 1% Antibiotic-Antimycotic, ITS+1 
Liquid Media Supplement (I2521- insulin-transferrin-selenium - liquid media supplement, Sigma, USA), 
17mM L-ascorbic acid (A4544 Sigma, USA), 0.1M sodium pyruvate (P4562 Sigma, USA), 35mM L-
proline (P5607 Sigma, USA), 1mM dexamethasone and 10ng/ml of Human TGF‐β1(Transforming 
Growth Factor‐β1, 14‐8348, eBioscience). Encapsulated hNCs and ATDC5 were cultured in the 
previous mentioned culture mediums. Additional controls consisted of κ-carrageenan hydrogel samples 
without cells, kept in the same culturing conditions for the selected time periods. At the end of each 
time of culture the samples were retrieved, washed with PBS solution and further processed according 
to the characterization assays to be performed, as described below. 
 
V.2.6. Biological evaluation 
V.2.6.1. CELLS MORPHOLOGY AND VIABILITY (CALCEIN AM ASSAY) 
The morphology of the different cells, before encapsulation was examined using an inverted light 
microscope (Zeiss, Axiovert 40 CFL, 459306) and images were obtained using a digital photo camera 
(PowerShot G6, Canon). The viability of the cells encapsulated in the κ-carrageenan hydrogel along the 
culture period was assessed using the Calcein AM assay. For this purpose, Calcein AM dye (C3099, 
Invitrogen, SUA) solution of 1/1000 was prepared in culture medium. At the end of each time point of 
the study, the κ-carrageenan hydrogels samples with encapsulated cells were collected from the 
culturing plates and incubated in the calcein AM solution for 15–30 min at 37 0C and afterward washed 
in sterile PBS. The stained samples were placed on a microscope slide and observed under a 
fluorescent microscopy with a 485±10 nm optical filter (Reflected/Transmitted light Microscope, Zeiss 
Germany). 
V.2.6.2. METABOLIC ACTIVITY: MTS ASSAY 
The metabolic activity of hASCs, hNCs and ATDC5 cells encapsulated in κ-carrageenan hydrogel and 
cultured for the pre-determined time points was assessed using the CellTiter 96 One AQueous One 
Solution Cell Proliferation Assay kit (MTS, Promega, Madison), that is based on bioreduction of the 
substrate, into a brown formazan product by dehydrogenase enzymes in metabolically active cells and 
is commonly used for cell viability evaluation. Briefly, cell–hydrogel constructs (n=9) were washed in 
PBS and placed in a mixture containing serum-free cell culture medium DMEM (without phenol red) 
and MTS reagent at a 5:1 ratio and incubated for 3 h at 37 0C in a humidified atmosphere containing 5 
%CO2, at the end of which 100 µL was transferred to 96 well plates and the OD determined at 490 
nm.  
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V.2.6.3. CELL PROLIFERATION: DNA QUANTIFICATION 
The proliferation of the encapsulated cells in the κ-carrageenan hydrogels was assessed using a 
fluorimetric double-strand DNA quantification kit (P7589-PicoGreen, Molecular Probes, Invitrogen, UK). 
For this purpose, samples collected at 0, 7, 14 and 21 days of culturing, were properly washed in PBS 
and then transferred into 1.5 mL microtubes containing 1 mL of ultrapure water. Prior to dsDNA 
quantification, cell-hydrogel constructs and the sample controls (hydrogel samples without cells), were 
thawed and sonicated for 15 min. Samples and standards (ranging from 0 to 2 µg· mL-1) were prepared 
and mixed with a PicoGreen solution in a 200:1 ratio and were added to a 96-well opaque white plate. 
Each sample or standard was made in triplicate. The procedure followed can be found elsewhere [24] 
and was based on manufacture instructions. The plate was incubated for 10 min in the dark, and 
fluorescence was measured on a microplate reader (Bio-Tek, Synergie HT, USA) with an excitation of 
485/20 nm and an emission of 528/20 nm. A standard curve was created, and sample DNA values 
were read from the standard graph. 
 
V.2.6.4. TYPICAL PROTEOGLYCANS STAINING - ALCIAN BLUE, SAFRANIN O 
Alcian blue and Safranin O staining were used to evaluate cartilage extracellular matrix component 
deposition, namely glycosaminoglycans, on samples that were collected at the end of the experiment 
(21 days of culture). Alcian blue (Sigma A3157) staining was performed by incubating the monolayer 
cells or the cell laden hydrogels for 30 minutes. After that, the stain was poured off and the samples 
were washed and dehydrated. The Safranin O staining consisted of staining the cells with Weigert‘s iron 
hematoxylin working solution for 7 minutes and 0.1 % Safranin O for 5 minutes.  Samples were washed 
after each staining step, left to air dry and then rinsed in absolute alcohol. Stained cells were observed 
under a light microscope (Reflected/Transmitted light Microscope, Zeiss Germany) and images 
captured using a camera (Axion MRc5, Zeiss).  
 
V.2.6.5. RNA ISOLATION AND QUANTITATIVE REAL-TIME RT-PCR ANALYSIS OF CHONDROGENIC MARKERS 
The mRNA expression of chondrogenic genes (Sox9, aggrecan, collagen type I, collagen type II and 
collagen X) by the different cell types studied encapsulated in k-carragenan hydrogels was quantified by 
real time qRT-PCR analysis. Total RNA was extracted using TRI Reagent® RNA Isolation Reagent 
(T9424, Sigma, USA) following the manufacture‘s instruction. First-strand complementary DNA (cDNA) 
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was synthesized from 2 µg of RNA of each sample reverse transcribed with qScript™ cDNA Synthesis 
Kit (Quanta Biosciences, USA) in a 40 µL reaction using a MJ Mini™ Personal Thermal Cycler (Bio-Rad 
Laboratories, USA) machine. Real-Time qRT-PCR was performed to detect amplification variations using 
PerfeCTa® SYBR® Green FastMix®, (Quanta Biosciences, USA) on Eppendorf Mastercycler® ep 
realplex gradient S machine according to manufacturer‘s instructions in a 20 μL reaction contain 2.5 
μL of each primer. The relative quantification of the gene expression was calculated using the 2-ΔCt and 
2-ΔΔCt method [25]. The mRNA expression levels of target genes were normalized to the average 
expression of endogenous housekeeping gene GAPDH (glyceraldehyde-3-phosphate dehydrogenase) 
value. Each quantitative real time PCR run was carried out with an initial incubation at 95 0C for 2 min 
followed by 45 cycles of denaturation (95 0C, 30 s), corresponding annealing temperature for 30 s and 
extension step at 72 0C for 30 s. A melting curve of 21 minutes and a hold step at 5 0C was performed 
at the end. 
 
V.2.7. Statistical analysis 
Sets of triplicates were expressed in mean ± standard deviation for water content and degradation rate 
(n=3), MTS, DNA (n=9) and qRT-PCR data (n=3). First, a Shapiro-Wilk test was used to ascertain about 
the data normality. The results indicated that at the 0.05 level, the data was significantly drawn from a 
normally distributed population and analysis of variance (ANOVA one way) followed by Tukey test was 
used to determine significant differences between groups and conditions. The difference was 
considered significant when p < 0.05 [26].  
 
V.3. RESULTS AND DISCUSSION 
Tissue engineering is an emerging approach for the regeneration of damaged cartilage tissue due to 
disease or trauma [27] and since cartilage lacks self regenerative ability it is essential to develop 
methodologies for delivery of clinically relevant number of cells and/or cytokines and growth factors to 
the defect site. It is well known that in many situations, cells alone are not able to efficiently initiate a 
regeneration process once implanted, due to the dispersion or immune system rejection. Cell 
encapsulations techniques through hydrogels systems confer means to overcome some of these 
problems [28]. The motivation of using a κ-carrageenan hydrogel as a cell support was to take 
advantage of its intrinsic properties and composition, being a hydrophilic polysaccharide with high 
swelling properties, characterized by its sulphate group‘s content, similar to GAGs constituents. 
Additionally, it is a thermo/reversible and an ionic gel with the ability to form hydrogel at conditions that 
 
__________________________Chapter V. Chondrogenic phenotype of cells encapsulated in carrageenan__ 
179 
 
allow in situ gelation and direct encapsulation of cells. These hydrogels have been investigated as drug 
delivery or growth factor delivery systems [29-31] immobilization of enzyme [32] but have been very 
little explored until the present time for cartilage restoration [33]. In this study we aimed at analyzing 
the behavior of κ-carrageenan hydrogels as encapsulation systems for adipose stem cells and primary 
chondrocytes. 
 
V.3.1. Water content and degradation rate 
Besides the increase in the mass of the hydrogels, high water content ability may influence the 
biological behavior of the cells. The matrix environment, in which cells are grown, influences the type 
and extent of cellular response, which in turn affects cell viability and proliferation. Therefore the water 
content/ degradation rate of the developed hydrogels was evaluated in simulated physiological 
conditions, as the diffusion, exchange of nutrients and waste throughout the entire hydrogel are related 
to the level of water being substituted with the surrounding medium. κ-carrageenan has an abundant 
number of hydrophilic groups, such as sulphate groups, which can promote a high water uptake in the 
structure. No previous dehydration of the hydrogels was performed, envisioning a better simulation of 
their application at the in vivo scenario. Significantly higher water content was observed for the 
hydrogels immersed in PBS as compared to the hydrogels dipped in DMEM/10 %FBS (Figure A1), after 
21 days, possibly due to the ionic composition of the solutions.  Previous research studies have shown 
that the swelling behavior of hydrogels depends of external environment such as ionic strength, 
temperature, pH [34]. The high water content of the hydrogels immersed in PBS could relate to the 
higher exchange between the ions from the medium and the potassium ions needed for the cross 
linking of κ-carrageenan hydrogel. Thus, the lower water content registered for the hydrogels exposed 
to DMEM/10 %FBS can be explained by the lower ionic exchange but also due to possible binding of 
the fetal bovine serum proteins, present in the culture medium, to the κ-carrageenan hydrogels sites. 
Nevertheless, all the hydrogels samples exhibited water contents superior to 98% either in DMEM/10 
%FBS or in PBS medium. The degradation experiments were performed at neutral pH, resembling 
physiological conditions, (Figure 1, A2) and, in general, the results show a higher decrease in dry mass 
for hydrogels in PBS as compared to hydrogels incubated in DMEM/10 %FBS, in agreement with the 
water uptake results. Water content and degradation of the hydrogels with encapsulated cells, were 
also evaluated  after culturing for 7, 14 and 21 days at 37 0C (Figure 1, B1 and B2). The highest water 
uptake was registered for the κ-carrageenan laden with ATDC5 cells, followed by hydrogels loaded with 
hNCs and hASCs cells. The mass loss difference found between the different cells type could be 
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associated to the particular stage of their growth cycle at each time point analyzed. For hASCs, this 
behavior could be linked to a higher extracellular matrix formation, since the stem cells undergo 
differentiation stimulated by the culturing media. In fact, cells encapsulation and extracellular matrix 
deposition may result in progressive increase in the mass or in the mechanical properties for the 
hydrogels, as shown before for other systems [35]. In this study, this was corroborated with the qRT-
PCR data (see below) as we observe an increase in the aggrecan and collagen gene expression for 
hASCs and hNCs (demonstrating higher ECM deposition) and the lowest expression for ATDC5 cells. 
 
 
Figure V- 1. (A) Water content and (B) degradation rate of κC hydrogels as a function of time, registered 
after immersion in DMEM/10%FBS and in PBS solution at 37 °C and pH 7.4. (C) Water content and 
(D) degradation rate of κC hydrogels with encapsulated cells (hASCs, hNCs, and ATDC5) versus 
immersion time in culture medium (specific for each type of cell). Values reported as averages (n = 3) 
± SD. 
 
V.3.2. Cell morphology and distribution 
Adult stem cells have recently received great attention as an alternative resource to overcome the 
limited supply, as well as the dedifferentiation process often observed in primary chondrocytes in vitro 
expanded in monolayer. The use of cell lines in cell based therapies is not considered safe as these 
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cells are often derived from tumors and typically accumulated genetic changes with increasing passage 
levels [36]. Optical microscopy was used to analyze hASCs, hNCs and ATDC5 cell morphology in 
monolayer after 7 days in culture (Figure 2A). Images depict the morphology of the different cells types, 
hASCs and hNCs presenting fibroblast like appearance due to chondrogenic phenotype instability and 
ATDC5 cells exhibiting extended, polygonal shape [37]. In monolayer culture, ATDC5 cell seemed to 
achieve confluence faster than hASCs and hNCs. Once different cells were encapsulated in the same 
hydrogel, the cell behavior was expected to be different, independently of additional influence of the 
hydrogel matrix [38]. Fluorescence microscopy images of the cell laden hydrogels are presented in 
Figure 2B. The viability of encapsulated cells within the polysaccharide hydrogel was confirmed by the 
positive cell staining with Calcein AM. The fluorescence images also show homogeneous distribution of 
all cells encapsulated in the hydrogels, while hASCs depicted a tendency to form cell clusters.  
 
 
Figure V- 2. (A) Micrograph images obtained from 2D-cultured cell monolayer of hASCs, hNCs, and 
chondrogenic cell line after 7 days in expansion; magnification 20× with 100 μm scale bar. (B) Calcein 
AM staining of hASCs, hNCs, and ATDC5 encapsulated in κC hydrogels on day 7 of culture; 
magnification 20× with 100 μm scale bar. 
 
V.3.3. Metabolic activity and proliferation of encapsulated cells  
Viability of encapsulated cells within κ-carrageenan hydrogels during 3 weeks of culture was assessed 
using the MTS assay. In general, it was observed a decreased viability over time for all types of cells 
encapsulated in κ-carrageenan hydrogel (Figure 3A), as it is typically observed in cells encapsulated in 
hydrogels [39-41]. This drop in cell proliferation could be due, at least partially, to the fact that cells are 
being released from the hydrogels systems during culturing owing to degradation of the hydrogels. 
Furthermore, there are works reporting that ions needed for the hydrogel formation may influence the 
cell viability/proliferation and that low concentration have higher cell viability [42, 43]. Thus, remaining 
100μm
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potassium ions could have also contributed to the decrease in cells viability. The effect of hydrogel 
concentration and thus its stiffness is also thought to affect encapsulated cells, since it is known the 
inverse dependency between the permeability and the stiffness [44]. The data obtained also 
demonstrated that human adipose derived stem cells and nasal chondrocytes, once encapsulated 
within the biodegradable hydrogel, are more metabolically active than ATDC5 cells (p < 0.05). DNA 
quantification (Figure 3B) shows that hASCs encapsulated in κ-carrageenan hydrogels exhibit higher 
cell content than hydrogels laden with hNCs and ATDC5. This difference was found statistically 
significant (p < 0.05) at 14 and 21 days of culture. There are several hypotheses for the observed 
differences among the cells used. Each cell type was incubated in a different medium therefore we 
cannot rule out the effect of the cell culture medium and added supplements. This is probably related 
to the different growth profile of the different cells analyzed. Cell metabolic activity and proliferation 
data clearly indicates that κ-carrageenan, an easy-to-handle, simple and non toxic hydrogel, formed 
under mild conditions with in situ gelation properties, sustains cell growth and proliferation for long 
time in culture using different cell types.  
 
Figure V- 3. (A) Metabolic activity results based on MTS test performed on 0, 7, 14, and 21 days of 
culture. (B) Cell content obtained from by DNA quantification of hASCs, hNCs, and ATDC5 
encapsulated in κC hydrogels and cultured for 21 days in specific mediums. Error bars represent 
means ± SD (n = 9). The statistics using one-way ANOVA indicates that the mean difference is 
significant at the 0.05 level (P < 0.05). The symbol ∗ indicates statistical significance between hASCs 
or hNCs and ATDC5 cell type in terms of metabolic activity response, and # implies statistical 
significance on day 14 and 21 between hASCs and hNCs or ATDC5 in the proliferation rate. 
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V.3.4. GAGs deposition 
The glycosaminoglycans (GAGs) deposition in the hydrogels laden with the different cell types was 
evaluated by histological staining. Light microscopy images of sample sections obtained from hydrogels 
with encapsulated hASCs, hNC or ATDC5 cells, stained with Safranin O and Alcian blue, revealed 
positive staining for both cartilage ECM markers, confirming the extracellular matrix secretion by all the 
cell types embedded in the κ-carrageenan hydrogel, after 3 weeks of culture (Figure 4). It is known that 
the extracellular matrix is not a static structure but a dynamic network of molecules secreted by cells 
[45, 46] and thus the  staining indicated a progressive increase in intensity over the period of culture 
(data not presented). The cell concentration chosen for the cells experiments was 5x106 cells/ml, based 
on previous works [17, 47], and was the same for all the cell types investigated to allow a more 
straightforward comparison among the outcomes produced by the different cell types. Nevertheless, 
cell density has an important role in extracellular formation and may affect differently the different cell 
types used herein [48]. It was noteworthy that the distribution of the cartilage matrix in the hydrogels 
was homogeneous for all cells types. Furthermore, adipose derived stem cells exhibited stronger 
staining intensity, clearly demonstrating the chondrogenic differentiation undergone by these cells 
embedded in k-carragenan and stimulated by the chondrogenic supplements in the culture media. The 
round shape cell morphology observed is a further indication  of chondrocyte phenotype achieved by 
hASCs  [49]. These results show that κ-carrageenan hydrogels is not only acting as a cell vehicle, but is 
also supporting cells functionality, namely the chondrogenic differentiation, suggesting that  this 
material can actually mimic  ECM properties to a certain range, rendering them attractive for cartilage 
regeneration strategies.  
 
 
Figure V- 4. Optical microscopic images of histological sections obtained from κC hydrogels with 
encapsulated cells, collected after 21 days of culture and stained with Alcian Blue and Safranin O. The 
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scale bar corresponds to 100 μm and the magnification used was 20×. Embedded pictures correspond 
to light microscopy images of stained hASCs, hNCs, and ATDC5 cell monolayers after culturing for 3 
weeks. 
 
V.3.5. Real-time qRT-PCR 
The results obtained from the genotypic quantification of cartilage related genes for hASCs, hNCs and 
ATDC5 after 7, 14, and 21 days of culture within κ-carrageenan hydrogels are presented in Figure 5. 
The relative expression of the cartilage specific genes was normalized against the housekeeping gene 
GAPDH and compared to initial culture time. A constitutive expression of all mRNA transcripts (i.e. 
SOX9, aggrecan – AGCR, collagen type I - COL1, collagen type II - COL2 and collagen type II - COLX) 
were found during the 21 days of culture. In general, hASCs encapsulated in κC showed higher levels 
of all markers analyzed, except collagen X, as compared to hNCs and ATDC5 cells. Specifically, the 
mRNA levels in hASCs cells for day 21 in culture were found to be upregulated for the following 
molecules: SOX9 (39.72-fold; p < 0.05), AGCR (53.57-fold; p < 0.05), type I collagen (10.35-fold; p < 
0.05), type II collagen (94.23-fold; p < 0.05) and type X collagen (5.7-fold; p < 0.05). SOX9 followed a 
particular high expression pattern, increasing until the last day (Figure 5A). It has been demonstrated 
that a highly expressed SOX9 stimulates the production of the AGCR and COL2 [50]. In fact, the results 
obtained from statistical analysis of the AGCR expression by hASCs showed significant increase (p < 
0.05, Figure 5B) between 14 and 21 days of culture. Along with aggrecan [51], collagen type-II, is a 
major structural component of cartilage, particularly articular cartilage [52]. Collagen type II is the most 
important protein produced by chondrocytes and the tensile property of cartilage is depended of that, 
while aggrecan is responsible for the compressive properties [53]. The expression of the COL2 
transcript was detected for all time points, with low values for day 14 and a significant increase for day 
21 (p < 0.05, Figure 5D). Even if collagen type 2 exhibits a decreases expression at day 14, aggrecan 
gene expression has an increase, as these chondrogenic markers are interplaying together being 
expressed differently during the chondrogenic differentiation. In contrast, for hASCs, collagen type I 
expression showed no significant increases between 14 days and 21 days of culture (Figure 5C) 
suggesting that it was formed an elastic cartilage-like tissue (characterized by high expression of 
collagen type II) instead of  fibrocartilage, usually characterized by a the expression of collagen type I. 
In this system, hASCs were likely stimulated down the chondrogenic pathway by TGF-β1 growth factor 
present in the chondrogenic medium [54]. Significant increase mRNA levels of COL2 gene was 
registered for hNCs during the 21 days of culture (p < 0.05) although at lower levels as compared with 
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the fold increase expression for the stem cells (Figure 5D). For the ATDC5 cells it was registered a high 
expression for COL2 gene and a low upregulation for AGCR at day 14 but no significant levels of the 
remaining genes analyzed were recorded (Figure 5D and 5B). Interactions with κC matrix may have 
subsequently guided cell behavior favoring chondrogenic induction, thus explaining the regulation in 
COL2 gene expression among different cell types, as suggested by other works [55]. Collagen type X is 
expressed in identical levels values for all types of cultures and all time point (Figure 5E). All cell types 
show an increased expression marker of this gene, frequently associated with the dedifferentiation of 
chondrocytes, suggesting that increasing culturing time may compromise the functionality of these cells 
[56, 57]. ATDC5 culture produces chondrocytes maturation and apoptosis, indicating that this cell line 
is also suitable to study in vitro the mineralization process [58]. In summary, the data gathered from 
real time RT-PCR analysis demonstrated that hASCs and nasal chondrocytes lead to better results in 
terms of chondrogenic potential when compared to ATDC5 cells. Moreover, hASCs showed higher 
phenotypic and functional characteristics against hNCs, demonstrating that these cells could be an 
alternative to the autologous approach already used in clinical applications. The obtained results also 
indicate that κ-carrageenan hydrogels are able to stimulate specific cellular responses at the molecular 
level when the encapsulated cells present a different growth profile with respect to early and late 
cellular events in the growth profile of cells. 
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Figure V- 5. Real-time analysis of chondrogenic-specific gene expressions—namely, (A) SOX9, (B) 
aggrecan, (C) collagen type I, (D) collagen type II, and (E) collagen type X—based on the mRNA 
produced by the encapsulated cells after 7, 14, and 21 days of culture. The expression of these genes 
was normalized against the housekeeping gene GAPDH and calculated by the Livak method. Error bars 
represent means ± SD. Statistical analyses were conducted using one-way ANOVA for n = 3; P < 0.05. 
 
V.4. CONCLUSION 
The κ-carrageenan systems enabled the viability and proliferation of different cells during long term cell 
culture and showed its efficiency to support the production of an organized extracellular matrix and 
other chondrogenic features, as well as its ability to support the chondrogenic differentiation of human 
adipose stem cells. In fact, hASCs showed a better cellular response when encapsulated in κ-
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carrageenan hydrogels than primary chondrocytes obtained from nasal septum cartilage. Taking into 
account these finding together with their wider availability and easier harvesting, it is possible to 
conclude that hASCs could serve as an alternative cells source to the chondrocytes transplantation 
therapy. Altogether, the results obtained from this study clearly indicate the great potential for the 
application of k-carragenan laden with hASCs in cartilage regeneration. 
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Chapter VI* 
 
CRYOPRESERVATION OF CELL LADEN NATURAL ORIGIN HYDROGELS FOR CARTILAGE REGENERATION 
STRATEGIES 
 
ABSTRACT 
 
The time span needed for obtaining a functional cartilage substitute using tissue engineering strategies, 
together with the need for specific patient oriented constructs has stimulated the growing interest for 
developing ―off-the shelf‖ products. One way to deliver such products is based on long-term storage 
processes, such as cryopreservation, that will provide clinical substitute available as needed and could 
be adapted to an autologous immediate solution for the patient. The aim of this study was to examine 
the effects of cryopreservation on the chondrogenic differentiation characteristics of human 
mesenchymal derived stem cells isolated from adipose tissue and encapsulated in κ-carrageenan 
hydrogels. These bioengineered constructs are anticipated to participate in a cartilage regeneration 
strategy providing temporary habitation for cell survival, proliferation and production of extracellular 
matrix which is expected to replace the hydrogel, enhancing the regeneration of native tissues in 
clinical settings. The results obtained show that the hydrogels withstand the cryopreservation with 
dimethyl sulfoxide, maintaining their structural integrity, while assisting cells proliferation and 
chondrogenic potential after cryopreservation. Thus, cell encapsulation systems of natural based 
hydrogels seem to be an interesting approach for the preservation of cartilage tissue engineered 
products. 
  
 
Keywords: Cryopreservation, natural origin polymers, hydrogels, cell encapsulation, κ-carrageenan. 
 
 
 
* This chapter is based on the following publication: 
Popa E. G., Rodrigues M. T., Coutinho D. F., Oliveira M. B., Mano J. F., Reis R. L., and Gomes M. E., 
"Cryopreservation of cell laden natural origin hydrogels for cartilage regeneration strategies", Soft 
Matter, vol. 9, issue 3, pp. 875-885, 2013. 
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VI.1. INTRODUCTION 
One of the main prospects of cartilage tissue engineering is the possibility of developing custom-made 
solutions for regenerative medicine on an individual patient basis, a major challenge being the 
preservation and storage of the bioengineered constructs aimed at ready-to-use applications. Since the 
process of developing tissue engineered constructs is typically time demanding, approaches to facilitate 
and accelerate their clinical use have emerged. Assuming this, the cryopreservation of cells, as well as 
more complex systems such as cell encapsulation devices, tissue-engineered constructs, and even 
laboratory-produced tissues and organs may be critical in the future. Thus, the scientific increment in 
the literature and current clinical experience for the repair of injured or diseased articular cartilage 
supports the need for providing such novel products like cultured cells on engineered tissues 
constructs to improve the clinical market options.   
Cryopreservation of various mammalian cell types has been a standard procedure for many years [1-3] 
envisioning cell preservation for future outcomes. Cell encapsulation is one of the primary techniques 
to colonize tissue-engineered hydrogels as cells are immunoprotected from the host environment once 
implanted. The most applied cryopreservation protocols use dimethyl sulfoxide (DMSO) (1 to 20% v/v) 
in serum-supplemented culture medium combined with slow-freezing rates [4]. However, the 
cryopreservation of tissue engineered constructs is typically associated with difficulties in preserving the 
3D structural properties of the constructs, and the challenge stands for reducing to minimum the cryo-
injury, predominantly related to ice formation upon freezing and thawing [5]. Nevertheless, complex 
cell-scaffolds constructs kept under routine cryopreservation procedures are emerging as potential 
banking constructs in regenerative medicine applications [6, 7]. Alternatives have been proposed with 
the use of several cryoprotectants [8-10], vitrification solutions [11, 12] or the entrapment of cells on 
artificial extracellular matrix (ECM), like hydrogels [13-16]. Artificial ECM/hydrogels may be viable to 
protect the cells from outside damage, whereas the cryoprotectants will protect the cell from 
intracellular or intercellular ice crystals formation. This system allows cells to be protected against 
mechanical damages during ice crystallization and the danger of disrupting cell–cell interactions is 
reduced through immobilization [17, 18].  
Natural hydrogels have been widely used in the biomedical field, as cell encapsulation and delivery 
systems, envisioning their application in several regenerative medicine therapies [19-22]. Among the 
different polymers studied, κ-carrageenan is a very versatile, thermosensitive hydrogel used to develop 
ionotropic matrices for in situ immobilization of cells [23]. Carrageenan belongs to a family of linear, 
water soluble, sulfated, anionic polysaccharides extracted from marine red algae [24, 25]. They are 
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highly flexible molecules with the ability to shape into different formats at room temperature due to its 
thermosensitive characteristic. The formation of irreversible carrageenan hydrogels can be obtained in 
the presence of potassium ions, which leads to the formation of more stable hydrogels. More recently, 
κ-carrageenan based systems have been proposed for cartilage regeneration strategies [26, 27] and 
for delivery systems of proteins and growth factors by our group [28-30].  
Although the cryopreservation of cells or tissues is a common method that provides advantages for 
cellular therapies [31] aimed at bioengineering cartilage, few studies have addressed the impact of 
cryopreserving constructs as a combined cell therapy. A fundamental objective of this work was to 
verify the viability, proliferative and differentiation capacity of human adipose derived stem cells 
(hASCs) into chondrocyte-like cells while encapsulated in the κ-carrageenan hydrogels, demonstrating 
the ability to maintain the metabolic functionality after cryopreservation. Another crucial goal towards 
the applicability of the proposed system into clinical settings was the analysis of the effect of 
cryopreservation on the morphological and mechanical properties of the system as a functional 
construct. The outcomes of this study suggest that this strategy could provide a ready-to-use pool of 
cells for cartilage clinical treatments. 
 
 
Figure VI- 1. Study design showing details of the preparation and cryopreservation process for the 
developed hASCs-κCR construct. 
 
VI.2. MATERIALS AND METHODS 
VI.2.1. Preparation of ionic κ-carrageenan hydrogels 
The ionic gelation process of the natural polysaccharide based κ-carrageenan (κCR, 22048, Sigma) 
was performed as described elsewhere [32]. Briefly, the κCR powder was mixed with distilled water to 
obtain the 1.5 % (w/v) polymeric concentration. The solution was warmed up in a water bath at 50 ºC, 
stirring until the complete dissolution and afterwards sterilized (121 ºC for 30 min) before cell culture 
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studies. In order to form hydrogel samples in the form of discs, 5 mL of κCR solution was poured into 
sterile plastic Petri dishes of 55 mm  and the freshly formed hydrogels were punched out into disc 
shape sample of 5 mm  x 3 mm height. The hydrogel formation was further stabilized by cross 
linking with 5 % (w/v) potassium chloride (KCl, P5405, Sigma) for 15 minutes. Afterwards the 
hydrogels samples were washed with PBS to remove the excess of KCl present on the surface. 
  
VI.2.2. hASCs isolation and expansion  
Human subcutaneous fat tissue samples were obtained under protocols established with the Plastic 
Surgery Department of Hospital da Prelada (Porto, Portugal). Adipose tissue derived stem cells from 
four female donors with a mean age of 35.25 years (± 8.55) and BMI of 26.26 (± 2.74) were isolated 
by enzymatic digestion as previously described [33]. Briefly, the adipose tissue samples were digested 
with 0.075 % collagenase type II (C6885, Sigma) in phosphate buffer saline (DPBS, 21600-044, 
Invitrogen) for 45 min at 37 ºC under gentle stirring. The digested tissue was filtered with a 100 μm 
filter mesh, and centrifuged at 1000 g for 10 min at 5 ºC. Afterwards the cell suspension was washed 
for 10 min with lysis buffer (155 mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA, pH= 7.3) to remove the 
erythrocytes, and additionally centrifuged at 800 g for 10 min at 5 ºC. The adherent hASCs were 
expanded in basal medium composed of Minimum Essential Medium alpha (MEM, 12000-063, 
Invitrogen) with 10% (v/v) fetal bovine serum (FBS, 10270, Invitrogen), 1% (v/v) antibiotic-antimycotic 
solution (15240-062, Gibco®), and 2.2 mg/mL sodium bicarbonate (NaHCO3, S5761, Sigma) with 
medium changes every three to four days. Cells were subcultured at a cell density of 3.5 x 103 
cells/cm2 until achieving a sufficient cell number to be used in the experimental assay. The hASCs 
used in this study were at passage three. 
 
VI.2.3. Cells encapsulation  
The κCR aqueous solution and the cell suspension were mixed until complete homogenization, and 
hydrogel discs samples loaded with hASCs were formed as described above, using sterile moulds. The 
hASCs were encapsulated at a density of 5 × 106 cells/cm3 into the κCR hydrogels and cultured for 14 
days either in chondrogenic or basal medium. The chondrogenic induction medium was composed of 
Dulbecco‘s Modified Eagle‘s Medium-low glucose (DMEM, D5523, Sigma), supplemented with 3.8 
mg/mL NAHCO3, 1 % (v/v) Antibiotic-Antimycotic solution, 10 % (v/v) FBS (fetal bovine serum, 
SH3007103, Fisher Scientific), 1× ITS+1 (insulin-transferrin-selenium - liquid media supplement, 
I2521, Sigma), 17 mM L-ascorbic acid (A4544, Sigma), 0.1 M sodium pyruvate (P4562, Sigma), 35 
 
___________________________________________________________Chapter VI. Cryopreservation of cell laden hydrogels__ 
197 
 
mM L-proline (P5607, Sigma), 1 mM dexamethasone (D2915, Sigma) and 10 ng/mL of human 
transforming growth factor‐β1 (TGF‐β1, 14‐8348, eBioscience). κCR hydrogel samples without cells 
kept in culture for the same time points under the same cell maintenance conditions and cell pellets, 
were used as controls. For the preparation of the 3D micromass pellets, aliquots of 2 × 105 cells in 0.3 
mL of medium were centrifuged at 1500 rpm for 15 min. Pellets were cultured for 14 days in a 37 ºC 
humidified atmosphere with 5 % CO2, and medium was changed once a week. At the end of cell 
culturing, part of the samples were retrieved, rinsed in PBS solution and characterized by light 
microscopy, mechanical analysis, live dead-assay, DNA quantification assay, histology analysis and 
reverse-transcription polymerase chain reaction (RT-PCR) assessment. Simultaneously, the remaining 
part of the samples was removed from culture and cryopreserved (Fig. 1).   
 
VI.2.4. Cryopreservation process 
Samples that underwent cryopreservation were frozen for one month before being cultured for 
additional 7 days in BM or CM. The cryopreservation process was based on the following protocol: each 
sample was individually placed in a polypropylene cryovial (479-0821, VWR) containing a solution of 10 
% (v/v) dimethyl sulphoxide (CryoSure DMSO, 11-32-30216, Wak-Chemie Medical GMBH) in FBS. The 
samples were cooled down to 4 ºC using an ice bath (30 minutes). Afterwards, cryovials were moved 
into a conventional freezer (-20 ºC; 1-2h) and then moved into a -80 ºC freezer. After 12 hours at -80 
ºC, samples were stored inside a liquid nitrogen tank (Statebourne Biosystem) at -196 ºC for one 
month.  
In total the experiment set-up included five groups, consisting of: i) hASCs- κCR hydrogels construct 
cultured in chondrogenic medium (CM); ii) hASCs-hydrogels construct cultured in basal medium (BM); 
iii) κCR hydrogels cultured in basal medium; iv) pellets cultured in chondrogenic medium (CM) and v) 
pellets cultured in basal medium (BM). Samples were evaluated before (BC corresponds to 14 days in 
culture before cryopreservation) and after cryopreservation (AC corresponds to 7 days of culture after 
cryopreservation). All samples were subjected to light microscopy observation, DMA (dynamic 
mechanical analysis) assays, live dead-assay, DNA quantification assay, histology and RT-PCR analysis 
(Table 1).  
 
Table VI- 1. Summary of the tested group cell-hydrogel constructs and pellets cultured in either basal 
medium (BM) or chondrogenic medium (CM) and characterization techniques performed on samples 
retrieved before (AC) and after cryopreservation (BC). 
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VI.2.4.1. MORPHOLOGY AND MECHANICAL PROPERTIES  
The full structure and morphological characteristics of the developed discs with encapsulated cells 
(cultured in CM or BM) and without cells (cultured only in BM) both before (BC) and after 
cryopreservation (AC) were observed under an inverted light microscope (Zeiss, Axiovert 40 PG-HITEC) 
equipped with a digital camera (Axiocam MRc5, Zeiss). The mechanical properties of 1.5 % (w/v) ionic 
κCR hydrogel discs BC and AC were characterized by DMA (TRITEC Admin 8000B, Triton Technology). 
The viscoelastic measurements were carried out at 37 ºC in 5% KCl and the samples were immersed in 
the culture medium until performing the assay. After equilibration, the DMA spectra were obtained 
during a frequency scan in the range of 0.1–10 Hz. The experiments were performed under constant 
strain amplitude (50 μm). A small preload was applied to each sample to ensure that the entire disc 
surface was in contact with the compression plates before testing and the distance between plates was 
equal for all samples being tested. At least five samples were tested for each condition.  
 
VI.2.4.2. VIABILITY AND PROLIFERATION OF THE ENCAPSULATED HUMAN ADIPOSE DERIVED STEM CELLS 
Live and dead assays using fluorescence labeling were used to assess the viability of the cells. In short, 
samples were collected, placed in a 48-well plate, and washed with PBS. Subsequently, 500 μL of 1 
mg/mL Calcein AM in PBS (1:500, C3099, Invitrogen) was added to each sample for 10 min at 37 ºC 
and later washed with sterile PBS. Afterwards, the samples were incubated with 300 µL of 1.5 mM 
propidium iodide in PBS (PI; 1:1000, P1304MP, Invitrogen) for 5 min at room temperature, previous to 
microscopic analysis (Reflected/Transmitted light Microscope, Axioimager Z1M, Zeiss).  
DNA quantification was performed using the fluorimetric PicoGreen double-stranded DNA assay 
according to the manufacturer instructions (Quant-iT™ PicoGreen® dsDNA Kit, P7589, Invitrogen). 
Briefly, cell-hydrogel constructs, collected at each time period, were rinsed twice in PBS to completely 
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remove the culture medium, placed in a microtube containing 1 mL ultra-pure water, and stored at - 80 
ºC to induce the lysis of cells by osmotic and thermal shock, respectively. Then, samples were thawed 
and the supernatant collected for the dsDNA quantification assay. The fluorescence of the samples was 
measured with a microplate reader (Synergie HT, Izasa) at Ex 480 nm and Em 520 nm. The DNA 
concentration was calculated using a standard curve (DNA concentration ranging from 0-2 µg mL-1) 
relating to the amount of dsDNA to the fluorescence intensity.  
 
VI.2.4.3. HISTOLOGICAL EVALUATION - TYPICAL PROTEOGLYCANS AND H&E STAINING 
Samples collected before and after cryopreservation were fixed with 3.7 % (v/v) neutral buffered 
formalin solution and stored at 4 ºC until analysis. Samples were further processed by a series of 
dehydration steps, embedded in paraffin (Microm EC350-2, Thermo Scientific) and sectioned at 3 µm 
(Microm HM 355, Thermo scientific). Toluidine Blue (TB) staining was used to evaluate the deposition 
of glycosaminoglycans (GAGs), a cartilage ECM. TB (T3260, Sigma) coloration was performed by 
dipping the cell laden hydrogels sections for 2–3 s in the staining solution. Afterwards, the stain was 
poured off and the samples washed, dehydrated, cleared in xylene (1.08681.1000, VWR), and 
mounted for further analysis. For haematoxylin and eosin (H&E) staining, after hydration, sample 
sections were colored with Papanicolaou Harris hematoxylin (05-12011/L, Bio-optica) for 3 minutes, 
washed in running tap water, and afterwards a blue stain enhancement was performed by an 
immersion in 0.5 % ammonium hydroxide solution (05002, Sigma) for 5–10 seconds. The sections 
were washed in running tap water and stained in Eosin-Y (05-M10003, Bio-optica) for 30 seconds. 
Finally, slides were dehydrated through series of alcohol immersions from 30 until 100 % (v/v) alcohol. 
The stained cells were visualized under a light microscope and images were taken by a digital camera 
(Axion MRc5, Zeiss).  
 
VI.2.4.4. IMMUNOLOCALIZATION OF TYPE I AND II COLLAGENS 
Fixed samples with 3.7 % (v/v) formalin solution were paraffin embedded and sectioned. Before 
removing the paraffin, the slides were warmed, and the antigen retrieval was performed for 20 minutes 
at 95 ºC using 10 mM citrate buffer. Afterwards the sections were washed in PBS, and endogenous 
peroxidase activity was quenched with 0.3% hydrogen peroxide (31642, Sigma) for 5-15 min. Sections 
were washed with PBS and blocked with 2.5% horse serum from R.T.U. Vectastain® Universal Elite 
ABC Kit (PK-7200, Vector Laboratories) for 1 h to avoid nonspecific staining and further incubated with 
primary antibodies (mouse anti-collagen II antibody - MAB1330, Millipore, and rabbit anti-collagen I 
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antibody - ab292, Abcam) overnight at 4 ºC, in a humidified atmosphere. Afterwards the slides were 
incubated with secondary antibody (R.T.U. Vectastain® Universal Elite ABC Kit) for 1 h at room 
temperature and developed with DAB substrate kit for peroxidase (SK-4100, Vector Laboratories). 
Slides were counterstained with haematoxylin, mounted and visualized under the light microscope. 
Controls were performed using normal horse serum replacing the primary antibodies. 
 
VI.2.4.5. RNA ISOLATION AND GENE EXPRESSION ANALYSIS (RT-PCR) 
RT-PCR analysis was performed to detect the gene expression of typical markers for chondrogenic 
differentiation, namely aggrecan, collagen type II, Sox9, collagen type X and collagen type I. Total RNA 
was extracted using TRI Reagent® RNA Isolation Reagent (T9424, Sigma) following the manufacture‘s 
instruction. First-strand complementary DNA was synthesized from 2 µg of RNA of each sample reverse 
transcribed (qScript™ cDNA Synthesis Kit, Quanta Biosciences) in a 20 µL reaction using an Eppendorf 
Mastercycler® ep realplex gradient S machine. mRNA expression of the genes of interest was 
measured in the hASCs laden κCR hydrogels as well as in the pellet culture systems, both before and 
after cryopreservation. The transcript expressions of target genes were analyzed to the expression of 
endogenous housekeeping gene GAPDH (glyceraldehyde-3-phosphate dehydrogenase). The primer 
sequence was obtained from Primer3 software (v 0.4.0), and synthesized by MWG Biotech (see Table 
2). Conventional PCR was performed using a High- Fidelity DNA Polymerase (Finnzymes) and dNTP Mix 
(Finnzymes) as well as a primer concentration of 0.2 mM in a 35 cycle 3-step reaction. The PCR 
products were detected in a 1.3 % agarose gel (SeaKem®LE agarose, Lonza) using a 100 bp DNA 
ladder (GeneRuler™ SM024, Fermentas). Images from the gels were taken using a UV Transiluminator 
(BioSpectrum AC Chemi HR 410, UVP) (n=3). 
 
Table VI- 2. Primers used for RT-PCR analysis and expected sizes of the PCR products. 
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VI.2.5. Statistical analysis 
All data values are presented as mean ± standard deviation. Differences were determined to be 
statistically significant with p < 0.05. For statistic analysis one-way ANOVA analysis of variance between 
groups with Tukey post test was carried out. 
 
VI.3. RESULTS 
VI.3.1. Cell laden hydrogel morphology before and after the cryopreservation process 
In the present study we have analyzed the effect of cryopreservation process on the chondrogenic 
features developed by the hASCs after encapsulation in κCR sulfated hydrogels. Cell laden hydrogels 
were cultured for 2 weeks before being cryopreserved for one month under standard conditions. 
Afterwards, constructs were thawed and cultured for an additional 7 days period.  
In order to analyze the morphology of hydrogels and the encapsulated cells, micrographs images were 
obtained from hASCs-hydrogel constructs culture in CM and BM, after and before cryopreservation (Fig. 
2). Macroscopically, the integrity of the hydrogels did not seem to be affected by the 
cryopreservation/thawing process, considering the maintenance of the shape after cryopreservation, 
with minor variations in the hydrogel volume (Fig. 2 insets). Exceptions in terms of surface morphology 
were found in the control hydrogel (without cell) where it is possible to observe shrinkage of the 
cryopreserved sample and wrinkles on the surface. In cell laden hydrogels, it is noticeable a better 
spreading of the hASCs before cryopreservation compared to after cryopreservation, when cell 
appeared more rounded with less visible cell to cell connections. Even so, microscopic images suggest 
that the cellular density is maintained after cryopreservation and that the hydrogel stability is overall 
maintained, keeping its structural cylindrical shape and the cells inside the hydrogels. Nevertheless, 
κCR hydrogels are sensitive to ionic environments, naturally present in cell culture media. Thus, 
despite κCR hydrogels show a perfect shape immediately after cryopreservation, the materials seem to 
be less stable after 7 days in culture, yet without compromising their functionality as cellular laden 
system. 
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Figure VI- 2. Optical microscopy images of hASCs-hydrogel construct and κCR hydrogel without cells 
collected before and after cryopreservation. The insets represent the full image of the discs, whose 
details are showed in the magnified image. Scale bars represent 100 μm. 
 
VI.3.2. Mechanical properties 
In the present study, it was performed a preliminary assessment of the stability of these hydrogels 
upon cryopreservation by dynamic mechanical analysis. DMA allowed determining the mechanical 
properties of κCR hydrogels with encapsulated hASCs after different culturing times (14 days before 
cryopreservation and 7 days after cryopreservation) in either chondrogenic or basal medium (as 
compared to κCR hydrogels without cells). The analysis was performed with the hydrogels immersed in 
a KCL solution at 37 ºC and throughout a physiological relevant range of frequencies. Storage (elastic) 
and loss (viscous) components of the complex modulus were determined and are presented in Fig. 3. 
The elastic modulus (E') curve shows the viscoelastic behavior of κCR hydrogels with or without cells 
before and after cryopreservation and how the stiffness of the polymeric material changes with the 
frequency. Increase in E‘ is observed for the conditions which were not exposed to the freeze-thawing 
cycles as compared to the samples that were cryopreserved and are not frequencies dependent. The 
storage modulus for the hASCs-hydrogel exposed to chondrogenic medium before cryopreservation 
holds the highest values, showing a stiffer structure, and tends to increase with increasing frequency 
from 85 to 120 kPa (Fig. 3). The influence on the loss factor (tan δ) of the freezing process and the 
growth factor addition to the medium is also presented in Fig. 3. All hydrogels showed a frequency-
dependent behavior, with damping increase in frequencies higher than 2 Hz. In general, a more 
prominent increase was observed in the hydrogels exposed to the freeze-thawing cycles. 
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Figure VI- 3. (a) Storage modulus (E') and (b) loss angle (tan δ) obtained from dynamic mechanical 
analysis upon compression of hydrogels with encapsulated hASCs and plain hydrogels cultured in 
chondrogenic and basal medium before and after cryopreservation. 
 
VI.3.3. Viability and proliferation of hASCs encapsulated in κ-carrageenan hydrogels  
Fluorescence microscopy images provided information about cell viability and morphology and the cell 
content was evaluated by DNA quantification. Fig. 4a depicts the live/dead imaging of hASCs 
encapsulated in κCR hydrogels and cultured in chondrogenic or basal medium. Stained in green are 
the viable cells, which enzymatically converted the non-fluorescent cell-permeant calcein AM into the 
intensely fluorescent calcein. A higher hASCs density in the hydrogel constructs is observed prior to 
cryopreservation with a lower number of positive viable cells present after cryopreservation. In the 
chondrogenic formulation, cells appear to be more agglomerated and spread compared to the basal 
conditions for the earlier time point. After cryopreservation, cells cultured in chondrogenic medium 
seem to be more biologically active than the ones cultured in basal conditions. 
The DNA content corroborated with the live/dead data analysis. Cell content measurements (Fig. 4 b, c 
and d) tend to decrease after cryopreservation. A decrease in cell content was registered (p<0.05) after 
cryopreservation both for constructs cultured in basal or chondrogenic media, but higher values 
(p<0.05) were registered for the samples cultured in chondrogenic medium both BC and AC (Fig. 4b). 
The cellular content of the hASCs-hydrogel construct and the pellet cultured in chondrogenic medium 
evidenced a similar pattern, when compared to the respective samples cultured in basal medium (Fig. 
4c and 4d). Nevertheless, the cellular content decrease is less accentuated in hASCs-hydrogel 
constructs than in the pellets, suggesting that the hydrogels supported cell content maintenance in 
culture post thawing. 
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Figure VI- 4. Cell viability (a) and proliferation [b), c), d)] of hASCs-hydrogel constructs culture in either 
chondrogenic or basal medium, before (BC) and after (AC) cryopreservation. a) Merged green/red 
fluorescence images of hASCs, Calcein-AM indicating live cells (green) and Propidium iodide dead cells 
(red). Scale bars represent 100 μm. b) Cell content obtained from dsDNA quantification assay for 
chondrogenic (CM) and basal (BM) medium. Values indicate mean ± standard deviation. Significant 
differences in cell amount for chondrogenic or basal medium BC and AC were registered (p<0.05). c) 
and d) Cell proliferation tendency based on dsDNA quantification for the hydrogels and the pellet 
control group. 
 
VI.3.4. Histological analysis 
Histological evaluation provided qualitative information to detect possible changes in cell morphology, 
ECM production, and overall hydrogel structure before and after cyoprezervation. Fig. 5 shows the light 
microscopy images of the constructs stained with TB and H&E stains. H&E showed well distributed 
hASCs throughout the hydrogel section in chondrogenic or basal medium either before or after 
cryopreservation. Also, the high amount of hASCs observed indicated that cells were successfully 
encapsulated in the hydrogels and remained enclosed in the polymeric structure during the 
cryopreservation/thawing cycle, not being particularly affected by the minor hydrogel fissures caused 
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by cryopreservation (Fig. 5). TB staining revealed the presence of negatively charged 
glycosaminoglycans (GAGs) in the cross-sections of the hASC-hydrogels constructs (Fig. 5). The 
localization of GAGs, one of the major cartilage ECM components, indicates possible deposition of a 
cartilage-like ECM. ECM localization is detected before and after cryopreservation indicating that the 
freeze/thaw protocol didn‘t affect extensively the GAGs production, and consequently the intrinsic 
metabolism of differentiated hASCs. After cryopreservation and in chondrogenic conditions, hASCs tend 
to agglomerate into multiple-cell vacuole. The micrographs also evidence that cells are individually or 
paired gathered inside vacuole-like structures typically related to the chondrocytes morphology and to 
native cartilage features. When encapsulated in κCR hydrogels, hASCs adopted a more spherical 
morphology, which is typically observed in encapsulation systems. 
 
 
Figure VI- 5. Hematoxylin - eosin (H&E) staining for cellular detection and overall distribution within the 
hydrogel. Detection of cartilage extracellular matrix, namely glycosaminoglycans (by Toluidine Blue, TB) 
of chondrogenically induced hASCs and undifferentiated hASCs encapsulated in κCR hydrogels discs. 
hASCS-hydrogel constructs were collected and stained BC and AC. Scale bars represent 100 μm. 
 
VI.3.5. Immunohistochemisty 
Complementarily, immunohistochemical analysis of the biomacromolecules typically present during 
cartilage development was investigated. Distribution of cartilage-like matrix was evaluated through 
immunolocalization of cartilage matrix proteins before and after the freeze-thaw process and posterior 
culture for additional 7 days in chondrogenic or basal medium. Before cryopreservation, the deposition 
of collagen type II seems higher in the chondrogenic formulation when compared to collagen type I. 
Fig. 6 shows that cells present in the κCR hydrogel were positively stained for both types of collagens 
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and these cartilage matrix components were homogeneously distributed throughout the hydrogels. 
Before cryopreservation, the hASCs cultured in basal medium seems to show lower expression of 
collagen II and collagen I when compared to the chondrogenic samples. After cryopreservation, the 
expression of collagen I seems to decrease in hASCs-hydrogels cultured in basal medium, evidenced by 
a decrease in the brownish color revealed by DAB, and increased blue associated to hematoxylin 
counterstain. Moreover, it was highlighted the presence of cells in lacunae, characteristic of native 
articular cartilage tissue. Overall, the cells maintained their chondrogenic properties throughout the 
culturing time before the freeze-thawing cycle. The intensities of collagen type I immunolocalization 
seems to increase in the chondrogenic condition after cryopreservation. Furthermore collagen type II 
and collagen type I expression appear to be similar in basal medium after cryopreservation. These 
cartilage matrix markers were distributed throughout the hASCs-hydrogel construct. Colony formation in 
the medium supplemented with TGF-β1, AC is detected, as previously referred. Overall and despite 
minor variations, cryopreservation seems not to interfere in the expression of proteins associated to 
cartilage ECM.  
 
 
Figure VI- 6. Immunohistochemical localization of collagen type II and collagen type I proteins in hASCs-
hydrogels exposed to chondrogenic or basal medium BC and AC. Scale bar = 100 μm. 
 
VI.3.6. RT-PCR 
To complement the immunostaining results, RT-PCR was performed in hASCs-hydrogel BC and AC. The 
results obtained from the genotypic evaluation of cartilage-related genes expressed by hASCs within 
κCR hydrogels are presented in Fig. 7. The expression of the cartilage specific genes was verified in an 
agarose gel, using GAPDH as housekeeping gene. The expression of transcripts associated to cartilage 
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(i.e. SOX9, aggrecan, collagen type I, collagen type II and collagen type X) was observed by 14 days of 
culture, just before cryopreservation. hASCs encapsulated in κCR showed higher levels of collagen II, 
collagen X, and SOX9 in chondrogenic conditions. Conversely, aggrecan seems to be more expressed 
in basal medium, while collagen I is similarly expressed in basic or chondrogenic media. In general, 
after cryopreservation, gene expression seems to be lower, almost undetected, in all conditions studied, 
except for the housekeeping gene and collagen X. 
 
 
Figure VI- 7. Representative image of the electrophoresis gels reporting the expression of cartilage-
related genes by RT-PCR. The gel shows the results obtained before and after cryopreservation protocol 
and cultured in chondrogenic or basal medium. 
 
VI.4. DISCUSSION 
Presently, cryopreservation protocols are the only mean for long term preservation of biological 
samples, thus playing an important role in cell and tissue banking assuming a greater importance 
when tissue engineering is approaching an everyday reality [34]. The relevance in exploiting ―ready-to-
use‖ cartilage engineered constructs fulfilling patient-specific characteristics combined with adequate 
preservation methodologies, anticipates the need for development of ―out of shelf‖ tissue substitutes. It 
is envisioned that such approaches will play a central role in future applications with tissue engineered 
products, as constructs could be prepared in advance, and scaled up assuring immediate availability 
and accessibility for clinical use.  
This study investigates the influence of cryopreservation using standard protocols in a promising 
engineered product composed of hASCs encapsulated in κCR hydrogels. Moreover, we proposed to 
evaluate if the chondrogenic potential as well as cellular viability and proliferative capacity of 
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encapsulated human adipose derived stem cells is restored after established freeze/thaw cycles. The 
method selected for cryopreservation of the developed system combines the cryoprotectant DMSO with 
FBS, using a temperature gradient until a long term preservation in liquid nitrogen (-196 ºC).  
At a macroscopic level, evidence suggested that this procedure does not significantly affect hydrogel 
structural integrity, as the morphology and stability of hASCs- κCR hydrogels was not altered radically 
by the cryopreservation process. The fissures observed on the surface of the hydrogel are not 
interfering with the overall constitution of the hydrogel (Fig. 2). The fact that κ-carrageenan hydrogels 
successfully underwent cryopreservation while preserving their structural integrity indicates that these 
carriers are easily manipulated and suitable to be used as efficient encapsulation systems under simple 
cryopreservation protocols. This statement is in accordance to literature reports which evidence the 
good freeze/thaw stability of carrageenan based hydrogels [35]. 
Moreover, dynamic mechanical analysis (DMA) was performed to better characterize the 
mechanical/viscoelastic properties of the hydrogels in a simulated physiological environment (wet state 
at 37 ºC). The non-cryopreserved constructs, register an increase with frequency which is not detected 
for the cryopreserved construct. During the days in culture prior to cryopreservation, DMA analysis 
indicated an increase in storage modulus and in viscoelastic properties of κCR gels with encapsulated 
cells suggesting an increase in the stiffness, possibly due to the extracellular matrix production. Fig. 3 
shows that in all the frequency range, the storage modulus is higher for the hASCs-hydrogel construct 
chondrogenically committed, which corresponds to the typical stiffness effect found more in these 
systems due to the cellular component and high secretion of ECM. DMA data indicated that the hASCs-
hydrogels show a viscoelastic behavior and maintain their mechanical properties after a freeze/thawing 
process. Furthermore, obtained values were described to be in the range of constructs  aimed at 
cartilage engineering applications with a compression modulus similar to the ones reported for agarose 
and alginate hydrogels [36]. The values of tan δ (higher than 0.2) reveal a clear viscoelastic behavior of 
the hydrogels. This is an important feature in biomaterials used for tissues subjected to periodic loads, 
such as cartilage, since it shows the material‘s ability to absorb mechanical energy. The increase of the 
loss factor for the freeze-thawed gels, along with the stability observed for E‘ values with frequency 
show that for high frequencies these hydrogels increase their ability to dissipate energy. Nonetheless, 
at frequencies corresponding to human movements, such as walking or running (around 1 Hz) no 
significant differences in the loss factor of the BC and AC hydrogels were observed. 
Previous reports about the functional application of κCR hydrogels show their applicability for in situ 
encapsulation of different types of cells, while keeping cellular proliferation and assisting the expression 
of cartilage extracellular matrix markers [23]. Microscopy analysis of hASC- κCR hydrogels revealed 
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lower cellular density and minor morphological variations in cell shape and cell-to-cell interactions after 
cryopreservation. In the particular case of encapsulated cells cultured in BM, morphological changes 
are more significant AC as they lose most of pseudopodia and their fusiform appearance into a more 
chondrocytic shape. This modification may be associated to cell adjustment to the freeze/thawing 
cycle, which is more evident in a basic culture medium without chondrogenic biochemical 
supplements. 
Besides the morphological aspect of the cells, the effect of cryopreservation on the viability and 
proliferation of hASCs encapsulated in κCR hydrogels was also studied. Overall, and despite an 
expected decrease observed upon cryopreservation, the constructs were able to maintain the cells 
viability and proliferation. It is known that the freezing/thawing process interferes with the biophysical 
and biochemical features of the cells, resulting in alterations of their functional competency and 
survival [38]. As a consequence, cryopreserved cells require a recovery time after thawing for adjusting 
sudden and radical micro-environmental changes. The observed decrease in cell content post 
cryopreservation might also be explained by the minor fissures observed in the κCR hydrogels post 
cryopreservation (Fig. 2), which could led to the release of some encapsulated cells from the system. 
Immediately after thawing, hASCs viability/cell content levels were higher compared to longer time in 
culture and tend to decrease with time. This trend was found both for hASCs- κCR constructs and 
pellets. The explanation may reside in the fact that short time in culture after cryopreservation is not 
sufficient to allow cellular reboot. While the rationale behind the short time in culture after 
cryopreservation was to study the immediate availability and functionality of the cell-hydrogel construct, 
longer time in culture, are expected to assure the cellular recovery from the cryopreservation process 
as reported previously [37].  
The more accentuated decrease in cell content observed in the pellets, as compared to the cell-laden 
hydrogels, suggests that hydrogels may act a protective barrier to intracellular ice formation or as a 
buffer for the cryoprotectant agent diffusion, as it has been previously reported [39], yet allowing the 
exchange of nutrients and oxygen. Interestingly, the cell contents registered for hydrogels cultured in 
chondrogenic conditions is significantly higher (p<0.5) than in basal medium cultures, before and after 
cryopreservation. The combination of κCR hydrogel and chondrogenic supplements may provide the 
necessary stimuli for cellular colonization despite chondrogenic differentiation.  
Histological findings indicated cellular morphology changes after the cryopreservation process. ECM 
proteoglycans deposition was observed in the pericellular regions of most cell clusters. Although adult 
chondrocytes do not divide or establish cell-to-cell contacts, these cells are responsible to produce a 
cartilagineous dense ECM [41], thus maintaining cartilage integrity and function. This finding may be 
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explanatory to the fact that stem cell chondrogenically differentiated produce and secreted ECM 
components. The pre-existing vacuoles observed in the histological micrographs (Fig. 5) formed before 
the cryopreservation cycles, typical to the chondrocytes phenotype, enlarge after cryopreservation and 
were colonized with migrating cells, creating cell agglomeration into the free spaces. This finding may 
be associated to the fact that enhanced tissue deposition is observed nearby these aggregate 
structures. H&E control staining revealed cells entrapped in the hydrogels and a good stability of the 
complex cell-hydrogel system.  
The immunolocalization of the proteins analyzed in this study (collagen type II and I) are known to be 
naturally present in cartilage ECM. Collagen type II is typically detected in elastic cartilage while 
collagen type I is involved in fibril formation of several skeletal tissues and expressed in fibrocartilage, a 
scar tissue, in vivo. Both forms of collagen II and collagen I were produced and retained in the form of 
ECM to an analogous extent before and after cryopreservation process (Fig. 6). Moreover, a positive 
localization was detected for the cells cultured in basal medium, i.e., in the absence of any 
chondrogenic inducer growth factor, suggesting that the 3D hydrogel environment was sufficient to 
stimulate the adipose derived stem cells to present typical cartilage-like morphology, namely vacuoles 
and rounded shape, as well as the synthesis of collagen II rich matrix. The deposition of extracellular 
matrix resulted from the 2 weeks of cell culturing prior cryopreservation. This time point was selected 
based on previous studies on hASCs chondrogenic differentiation [23]. Two-weeks were the shortest 
culturing time necessary to promote chondrogenic differentiation of hASCs with ECM production. The 
ECM observed in both chondrogenic and basal cultures may influence the cryopreservation effect on 
the hASCs- κCR constructs. Similarly to the functionality of the κCR hydrogels, the deposition of ECM 
may allow a controlled diffusion of the cryoprotectant into the cells located in the matrix [42].  
Genes commonly studied for chondrogenic differentiation analysis include collagen type I, II and X, as 
well as SOX9 and aggrecan. SOX9, a marker of early chondrogenesis, is also important in achieving a 
healthy cartilage mainly because SOX9 stimulates aggrecan and collagen II synthesis [43]. Although 
Collagen X has been associated to hypertrophic chondrocytes in vivo, it has also been described as a 
lineage specific marker for cartilage differentiation of mesenchymal stem cells [44]. It is well 
established that multipotent mesenchymal stromal cells (MSCs) undergoing chondrogenesis have a 
tendency to express collagens I and X in vitro [45]. Overall, the genes associated to the chondrogenic 
differentiation process are increased in hASCs-hydrogel constructs before cryopreservation for both 
culture conditions (CM and BM). After cryopreservation, gene expressions seem to be reduced in all 
conditions except for the housekeeping gene and for collagen X in chondrogenic medium. The decrease 
in gene expression after cryopreservation has been described in the literature [40], and may be 
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associated to the fact that cells are still recovering from the cryopreservation process and are still 
adapting to the new conditions. Although some cellular responses were already restored 7 days after 
cryopreservation, it is expected that later in time, cells will fully recover and express the chondrogenic 
related genes into the levels prior to cryopreservation [46]. Nevertheless, and since we are envisioning 
an "off-the-shelf" bioengineered product with immediate availability and ready-to-use application, a time 
compromise must be reached. That is, after cryopreservation protocols, the cell- κCR system must 
return to cell culturing just time enough to be functional, fulfilling the aims it was developed for. 
The broad range of biological properties of MSCs attracted the interest of many researchers to be used 
for diverse therapeutic applications. One advantage of using MSCs in this system rely on the fact that 
these cells possess a high plasticity and are dynamic in terms of cellular metabolic machinery [47], 
reacting more promptly to physicochemical variations in the environment than primary chondrocytes, 
which tend to dedifferentiate when cultured in vitro [48]. Furthermore, the applicability of stem cells in 
cryopreservation systems can disclose an even more promising approach of these cryopreserved 
systems into the regenerative medicine field, as stem cells are immune privileged and these products 
may fit different patients [49]. 
 
VI.5. CONCLUSIONS 
This study evidences that complex tissue engineered products aimed at clinical needs can be stored 
and preserved through the cryopreservation process. In the proposed system, it was observed that κ-
carrageenan hydrogels pledged structural stability at a macro-scale and integrity with or without 
encapsulated hASCs, registering suitable mechanical properties after the cryopreservation/thawing 
process. Also, encapsulated hASCs maintained cell viability and chondrogenic features upon 
cryopreservation by restoring cellular metabolic functionalities 1 week of cell culturing after thawing the 
constructs. The natural polymer  κ-carrageenan hydrogel seem to be resilient to the cryopreservation 
method used, and does not negatively interfere with hASCs chondrogenic potential demonstrating its 
promising application as cell carrier agent  in ―off-the-shelf‖ engineered tissue products. We envision 
future studies applying these systems for transplantation following an in vivo cartilage regeneration 
strategy. 
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Chapter VII* 
Evaluation of the in vitro and in vivo biocompatibility of carrageenan based hydrogels 
ABSTRACT 
 
Carrageenans are highly sulphated galactans, well-known for their thermogelation properties which 
have been extensively exploited in food and cosmetics industry but poorly explored in the biomedicine 
field. However, these natural origin polymers present a variety of properties and characteristics that 
may render them high potential for a number of different possible applications in this field. In this study 
we have assessed the in vitro and in vivo biocompatibility of κ-carrageenan hydrogels that have been 
explored for regenerative medicine and tissue engineering applications. For this purpose, it was 
evaluated first the in vitro cytotoxicity of the materials using a L929 mouse fibroblast cell line and next 
it was assessed the effect of κ-carrageenan hydrogels on the activation of human polymorphonuclear 
neutrophils cells (hPMNs) by the quantification of reactive oxygen species (ROS) by 
chemiluminescence. Subsequently it was studied the inflammatory/immune reaction to κ-carrageenan 
hydrogels upon subcutaneous implantation in rats. Explants were retrieved after 1 and 2 weeks of 
implantation, for histological and RT-PCR analysis. The cytotoxicity screening revealed that κ-
carrageenan hydrogels did not significantly affect L929 metabolic activity. Moreover, hPMNs contact 
with κ-carrageenan resulted in a reduced and a neglectable signal regarding the detection of 
superoxide and hydroxyl anions, respectively. The results from the in vivo experiments indicated that κ-
carrageenan seems to induce a low inflammatory response. Overall, the data obtained suggests that κ-
carrageenan hydrogels are biocompatible and thus can be further studied for their use in target 
biomedical applications.    
 
 
Keywords: Hydrogels, κ-carrageenan, adipose derived stem cells, chondrogenic differentiation, cartilage 
tissue engineering. 
 
 
* This chapter is based on the following publication: 
Popa E. G., Carvalho P. P., Dias A. F., Santos T.C., Santo V. E., Marques A. P., Dias I. R., Viegas C. A. 
A., Gomes M. E., and Reis R. L., ―Evaluation of the in vitro and in vivo biocompatibility of carrageenan 
based hydrogels", Submitted, 2013. 
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VII.1. INTRODUCTION 
Regenerative medicine and tissue engineering are interdisciplinary areas of research focused on 
generating therapies to repair, augment, or replace wounded, unhealthy or metabolically deficient 
tissues or organs [1-3]. In order to develop innovative and successful approaches that can provide 
better outcomes in specific clinical applications, it is critical to develop new biomaterials that can 
interface perfectly with the surrounding tissues at a structural, mechanical and specially at a biological 
level, once implanted or injected into the body [4, 5]. The first and main requirement for such 
biomaterials concerns its biocompatibility, i.e. its ability to perform in a specific situation with an 
appropriate host response [6]. Biocompatibility is not solely dependent on the material intrinsic 
characteristics but can also be defined by the target application in the sense that the material is 
required to induce a specific cell/tissue reaction [7]. To have a full picture of the biocompatibility of any 
proposed system in the biomedical field, the in vitro biological behavior must be fully characterized, 
previously to in vivo assays.  
Hydrogels have been widely used in regenerative medicine/tissue engineering approaches due to their 
high water content, soft and rubbery consistency and due to their structural and functional similarities 
to the natural extracellular matrix of human tissues [8, 9]. Moreover natural hydrogels offer the 
advantage of being similar to macromolecules that the biological environment is prepared to recognize 
[10, 11]. The issues of toxicity and lack of recognition by cells, which are frequently provoked by many 
synthetic polymers, may thereby be suppressed or minimized using natural hydrogels [12]. 
Carrageenans are important hydrophilic polysaccharides, which consist in a family of linear and 
sulfated galactans used in several industrial, environmental and commercial applications as gelling, 
thickening, emulsifying and stabilizing agents [13]. Besides the general advantageous features of the 
natural origin hydrogels above described, the characteristics and thus the medical potential of these 
seaweed polysaccharides, has increasingly attracted the attention of researchers in recent years. 
Carrageenan has been used to develop controlled release systems of drug for ophthalmic/buccal 
preparations [14-16], and of growth factors [17-19], and for immobilization of enzymes [20]. 
Nevertheless, the potential of this polysaccharide has only started recently to be explored for tissue 
engineering and regenerative medicine purposes [21-23].  
The main aim of this work was to evaluate κ-carrageenan hydrogels as potential biomaterials for the 
development of new tissue engineering and regenerative medicine therapies. The biocompatibility of κ-
carrageenan hydrogel was firstly screened using standard in vitro cytotoxicity assays and then assessed 
evaluating the activation of human polymorphonuclear neutrophils (hPMNs) through the detection of 
reactive oxygen species (ROS). For the in vivo evaluation, κ-carrageenan hydrogels were subcutaneous 
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implanted in rats for histological reverse transcription polymerase chain reaction (RT-PCR) analysis. In 
both in vitro and in vivo experiments, agarose gels were used as control material, given their well 
known biocompatibility and wide use in the biomedical field [24, 25].  
The outcomes of the present study demonstrated that the κ-carrageenan hydrogels did not elicit any 
biological negative effects, inducing an expected host response, and thus this material can be 
considered in subsequent studies for regenerative medicine applications. 
 
 
 
Figure VII- 1. Schematics of study design: A) raw material and hydrogel formation; B) typical protocol 
for cytotoxicity assays; C) overview of ROS detection assay assembly; D) implantation of the hydrogels 
in the created subcutaneous pockets and appearance of the animal after suturing. 
 
VII.2. MATERIAL AND METHODS 
VII.2.1. Preparation of materials  
The κ-carrageenan hydrogels (designated as κC), were prepared as follows: first the polymeric powder 
(22048, Sigma) was mixed with distilled water under constant stirring at 60 ºC to obtain a final 
concentration of 2 % (w/v). The polymer solution was then casted into a mould (plastic Petri dish) of 55 
mm  and kept at room temperature (RT) for 2-5 minutes forming a solid gel, which was further 
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stabilized for 15 minutes by crosslinking with potassium chloride (KCl, P5405, Sigma). Finally the gels 
were washed with PBS to remove the excess of l. Discs of Ø 8 ±0.01 mm x 2.5 ±0.46 mm height were 
then cut using a punching device. Agarose hydrogels were used as control material (referred from now 
on as AG) and were produced following standard procedures detailed elsewhere [26]. Briefly, a 2 % 
(w/v) sterile agarose low gel temperature (800257, MP Biomedicals) solution, prepared in sterile PBS, 
was heated to 70 °C for 30 seconds, until complete dissolution. The solution was cooled at RT 
promoting gelation due to temperature- and ionic-dependent reactions, like for the κCR (Fig. 1).  
 
VII.2.2. In vitro cytotoxicity evaluation: indirect contact test  
In the scope of the in vitro biocompatibility assessment it were performed, indirect cytotoxicity tests 
using extracts of the hydrogels being studied, based on ISO/EN 10993 part 5 guidelines [27].  
 
VII.2.2.1. CELL LINE USED FOR CYTOTOXICITY HYDROGEL EXTRACTS TESTING 
A mouse fibroblast L929 cell line, acquired from the European Collection of Cell Cultures (ECACC), was 
used for the cytotoxicity tests. The cells were grown as monolayers in Dulbecco‘s modified Eagle‘s 
medium (DMEM, D5523, Sigma) supplemented with 10 % fetal bovine serum and 1 % of antibiotic-
antimycotic solution. Trypsin was used to detach the cells from the culture flasks before the 
experiments were conducted. L929 cells were seeded in 96-well cell culture plates (4x103 cells/well, 
200 µl/well), in order to reach 70 % confluence after 24 h of incubation at 37 °C, in a humidified 
atmosphere with 5% CO2 (Fig. 1). 
 
VII.2.2.2. MEM EXTRACTION TEST AND MTS ASSAY 
The polymeric κCR and AG hydrogels, previously sterilized by steam power (121 degree for 20 
minutes), were extracted in complete culture medium (MEM) for 24 h at constant temperature (37 °C) 
and agitation (60 rpm). The ratio of hydrogel to extract fluid was constant and equal to 3 cm2/ml. Latex 
rubber was used as a positive control as it is known to have a strong cytotoxic effect leading to 
extensive cell death and lysis. The extracts of the fully hydrated hydrogels were filtered (filter pore size: 
0.22 μm) and placed in contact with the monolayer of the L929 cells. For this purpose, the culture 
medium from the well-plates with the L929 cells monolayers was removed and an identical volume 
(200µl/well) of extraction fluid of study materials and control was added. Cells grown in the presence 
of standard culture medium were included as negative controls. Cell response was evaluated after 1, 3, 
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and 7 days of incubation. The MTS assay was performed to assess the possible cytotoxicity of the 
hydrogels, determining the metabolic activity of the cells (Fig. 1). This assay is based on the 
bioreduction of the substrate (3-(4, 5-dimethylthiazol-2-yl)-5(3-carboxymethoxyphenyl)-2(4-sulfofenyl)-
2H-tetrazolium (Cell Titer 96® Aqueous Solution Cell Proliferation Assay, Promega), into a brown 
formazan product. Briefly, after 1, 3 and 7 days of culture, the extraction fluid was removed and a 
mixture containing serum-free culture medium without phenol red and MTS reagent was added to each 
well and incubated for further 3 hours at 37 ºC and 5% CO2 atmosphere. Supernatants were then 
transferred to new 96-well plates and the optical density (OD) was read at 490 nm in a microplate 
reader (Synergy HT, Bio-TeK Instruments).   
 
VII.2.3. In vitro assessment of human polymorphonuclear cells (hPMNs) activation 
VII.2.3.1. HPMNS ISOLATION 
hPMN cells were isolated from heparinized peripheral blood collected from healthy volunteers following 
a procedure detailed described elsewhere [28]. Briefly, each 10 mL of heparinized blood was poured 
into 10 mL of a 6% Dextran (D8906, Sigma) solution in PBS without Ca2+ and Mg2+ (Sigma). After 20 
min, about 6 mL of the top layer was removed with a glass pipette and carefully added onto 4 mL of 
Histopaque® (1077, Sigma). After a 25 min centrifugation at 21 °C and 2400 rpm, the bottom pellet 
was resuspended in 5 mL of PBS without Ca2+ and Mg2+ and the cells suspension was centrifuged for 
25 min at 21 °C and 2400 rpm. After this, the supernatant was discarded and 1mL of distilled water 
was added and the suspension was triturated three times with the glass pipette and shacked gently for 
35 s, in order to lyse the erythrocytes. Cells suspension was centrifuged for 25 min at 4 °C and 2400 
rpm and the cell pellet washed again with PBS without Ca2+ and Mg2+. The cell suspension was kept at 4 
°C until the assays were performed, within a maximum of 2 h.  
 
VII.2.3.2. REACTIVE OXYGEN SPECIES (ROS) QUANTIFICATION  
The production of superoxide anions and hydroxyl radicals by hPMNs after contacting with the studied 
hydrogels was detected by a chemiluminescence-based method (Fig. 1C). The isolated hPMNs, were 
used at a final concentration of 1.3×106 cells/mL. The reactive oxygen species quantification assay 
followed a methodology previously described [29]. In brief, to each 100 µL of cells suspension alone 
and in contact with the hydrogels were added 8 µg/mL PMA/PBS (phorbol 12-myristate 13-acetate, 
P8139, Sigma)  and 100 µL of 1.5 mM luminol/PBS (09253, Sigma) or 100 µL 5.4×10 -5M 
lucigenin/PBS (B49203, Sigma). Control conditions were simultaneously set without cell stimulant, the 
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PMA. All the plates were maintained on ice while setting the experiment. The chemiluminescence was 
read up to 2 hours in a microplate reader (Sinergy HT, Bio-TeK Instruments). 
 
VII.2.4. Hydrogel subcutaneous implantation 
The in vivo biocompatibility was evaluated upon subcutaneous implantation of hydrogels, using a total 
of 20 rats (12-weeks-old Wistar male rat with an average weight between 260 and 300 g), (Table 1). All 
animal studies were performed accordingly to the national guidelines and conducted in accordance 
with Portuguese legislation (Portaria nº1005/92) and international standards on animal welfare as 
defined by the European Communities Council Directive (86/609/EEC). Surgeries were performed 
under general anesthesia, intraperitoneal (IP) administration route using a combination of 
medetomidine (Dormitor® - 0.5mg/Kg) with ketamine (Imalgene® - 75mg/Kg). Post-surgical pain 
control, subcutaneous administration route, with carprofen (Rimadyl®, 2.5-5mg/Kg) was performed for 
each animal. κCR and AG hydrogels discs (Ø 8±0.01 mm x 2.5±0.46 mm height) were prepared as 
described above. Under surgical sterile conditions, two full thickness skin longitudinal incisions (about 
1 cm) containing the subcutis and the panniculus carnosus (skin and smooth muscle) were performed 
in the dorsum of each animal (anterior and posterior incisions). Cranial and lateral oriented 
subcutaneous pockets were created by blunt dissection, one in each side of the incision. The hydrogel 
discs were inserted into these pockets (four discs of the same materials per animal), and the 
panniculus carnosus and the skin were carefully sutured (Fig. 1). Negative control group was set for the 
time periods of implantation with empty pockets (EP). As positive control group, rats were injected with 
lipopolysaccharides (LPS) (1μg/g rat body weight, L4641, Sigma) 24h before the collection of samples. 
After each predetermined implantation time period (7 and 15 days), each animal was anesthetized with 
isofluorane and IP injection with an overdose of pentobarbital sodium (Eutasil® from Ceva Saúde 
Animal).  
 
Table VII- 1. Animal group conditions. 
Groups Conditions Time points Rat numbers 
Experimental κCR 
Day 7 
Day 15 
6 
Control Material AG (std) 6 
Negative Control EP (-) 6 
Positive Control LPS (+) 2 
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VII.2.5. Collection of explants  
At each time point, explants were retrieved from the four implantation sites of each animal together 
with the respective axillary and inguinal lymph nodes. Explants were either fixed in 3.7 % formalin for 
histological evaluation, or frozen for posterior PCR analysis. 
 
VII.2.5.1. HISTOLOGICAL CHARACTERIZATION  
For histological analysis, explants were subjected to standard histological tissue processing for paraffin 
embedding. Sections with 4 μm thickness were obtained using a microtome (HM355S, Microm, 
Thermo scientific) and stained with haematoxylin and eosin (05-12011/L, 05-M10003, Bio-optica) in 
an automatic stainer (HMS740, Microm, Thermo scientific). Immunohistochemistry was also 
performed on histological sections to assess presence/localization of recruited macrophages and 
activated lymphocytes and thus tissue response to the implants. In brief, sections were dewaxed, 
rehydrated and antigen retrieval was achieved by heating at 96 °C in 10 mM citrate buffer, pH=6, for 
40 minutes. Sections were washed in PBS and endogenous peroxidase activity was blocked with 0.6 % 
hydrogen peroxide in methanol for 10 min at RT. Afterwards, permeabilization was performed using 
Triton™ (X-100, Sigma) for 2 minutes followed by incubation with protein block buffer for 20 min at RT. 
Excess serum was removed by blotting and the sections were incubated overnight at 4 °C with either 
CD163 antibody (ED2, MCA342GA, AbD Serotec) to detect recruited macrophages or CD25 antibody 
(MCA494GA, AbD Serotec) to detect activated lymphocytes. After incubation, sections were rinsed with 
PBS for 5 min and incubated with polyclonal swine anti-mouse, goat, rabbit IgG antibody (Dako) for 1 h 
at RT. Further washes in PBS were performed prior to exposure of the sections to Vectastain elite ABC 
reagent (PK-6200, Vector Laboratories Ltd.) for 30 minutes at RT and the substrate reaction was 
developed using the 3,3′-diaminobenzidine (DAB) peroxidase substrate solution (SK-4100, Vector 
Laboratories Ltd.). Finally sections were counterstained with haematoxylin and mounted with Entellan® 
(4111, Inopat). Labeled sections were observed under a Transmitted light Microscope, (Zeiss) and 
images acquired with an MRc5 camera and the AxioVision V.4.8 software (Zeiss).  
 
VII.2.5.2. PCR ANALYSIS - CONVENTIONAL END-POINT RT-PCR 
Reverse transcriptase polymerase chain reaction (RT-PCR) analysis was used to detect at the molecular 
level, the expression of inflammatory markers, namely IL-1 alpha, IL-4, and IFN- gamma. The 
housekeeping gene was glyceraldehyde 3-phosphate dehydrogenase (GAPDH) chosen as an 
endogenous control for the experiments. The detailed description of the sequence of the primers used 
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is presented in Table 2. The explanted tissue was transferred to eppendorfs tubes with 1 mL TRI 
Reagent® RNA Isolation Reagent (T9424, Sigma) and stored at -80 °C until processing. The 
homogenization of the biologic tissue was achieved using a mortar and pestle. Total RNA was extracted 
from samples following the manufacturer‘s guidelines (TRI Reagent®). The amounts of isolated RNA 
from samples with A260/280 ratio between 1.6 and 2.0 were determined using Nanodrop ND-1000 
Spectrophotometer (Bonsai 06/2008 NanoDrop Technologies). A predetermined amount of RNA from 
each sample was reverse transcribed into cDNA using qScript™ cDNA Synthesis Kit (Quanta 
Biosciences) using a MJ Mini™ Personal Thermal Cycler (Bio-Rad Laboratories) machine. Amplification 
of the sequences of interest was performed using a GoTaq® Green Master Mix (M7112, Promega) and 
primers at a concentration of 10 μM in a 30 cycle 3-step reaction. The PCR products were visualized in 
a 1.7 % agarose gel (SeaKem ®LE agarose, Lonza) with a DNA marker pBR322 - Hae III (A5229, 
AppliChem). Images from the gels were taken using a UV Transilluminator (BioSpectrum AC Chemi HR 
410, UVP). 
Table VII- 2. Primer pair sequences and annealing temperatures used in the RT-PCR analysis 
 
 IL-1 alpha: interleukin-1 alpha; IL-4: interleukin-4; IFN-γ: interferon-gamma; GAPDH: glyceraldehyde 3-phosphate 
dehydrogenase; Tm: annealing temperature; Bp: base pair. 
 
VII.2.6. Statistical analysis 
Statistical analyses for the cytotoxicity results were conducted by a two-way ANOVA with Tukey‘s test 
using the GraphPad Prism statistic software. Test ascertains about the data normality and the 
significance value was set at p < 0.05. Mean values and standard deviations are reported for the 
cytotoxicity measurements and in vitro ROS quantification assay.  
 
VII.3. RESULTS  
VII.3.1. In vitro cytocompatibility assessment 
The in vitro cytotoxicity of the hydrogel extracts was assessed as a first screening of the materials 
biocompatibility. Thus, the cytotoxicity of κC and AG hydrogels was assessed by an MTS assay, after 
 
Target 
gene 
Sequences Tm  
[ºC] 
Bp 
Sense Antisense 
IL-1α GCAAAGCCTAGTGGAACCAG GCAGAAGGTGCACAGTGAGA 59.4 244 
IL-4 TTTTGAACCAGGTCAACACCA GTGAGTTCAGACCGCTGACA 57.4 - 
IFN-γ GCCCTCTCTGGCTGTTACTG CTGATGGCCTGGTTGTCTTT 59.4 221 
GAPDH GGTGATGCTGGTGCTGAGTA GGATGCAGGGATGATGTTCT 58.4 81 
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culturing L929 cells for 1, 3 and 7 days with the extracts of the materials (Fig. 1). Data obtained from 
the MTS assay revealed that the metabolic activity of L929 cells after being in contact with the different 
material extracts varied along the time of the experiment. A decrease in cells metabolic activity 
(p<0.01), in relation to negative control (100% of metabolic activity), was observed from day 1 to day 3 
in the presence of the κCR hydrogel extract, although this decrease was overcome at day 7 (p<0.001). 
Furthermore, a significantly lower metabolic activity was registered at days 3 and 7 in the presence of 
κC extracts in comparison to AG extracts (Fig. 2). 
 
Figure VII- 2. Percentage of metabolic activity in relation to negative control, of L929 cells cultured with 
leachable from κ-carrageenan (κC) and agarose (AG) hydrogels, and from the latex membranes after 1, 
3 and 7 days of culture, data obtained from the MTS assay. The AG hydrogel extract was used as a 
control material and the extract of latex was used as positive control for cytotoxicity. Statistical analyses 
were conducted using two-way ANOVA, data was expressed as means ± standard deviation (S.D.); n = 
3. Statistically significant differences were register, symbol † for p<0.01 and symbol § for p<0.001. 
 
VII.3.2. Chemiluminescence assay 
The effect of κC and AG hydrogels over hPMNs activation was assessed by the detection of the 
production of reactive oxygen species (ROS) using a chemiluminescence assay. The 
chemiluminescence results showed that the κC hydrogels (Cells_ κC _Lucigenin), contrarily to AG 
hydrogels (Cells_AG_Lucigenin, Fig 3c), lead to hPMNs activation and the production of superoxide 
anion (O2-) as detected in the presence of lucigenin. Nonetheless, cells in the presence of the κC 
hydrogels retained their intrinsic capacity of reaction as demonstrated after the addition of cells 
stimulant PMA (Cells_ κC _PMA_Lucigenin), condition in which the levels of luminescence were close 
to the maximum detected after stimulation in the absence of the κC hydrogels (Cells_PMA_Lucigenin) 
(Fig. 3a). Similar profiles in terms of capacity of reaction after PMA stimulation in the presence (Cells_ 
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κC _PMA_Luminol) and absence (Cells_PMA_Luminol) of κC hydrogels were observed regarding the 
production of hydroxyl anion (HO-), detected in the presence of luminol. However, cells in the presence 
of the κC hydrogels and without any further stimulation (Cells_ κC _Luminol) do no lead to the 
production of HO- maintaining along the assay the basal level of activation resulting from the isolation 
process (Cells_PBS_Luminol) (Fig. 3b) As for the AG hydrogels, although the behavior regarding the 
production of HO- (Fig. 3d) did not vary from that observed for the κC hydrogels, hPMNs capacity of 
producing O2- after PMA stimulation in the presence of AG hydrogels (Cells_AG_PMA_Lucigenin) was 
different. Although cells in the presence of the AG hydrogels (Cells_AG_Lucigenin) kept the basal level 
of activation resulting from the isolation process (Cells_PBS_Lucigenin), after stimulation 
(Cells_AG_PMA_Lucigenin) the signal corresponding to the O2- detection is not only delayed in time, in 
relation to the potential maximum hPMNs activation profile (Cells_ PMA_Lucigenin), but is also of lower 
intensity (Fig. 3c) than the one detected in the presence of κC hydrogels (Cells_ κC _PMA_Lucigenin) 
(Fig. 3a). 
 
Figure VII- 3. Chemiluminescence measurements of hPMNs activation with and without PMA 
stimulation, based on the detection of superoxide and hydroxyl anions by oxidation of lucigenin (a, c) 
and luminol (b, d) respectively, in the presence and absence of κC (a, b) and AG (c, d) hydrogels. 
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VII.3.3. Explants characterization 
The explants, comprising the implanted hydrogels and surrounding tissue, were collected and 
processed for histological and RT-PCR analysis. At the time of implant retrieval, there were no 
macroscopic signs of infection, necrosis or swelling in any of the animals and no exudates were formed 
around the implants. The tissue response to the implanted hydrogels investigated in this study included 
the characterization of different cell populations responsible for the inflammatory reaction the 
macrophages – MØ and lymphocytes.  
 
VII.3.3.1. HISTOLOGY – H&E 
The local and systemic host responses to the implanted hydrogels were analyzed after histological 
processing of the explants comprising the implanted κC and AG hydrogels and respective surrounding 
tissue, and of the axillary and inguinal lymph nodes, respectively. Paraffin wax embedded sections 
stained with H&E confirmed absence of edema and necrosis for all conditions (Fig. 4).  
After 7 days of subcutaneous implantation, tissue sections corresponding to the place of implantation 
of κC hydrogels presented moderate signs of inflammation essentially characterized by the presence of 
PMNs (Fig. 4). The stained histological sections exposed that, after 7 days of implantation, the AG 
hydrogels maintained its integrity contrarily to the κC hydrogels, which were completely disintegrated 
(Fig. 4). At day 7, in the explants sections corresponding to the negative control group, defined by the 
rats with empty pockets (EP) the presence of vascularized adipose tissue was noticed. The 
experimental groups showed the presence of an inflammatory infiltrate characterized by the presence 
of PMNs, macrophages and also blood vessels representative of an acute persistent reaction.  
At day 15 days post-implantation the inflammatory infiltrate is mainly characterized by MØ for all the 
groups (Figure 4), continuing the phagocytic work started by PMNs at earlier stages of the inflammatory 
process. The extension of the observed inflammatory infiltrate was slightly higher in κC than in AG 
hydrogels, demonstrating that the former elicited higher recruitment of inflammatory cells in 
comparison to AG (Fig. 4). At this stage, it is clear the degradation of AG hydrogel by the cells, while the 
presence of κC hydrogels material is not detected for the same time analyzed (Fig. 4). Foreign body 
giant cells, one of the typical features of chronic inflammation, were not observed.  
In terms of systemic reaction, the lymph nodes at 7 days depicted vascular channels, a mixed 
inflammatory infiltrate composed of fibroblasts, neutrophils and lymphocytes, and fibrous stroma of the 
node, independently of the tested group. Higher presence of the inflammatory infiltrate cells were 
detected at day 15 especially for κC and LPS group. Nonetheless, after 2 weeks, the analysis of the 
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explanted lymph nodes after H&E staining revealed the absence of germinal centers in their cortex (Fig. 
5). 
 
Figure VII- 4. Micrographs of H&E staining of explants sections obtained after 7 and 15 days of 
subcutaneous implantation of κC, AG hydrogels. The negative control group corresponds to the empty 
pockets (EP (-)) while the positive control (LPS (+)) corresponds to the group injected with LPS 24 
hours before the defined time point. The abbreviations corresponds to BV - blood vessels; PMNs – 
polymorphonuclear neutrophils; MØ - macrophages; AT - adipose tissue; H - implanted hydrogel. 
 
 
Figure VII- 5. Micrographs of the lymph nodes, stained with H&E, explanted from the κC, AG, EP, LPS 
groups after 7 and 15 days of subcutaneous implantation; the scale bar corresponds to 100 µm. 
Medullar region of the lymph nodes are represented in higher magnification images. Arrowhead 
indicates lymphocytes and long thin arrow designate neutrophils. 
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VII.3.3.2. MACROPHAGES RECRUITMENT AND LYMPHOCYTES ACTIVATION 
The CD163 immunodetection confirmed the presence of mainly recruited macrophages, while CD25 
immunostaining showed few positive activated lymphocytes, after one week of subcutaneous 
implantation (Fig. 6). The densities of the inflammatory cells seem to increase with time; while M2 
macrophages seem to be recruited in significant numbers in both experimental (κC) and control 
material (AG) groups, activated lymphocytes were mostly identified after implantation of κC hydrogels.  
 
 
Figure VII- 6. Micrographs of 7 and 15 days post-implantation explants after immunohistochemical 
labelling for recruited macrophages (CD163) and activated lymphocytes (CD25). Scale bar corresponds 
to 100µm. Arrows indicate positive cells for the CD163, arrow heads represent positive staining for 
CD25 and H is the abbreviation for implanted hydrogel. 
 
VII.3.3.3. ANALYSIS OF PRO-AND ANTI-INFLAMMATORY GENES EXPRESSION 
The expression profile of pro- and anti-inflammatory within the resolution of an inflammatory process is 
expected to result in a pro-wound healing pattern of cytokines. The expression of IL-1 alpha and IFN-
gamma, along with the absence of IL-4 was observed at day 7 of subcutaneous implantation of both 
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hydrogels (Fig.7). At day 15 of implantation it while IL-1 alpha expression was still detected, both the 
absence of expression of IL-4 and IFN-gamma were observed.  
 
Figure VII- 7. IL-1 alpha, IL-4, IFN- gamma, GAPDH expression analysed by RT-PCR  and visualized on a 
1.7 % agarose gel stained with ethidium bromide. (Left to right) Lanes 1–4: 7 days after subcutaneous 
implantation; lanes 5–8: 15 days after implantation. 
 
VII.4. DISCUSSION 
In has been reported that carrageenan sulfated polysaccharides have diverse biological activities 
derived from their chemical composition (varying amounts of ιota, κappa or lambda carrageenan 
precursors), sulfate content, molecular weight and extraction procedures [30, 31]. Moreover, the 
structural similarity of carrageenan, based on sulfated galactose or modified galactose residues, with 
components of the extracellular matrix, namely glycosaminoglycans (GAGs), might lead to specific 
biological reactions [32]. Carrageenan biocompatibility, including their immunomodulatory role has 
been discussed in several studies [33-35]. Most of these studies were centered in the use of lambda-
carrageenan solution and typically they lack data regarding dose, type of carrageenan or seaweed 
source, making it difficult to establish consensus among the reported results [36-39]. In this context it 
was essential to evaluate the newly developed hydrogels in terms of biocompatibility starting with in 
vitro testing followed by in vivo assessment, thus allowing understanding as much as possible 
carrageenan cytotoxicity and tissue compatibility. 
The metabolic activity of L929 cells exposed to hydrogel κC extract indicated that this natural origin 
polysaccharide does not induce a harmful effect on cells demonstrating the extremely low cytotoxic 
levels of the κC hydrogels. Similar results were observed for the AG hydrogel extract although a 
significantly higher metabolic activity, in comparison to κC hydrogels, was registered at day 7. A 
possible explanation for these results may be the difference in the gelation and the degradation 
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mechanism of the two polysaccharides. κC hydrogels are thermosensitive and ionic hydrogels while the 
gelation mechanism of AG is fully temperature dependent. The degradation of κC hydrogels when 
subjected to ionic environment such as culture medium can alter the stability of the gel, following its 
dissolution. Therefore, since κC degradation is faster, it is possible that a higher amount of degradation 
products are released during the extraction procedure, thus affecting the cell metabolic activity. 
Moreover, the cell behavior may also be influenced by potassium ions, the gelation agent, released 
from the hydrogels.  
Human polymorphonuclear neutrophils are crucial in the early development of an inflammatory 
response and dictate the progression of the host reaction [29, 40]. Typically, hPMNs experience a 
respiratory burst upon activation, releasing ROS that aim to eliminate the foreign inflammatory agent. 
ROS have been implicated in several key cellular processes, including oxidative stress damage [41] 
tumor promotion [42] and most recently, cell growth and DNA synthesis [43], but at high concentration 
can damage the cell structures [44]. Thus, assessing the release of ROS in vitro by placing hPMNs in 
contact with κC hydrogels is a way to predict, with the limitations of any other in vitro system, the initial 
material-host interactions that occur upon implantation. When hPMNs were in contact with κC 
hydrogels, a small amount of O2- anions were detected but no signal corresponding to luminol oxidation 
by OH- anions was observed. Moreover, cells were able to retain their intrinsic capacity to produce both 
ROS as demonstrated by the increased signal observed under the same conditions but in the presence 
of PMA stimulation. Nonetheless, the intensity of the detected signal was lower in the presence of the 
κC hydrogels, and slightly shifted in time in the case of the O2- detection. While the diminished intensity 
might be consequence of the interaction/scavenging of the ROS by the materials, the delayed detection 
most likely results from the cell-material interactions that interfere with the PMA activation pathway 
[45]. In fact, an even more pronounced signal was observed in the presence of AG hydrogels and upon 
hPMNs PMA activation and in particular in the detection of the O2- anions. This suggests a different 
interaction between hPMNs and the studied hydrogels, naturally arising from their distinct nature, and 
consequently a potentially different in vivo response. It has been shown, that hPMNs attachment to 
surfaces alters not only their shape but modulates their activity with regard to ROS production [46, 47]. 
It is therefore expected that direct hPMNs-hydrogel interactions contribute to the initial respiratory burst 
which, considering the obtained results, is not foreseen as factor that might contribute to an intense 
inflammatory reaction.   
This was in fact confirmed after subcutaneous implantation of the studied hydrogels as no physiologic 
signs of severe inflammation were observed. The typical reaction characterized by the presence of 
PMNs and macrophages was observed for both κC and AG hydrogels. The materials induced an influx 
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of neutrophils at early time points aiming at phagocytosis the foreign body which then progressed into 
an inflammatory infiltrate mainly composed by mononuclear cells, i.e. macrophages, lymphocytes and 
some fibroblasts. Administration of carrageenan has been reported to interfere with the phagocytic 
activity [48] and to be cytotoxic for macrophages in a concentration-dependent manner. The 
degradability of κC hydrogels is mostly based on hydrolysis of either the cross-linker or the polymer 
backbone [49] as this natural polymer requires the presence of ions for the formation of a stable 
hydrogel. These physically cross linked hydrogels tend to lose their stability after implantation due to 
the exchange of monovalent with divalent ions that are present in higher concentrations in physiological 
environments, as discussed for other systems [50]. Moreover, it is possible to convey that κC was 
degraded by matrix metalloproteinases secreted by the cells from the implantation site surroundings 
[51]. The absence of necrosis at the κC hydrogels implantation sites seems to indicate that 
macrophages were able to engulf the hydrogels, even showing higher degradation rate than AG 
hydrogels, within a context of a moderate inflammatory process. Moreover, the analysis of the lymph 
nodes after κC implantation did not indicate an activation state or an induced systemic host reaction. 
Apparently, no molecules of the materials were transported throughout circulation to induce a remote 
response.  
Macrophage phenotype has been characterized as pro-inflammatory (M1) or immunomodulatory and 
tissue remodeling (M2). These, specifically express the CD163 surface marker and are commonly 
associated to the release of anti-inflammatory cytokines [52]. Macrophages expressing CD163 have 
been identified in significant numbers at the implantation sites of both hydrogels though a higher 
number seems to be present in the κC hydrogel group in comparison to AG hydrogel, especially at day 
15 post implantation. This can be explained by the differentiated progression of the inflammatory 
process that is likely to be more advanced, thus expected to be resolved faster, in the κC hydrogel 
group due to their earlier degradation. The presence of AG hydrogels after 15 days of implantation 
contribute to the persistence of the reaction and to more pro-inflammatory stage characterized by a 
lower amount of M2 macrophages. IL-1 alpha expression at the different implantation times confirmed 
the inflammatory character of the reaction to both hydrogels studied. This cytokine is, at early stages of 
reaction, secreted by macrophages and endothelial cells, then stimulating the activation of B and T 
lymphocytes [53]. In response to IL-1 alpha secreted by activated macrophages, activated lymphocytes 
secrete IFN gamma [54]. Interestingly, our results confirm the expression of IFN gamma a day 7 post-
implantation but not at day 15, in which activated lymphocytes, CD25 positive cells, were identified. 
Moreover, the subcutaneous implantation of the hydrogels did not induce IL-4 expression, a T-cell 
derived inflammatory cytokine that inhibits macrophages response. Thus, at the end of latest 
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implantation period a typical acute inflammatory process caused by the degradation of the hydrogels 
occurs. Although the differences observed for the two implanted types of hydrogels were tenuous, the 
resolution of the inflammatory process is expected to be faster for the κC hydrogels group.  
 
VII.5. CONCLUSIONS 
The results presented in this study show that κC extracted proved to be cytocompatible, and did not 
significantly promote the stimulation and the respiratory burst of hPMNs. The inflammatory reaction 
observed after subcutaneous implantation of the materials, represented a typical acute response upon 
injury. The dissolution of the κC hydrogel components did not lead to the formation of toxic products 
and the biomaterial could be readily resorbed or excreted. Based on these observations it is possible to 
establish that κC hydrogels can be further studied for medicine regenerative applications, particularly 
for systems aiming at fast cell/bioactive molecules delivery.  
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CHAPTER VIII 
Preliminary evaluation of the in vivo behavior of κ-carrageenan hydrogels laden with human adipose 
derived stem cells  
 
ABSTRACT 
 
Recent studies have shown that human adipose derived stem cells (hASCs) loaded in κ-carrageenan 
hydrogels promote in vitro formation of cartilage-like tissue that exhibits increased mechanical 
properties with time in culture. These results show that κ-carrageenan holds adequate properties to 
enable the in vitro functionality of encapsulated hASCs, positioning them as valid alternatives to 
hydrogels currently used in cartilage regenerative strategies. Nevertheless, in vivo studies revealed a 
fast degradation of the κ-carrageenan hydrogels (without cells), upon their subcutaneous implantation 
in a rat model. 
Therefore, the present work was designed to assess the behavior of the κ-carrageenan hydrogels either 
freshly laden with hASCs or pre-cultured in chondrogenic medium, as compared to the hydrogels alone.  
The hydrogels were produced by an ionotropic gelation method and human adipose stem cells were 
encapsulated in a 1.5 % (w/v) κ-carrageenan solution at a cell density of 5x106 cells/mL-1. hASCs laden 
hydrogels were subcutaneously implanted in rats, either right after encapsulation or after pre-culture in 
chondrogenic medium for 1 week. Explants were analyzed by histological techniques, revealing normal 
cell morphology, and suggesting that the presence of cells improves the stability, preventing the faster 
degradation of the hydrogels, in agreement with previous in vitro outcomes and supporting the claim 
that hASCs laden κ-carrageenan hydrogels hold a great potential in the field of cartilage regeneration. 
 
 
 
 
Keywords: adipose derived stem cells; cartilage; chondrogenic differentiation; hydrogels; κ-carrageenan. 
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VIII.1. INTRODUCTION 
Cartilage is a connective tissue composed of extracellular matrix (ECM) on which the chondrocytes are 
embedded, characterized for being avascularised and for presenting a low metabolic rate [1-3]. The 
limited regeneration capacity of this tissue can create disability states associated to pain and 
decreasing of the quality of the life [3]. Several strategies have been pursued in order to replace the 
degenerated cartilage, but none of them was considered to be fully satisfactory [4-6]. Tissue 
engineering is considered the most promising alternative approach to develop cartilage regeneration 
therapies based on the use of biomaterials and cells, sometimes combined with bioactive agents [7, 8]. 
Several materials of natural origin have been studied and proposed to support cells development and 
functional cartilage tissue formation [9-18]. The use of hydrogels has gathered a strong importance in 
this research field, mainly because they can be injected into the tissue defect, adapting to the precise 
geometry and allowing for an higher safety of the implantation procedure [19]. Additionally, hydrogels 
obtained from natural origin polymer have also shown to enable the adequate functionality of 
encapsulated cells and therefore providing suitable matrices for their in vivo delivery [20]. Recently, 
carrageenan polysaccharide was proposed by the 3B‘s research group for application in the cartilage 
tissue-engineering field [21, 22] owing to its advantageous properties in comparison to other hydrogels, 
namely the ionic and temperature dependent gelling mechanism and chemical composition [23, 24]. 
Cells constitute one of the fundamental components of any cartilage tissue engineering approach. 
Although primary autologous chondrocytes have been widely used for the regeneration of cartilage, 
adipose tissue derived stem cells (ASCs) have promising future application in this field, mainly due to 
their wide availability in the human body, easiness of the harvesting procedures, the high number of 
stem cells and for their great chondrogenic differentiation potential [25-35]. 
In a previous study [24], it was shown that, due to the ionic nature of κ-carrageenan, the amount of 
ions present in the medium significantly affects the hydrogels swelling properties and ultimately the 
degradation profile of the hydrogel. Moreover, the in vitro culturing of κ-carrageenan hydrogels laden 
with stem cells in chondrogenic medium increased the mechanical properties of the constructs along 
with time in culture time, suggesting that the increased extracellular matrix production is responsible 
for enhanced mechanical properties and progressive maturation of the tissue formed in vitro. However, 
when κ-carrageenan hydrogels without cells were subcutaneously implanted, revealed their low stability 
in vivo. Therefore, the aim of this study was to evaluate if the encapsulation of cells could improve the 
in vivo behavior of the developed κ-carrageenan hydrogels. For this purpose, the cell laden hydrogels, 
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with or without pre-culture in chondrogenic medium, as well as hydrogel with no cells, were implanted 
in a rat subcutaneous model for 7 days and the explants evaluated by histological techniques. 
 
VIII.2. MATERIALS AND METHODS 
VIII.2.1. κ-Carrageenan hydrogel preparation 
An aqueous solution was prepared by dissolving the κ-carrageenan powder (22048, Sigma Fluka) in 
distilled water, and heating at 60 °C while stirring constant until complete dispersion. The κ-
carrageenan solution was autoclaved during 30 minutes at 120 °C before use, with a final 
concentration of 1.5 % (w/v) and 5 % (w/v) of potassium chloride (KCl, P5405, Sigma). The hydrogels 
discs were formed using 48 well plates and KCl for 10 minutes, in order to stabilize the 3-dimensional 
structure. Afterwards, the gels with dimensions of 11.5 ±0.01 mm x 1.8 ±0.24 mm height were 
washed with phosphate buffered saline (PBS, D5652, Sigma) for further use.  
 
VIII.2.2. Human adipose derived stem cells isolation and expansion 
Human liposuction aspirate samples were obtained upon patient informed consent from donors 
undergoing lipoaspiration procedures under a protocol established with the Department of Plastic 
Surgery of the Hospital da Prelada, Porto, and approved by the local Ethical Committee. The human 
adipose derived stem cells (hASCs) were enzymatically isolated as previously described [36]. Briefly, 
the adipose tissue samples were digested with 0.2 % collagenase type II (C6885, Sigma) in PBS for 45 
min at 37 °C under gentle stirring. The digested tissue was filtered, centrifuged at 1200 rpm for 10 
min at 20 °C and washed 5 min with lysis buffer to remove erythrocytes. The supernatant was 
removed and cells were resuspended in alpha Minimum Essential Medium (α-MEM, 12000-063 Gibco, 
Invitrogen) with 10 % FBS (10270-106 Gibco, Invitrogen; heat inactivated), 1 % Antibiotic-Antimycotic 
(15240-062, Invitrogen) and sodium bicarbonate (S5761-NaHCO3, Sigma). Human ASCs were plated 
at a density of 3.5 x 103 cells/cm2 and incubated at 37 °C in a humidified atmosphere of 5 % CO2.  
 
VIII.2.3. Encapsulation of hASCs in κ-carrageenan hydrogels  
Cells were resuspended in κ-carrageenan 1.5 % (w/v) solution for complete homogenization with a final 
concentration of 5x106 cells·mL-1. Hydrogel discs containing human ASCs were prepared as previously 
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described. After preparation the discs with encapsulated cells were cultured in chondrogenic 
differentiation medium for 7 days. Hydrogels disc with hASCs pre-cultured or κ-carrageenan laden with 
cells freshly prepared, were subcutaneously implanted for 7 days. Additional controls consisted of κ-
carrageenan hydrogel samples without cells and empty defects were created. The chondrogenic 
differentiation medium was composed of Dulbecco‘s Modified Eagle‘s Medium- low glucose (DMEM, 
D5523, Sigma), supplemented with 10 % FBS (10270-106 Gibco, Invitrogen), 1% Antibiotic-Antimycotic 
(15240-062, Gibco, Invitrogen), ITS+1 Liquid Media Supplement (I2521- insulin-transferrin-selenium - 
liquid media supplement, Sigma), 17 mM L-ascorbic acid (A4544, Sigma), 0.1 M sodium pyruvate 
(P4562, Sigma), 35 mM L-proline (P5607, Sigma), 1 mM dexamethasone (D4902, Sigma) and 10 
ng/ml of human TGF‐β1 (Transforming Growth Factor‐β1, 14‐8348, eBioscience). 
 
VIII.2.4. Subcutaneous implantation of cell loaded κ-carrageenan  
Surgeries were made on 9-week-old male Wistar rats under standard sterile conditions. Briefly, the rats 
were anesthetized with an intraperitoneal injection of a combination of medethomidine (30-100 μg/kg) 
plus ketamine (50-100mg/kg). After shaving the hair and disinfection with povidone-iodine (Betadine), 
a longitudinal incision was made on four distinct regions of the back of the rats. Ionic κ-carrageenan 
hydrogels with and without cells were subcutaneously implanted. Empty defects were used as controls. 
Then, the wounds were closed with a nonabsorbable polypropylene suture 4-0 (Figure 1). All the animal 
experiments were performed accordingly with the National Ethical Committee for Laboratory Animals 
and conducted in accordance with Portuguese legislation (Portaria nº1005/92) and international 
standards on animal welfare as defined by the European Communities Council Directive 
(86/609/EEC). Each rat received the implantation of 4 constructs randomly placed on their back, as 
represented in figure 1. Animals were placed on a heating pad under a warming light and observed 
until they recover consciousness. The rats were assessed for 30 minutes following their return to 
consciousness to assess evidence of distress and placed in cages (2/3 per cage). Animals received 
analgesia preoperatively (lidocaine) and during the post-operative period (carpofen) as needed based 
on evidence of discomfort. This was evaluated by animal behavior, feeding, and vocalization. Sutures 
were removed after 7 days postoperatively and animals were euthanized by asphyxiation with CO2. The 
explanted tissues were fixed in 4% formalin, embedded in paraffin, sectioned and processed for 
histological analysis. 
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Figure VIII- 1. Schematics of the implantation of four individual subcutaneous pockets, created by blunt 
dissection, with the different studied groups. 
 
VIII.2.5. Histological analysis 
Samples were collected at the end of the pre- fixed experimental endpoint (7 days), dehydrated and 
embedded in paraffin. Sections were cut at 4 µm and placed on microscopy slides. Hematoxylin-eosin 
(H&E) and Masson Goldner Trichrome (MGT) staining were performed. For H&E staining, after 
hydration the sample sections were colored with Papanicolaou Harris hematoxylin (05-12011/L, Bio-
optica) for 3 minutes, washed in running tap water and afterwards a blue stain enhancement was 
performed by an immersion in 0.5 % ammonia (05002, Sigma) for 5–10 seconds. The sections were 
washed in running tap water and stained in Eosin-Y (05-M10003, Bio-optica) for 30 seconds. For MGT 
different stains were used: Weigert‘s iron hematoxylin for nuclei, picric acid for erythrocytes and light 
green for collagen. After typical hydration steps, Weigert‘s iron hematoxylin reagent was added to the 
sections and left to act for 15 minutes. Without washing, the slides were drain and picric acid alcoholic 
solution was added to the section for 4 minutes. After quick wash in distilled water the other reagents 
were put on the section to act for a total of 15 minutes. Finally all slides were dehydrated through 
series of alcohol immersions from 30 % until 100 % alcohol. The final step for all the staining 
performed was the immersion in the clearing agent Histoclear® (National Diagnostics) or xylene 
substitute for 1-2 minutes and mounted using Microscopy Entellan® (Merck &Co., Inc.) for later 
observation. Stained sections were observed under a light microscope (Reflected/Transmitted light 
Microscope, Zeiss).  
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VIII.3. RESULTS AND DISCUSSION 
κ-Carrageenan hydrogels have been previously proposed for applications in cartilage regeneration since 
they enable to encapsulate/deliver cells under mild conditions [21, 24]. In these studies, cells have 
been encapsulated in κ-carrageenan hydrogels and cultured in vitro for extensive periods of time. The 
cells were viable, proliferated and formed a hyaline-like ECM composed of collagen type II. Figure 2 
shows human adipose derived stem cells efficiently encapsulated in the κ-carrageenan hydrogels and 
homogeneously distributed, exhibiting a round-shaped morphology typical of native human 
chondrocytes. The rounded shape was more obvious when stem cells were cultured in the presence 
chondrogenic differentiation medium assuming a chondrogenic phenotype. Although carrageenan is 
sensitive to mediums rich in electrolytes, such as physiological environment, destabilizing the hydrogel, 
previous in vitro studies have shown that the stiffness and the stability of the structure was increased 
with cell loading, [24].  
 
Figure VIII- 2. A - Calcein AM staining of human adipose stem cells (hASCs) encapsulated in κ-
carrageenan hydrogels cultured in chondrogenic and basal medium. Fluorescent images showing the 
viability and distribution of encapsulated hASCs after 21 days of culture, magnification 5x, with 100 μm 
scale bar. B - Haematoxylin&Eosin staining of hASCs encapsulated in κ-carrageenan hydrogels, 
exhibiting vacuoles morphology and cell clusters formation, scale bars have 100 µm and images are 
taken at 20x magnification. 
 
Nevertheless, upon subcutaneous implantation of the hydrogels without cells, the evaluation revealed 
low stability/fast degradation of the hydrogels with time. Thus, in this study it was evaluated the 
stability of the hydrogels once cells (hASCs) were loaded and, in some cases, pre cultured in 
chondrogenic media. Cell-laden hydrogels have a higher stability due to the increase in ECM deposition 
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within the hydrogels, as observed in vitro. As such, κ-carrageenan hydrogels discs with cells were 
subcutaneously implanted in wistar rats and histological analysis was conducted upon harvesting the 
explants, 1 week after the surgeries. Upon explantation, no evident macroscopic changes of the 
hydrogel samples and surrounding tissues were observed and the samples maintained its structural 
integrity.  
Figure 3 shows different histological sections of explants corresponding to the cells laden κ-
carrageenan hydrogels, obtained upon 7 days of subcutaneous implantation. Hematoxylin-eosin 
staining performed provided relevant information on cell morphology and distribution within the 
hydrogel matrix. The histological analysis of the explanted samples showed good integration within the 
surrounding host tissue. The observations also indicate that explants correspondent to hydrogels laden 
with cells exhibited higher cell density when compared to hydrogels alone. The presence of the cells in 
the hydrogels seems to have created consistent adhesion interface with the surrounding tissue, as can 
be observed in figure 3. κ-Carrageenan alone and the empty pocket (EP) presented similar 
morphologies, exhibiting good integration/ingrowth of surrounding tissues, although this feature was 
detected more frequently in κ-carrageenan hydrogels.  
It is clear t that the presence of cells increases the stability of hydrogels, providing further evidence that 
the subsequent deposition of extracellular matrix components within the hydrogel, facilitated by the 
gradual degradation of the gels, by it turn increases their stability. It has been proved that the 
biomechanical properties of articular cartilage greatly depends on composition, density of its ECM and 
interstitial fluid flow (water and solutes) [37]. So, cells encapsulation and extracellular matrix deposition 
may result in progressive increase of the mechanical properties of the 3D structures, as shown before 
for the cell laden hydrogels cultured in vitro  [38]. The cells incorporated in a matrix are expected to 
confer an improved advantage in new tissue formation and integration due to the role they can develop 
in tissue regeneration, both directly or indirectly, through the production/release of soluble factors that 
participate in these processes. 
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Figure VIII- 3. Micrographs of the sections of the explanted κ-carrageenan hydrogels loaded with 
predifferentiated for 7 days and undifferentiated cells stained with H&E and MGT. The images shown 
correspond to samples collected after 7 days of culture.  
 
VIII.4. CONCLUSIONS 
This work presents κ-carrageenan as a potential hydrogel for cell delivery with application in the 
regeneration of cartilage. The results obtained using κ-carrageenan hydrogels as cell loading matrix, 
prepared via ionic cross linking reaction, demonstrate that this system could be an alternative cell 
delivery hydrogel systems. The results clearly demonstrate the positive influence of the systems laden 
with cells, showing that human adipose stem cells encapsulated in κ-carrageenan hydrogels pre-
differentiate into the chondrogenic lineage, forming ECM like matrix that is responsible for higher 
stability of the final constructs.  
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CHAPTER IX 
IX.1. GENERAL CONCLUSION 
Current clinical repair methods cannot restore original properties nor promote the full regeneration of 
native cartilage tissue and consequently a great deal of efforts regarding the development of more 
efficient solutions, based on tissue engineering and regenerative medicine concepts, was the 
motivation background in this thesis.  
In native cartilage tissue, cells are embedded within the extracellular matrix (ECM) therefore, using 
hydrogels to encapsulate cells seems as an obvious choice as they provide an hydrated 3D 
environment that can be designed to mimic the composition/properties of the native ECM. Several 
natural origin hydrogels have been widely investigated for cartilage tissue engineering (TE) applications 
yet, an optimal material is still to be found. Carrageenan hydrogels offers great potential for such 
purpose due to its specific properties, but so far, almost unexplored in the biomedical field. Some of 
the advantages that such hydrogels may bring over current systems include the thermoreversible and 
ionic hydrogel characteristics that enable mild condition for cell encapsulation purposes and versatility 
of processing, obtaining various shapes/formats. The resemblance of their chemical structure to the 
glycosaminoglycans that compose the ECM of tissue and the presence of functional groups allow them 
to be easily chemically modified, rendering improved functions. Therefore, the main objective of this 
work was to develop and optimize carrageenan based hydrogels systems with adequate properties for 
the encapsulation/delivery of cells targeting cartilage repair strategies based on TE concepts. Thus, the 
work described also focused on the assessment of the in vitro chondrogenic potential of such systems 
laden with different cell types, as well as on their in vitro and in vivo biocompatibility evaluation. 
The work developed under the scope of this thesis allowed to obtain several conclusions that are be 
detailed bellow. The majority of the work herein described was centered on κ-carrageenan based 
systems; however, the first chapter concerning experimental work focused on the development and 
characterization of new hydrogel systems based on alginate and two different types of carrageenan, 
processing these blends into different formats and optimizing their properties to sustain the viability of 
encapsulated cells. Several different aspects were considered, such as, the use of different types of 
carrageenan (ιota and κappa), different concentrations of the polymers and various concentrations of 
the salts used for the ionic gelation. Spherical beads have been obtained by an extrusion technique and 
the fibers were prepared using a coagulation bath. Alginate was found to be inappropriate for 
applications that required defined shape due to their fast gelation and inadequate mechanical strength. 
Carrageenan showed to be able to withstand higher loads under compression and a gelation time 
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suitable for cell encapsulation. Assessment of the viability and proliferation of ATCD5 chondrocytes 
encapsulated onto the developed beads and fibers after different periods of culturing for 1, 7, 14 and 
21 days, revealed enhanced outcomes for κ-carrageenan hydrogels in comparison to ι-carrageenan, 
probably related to the higher content of ester sulphate groups along the polymer chain. Overall, the 
stability and the biological behavior of the beads and fibers were mostly influenced by the concentration 
and ratio of the polymer mixture.  
In the study carried out in chapter IV, it was determined the physical characteristics, such as swelling 
and mechanical properties of the carrageenan hydrogels. The hydrogels exhibited a pH-dependent 
swelling kinetics and it was found that the amount of ions present in the medium also affects 
significantly the hydrogels swelling properties. The mechanical properties of these hydrogels, as shown 
by the storage moduli (0.2 hydrogel alone and 0.4 MPa when cells were laden) were fairly positive 
when compared to other natural origin hydrogels considering the envisioned applications. In addition, 
the in vitro culturing of human adipose derived stem cells (hASCs) incorporated within the hydrogels 
led to the formation of a cartilaginous matrix rich in proteoglycans and collagen type II, showing 
evidences of commitment of the encapsulated cells towards the chondrogenic pathway. The 
extracellular matrix production seems to be responsible for the increase in the dynamic mechanical 
properties of the cell laden hydrogels, providing further evidence of their suitability for cartilage tissue 
engineering. 
Along with the initial evaluation of the hydrogel, the assessment of the in vitro chondrogenic potential of 
κ-carrageenan hydrogels laden with different cell types namely, a chondrocytic cell line, primary 
chondrocytes cells and hASCs, often proposed for cartilage regeneration strategies, was performed in 
chapter V. Several studies demonstrated that different cell types have variable responses to identical 
embedding materials due to the different cellular metabolism. Cell lines for example, divided more 
quickly, primary cells and stem cells are more sensitive with differences in doubling times, or number. 
Moreover limitations associated with the harvesting (availability, additional surgical intervention, donor 
site morbidity) isolation and in vitro proliferation procedures (chondrocytes easily dedifferentiate) must 
be carefully considered when selecting an optimal cell type for use in a tissue engineering approach. 
Overall, the biological evaluation of κ-carrageenan hydrogel revealed that this polymer enables long 
term viability and proliferation of different cells. During 3 weeks of culture, all cells types encapsulated 
within the hydrogel developed a cartilage-like extracellular matrix rich in proteoglycans and type II 
collagen, indicating a stable chondrocyte phenotype. However, encapsulated hASCs exhibit the highest 
proliferation rates and highest levels of chondrogenic markers expression, as compared to the other 
cell types studied. These findings encourage both the use of κ-carrageenan hydrogels as cell 
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matrices/delivery carriers and the use of hASCs for applications in the regeneration of articular 
cartilage defects.  
One of the main prospects of cartilage tissue engineering is the possibility of developing custom-made 
autologous regenerative medicine solutions on an individual patient basis that can offer also ―off the 
shelf‖ availability for application upon an immediate clinical need. Therefore, the development of 
efficient preservation and storage procedures will provide products available as needed, which could be 
adapted to an autologous immediate solution. Thus, the study in chapter VI aimed to examine the 
effects of cryopreservation on the chondrogenic differentiation of hASCs encapsulated in κ-carrageenan 
hydrogels. The developed systems maintained their mechanically stability and cellular viability upon 
exposure to lower temperatures and the assessment of chondrogenic features indicated a fair 
chondrocyte phenotype after cryopreservation. In summary, hASCs-hydrogel constructs have high long 
term storage potential and a ready-to-use bioengineered tissue substitutes for cartilage regeneration 
strategies. Thus, cell encapsulation systems of natural based hydrogels may be an interesting approach 
for the long term preservation of cartilage tissue engineered products.  
The development of new biomaterials requires extensive biological testing to demonstrate the safety 
and the functionality of the material and its degradation components and/or incorporated cells. Thus, 
chapter VII was devoted to investigate the in vitro and in vivo biocompatibility of the developed system, 
including in vitro experiments with human polymorphonuclear cells and the in vivo evaluation of the 
host reaction to the subcutaneous implantation of κ-carrageenan. The cytotoxicity tests performed 
revealed that the developed hydrogels were nontoxic and did not inhibit cell growth. The in vitro 
biological screening using hPMNs and the in vivo subcutaneous implantation designed to assess for the 
inflammatory reaction, revealed that the materials do not cause severe host response. At implant 
retrieval there were no macroscopic signs of a considerable inflammatory reaction in any of the animals 
and no cellular exudates was formed around the implants. 
The final stage of the work described in this thesis involved the in vivo assessment of loaded stem cells 
pre-differentiated or stem cells non-differentiated in κ-carrageenan hydrogels addressing fundamental 
questions concerning the in vivo degradation of the hydrogel and possible in vivo differentiation of 
encapsulated cells. The findings suggest that with addition of cells, the stability and the stiffness of κ-
carrageenan hydrogels was improved, as previously found from the in vitro studies.  
In summary, the overall results showed to be very promising for all types of cells encapsulated in 
carrageenan based hydrogels, positioning them as valid alternatives to commonly used standard 
hydrogels. Moreover, knowing that κ-carrageenan forms a hydrogel with potassium ions and the 
temperature-induced gelation enables its application as a cell-carrier or as an in vivo injectable system. 
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IX.2. OUTLOOK AND PERSPECTIVES  
Herein it was reported that ionic hydrogels based on carrageenan provide easy and inexpensive 
methods for producing cell friendly matrices, which enable stem cells differentiation into chondrocytes-
like cells, producing cartilage ECM components. Even though the outcomes of the described studies 
clearly demonstrate the potential for successful application of carrageenan hydrogels loaded with 
human adipose derived stem cells, additional research directions are considered fundamental to 
consolidate the merits of such approach for cartilage regeneration.  
For example, further studies should address in detail the injectability of the developed systems at 
physiological conditions, although it was demonstrated that by mixing the polymeric κ-carrageenan with 
the cross linker and subsequently adding the cell suspension, it was possible to extrude the system. In 
other words, κ-carrageenan hydrogels offer versatility in terms of administration given that it could be 
either applied as a ―solid‖ construct with various specific shapes or delivered in an injectable way into a 
tissue defect. Simultaneously it is important to determine if tissue regeneration in vivo is achieved in a 
similar manner with or without in vitro pre-culturing of the cell laden hydrogels. 
During all experimental trials it was observed a fast temporal weight loss of the 3D carrageenan 
hydrogel when exposed to environments rich in electrolytes, ions and cations that destabilize the 
hydrogel. This behavior, which is commonly observed in ionic hydrogels, can eventually be overcome 
through different strategies, namely by the addition of ions and/or repeating the cross-linking step in 
the presence of potassium chloride. Such improvement could allow a more precise control and tailoring 
of the degradation profile of the hydrogel structure. Other ways of preventing the dissolution of the 
hydrogels, is by taking advantage of the carrageenans chemical structure and modify it introducing 
groups which are more difficult to degrade. In fact, such strategy has been recently attained, by 
introduction of photocrosslinkable methacrylate moieties, enhancing the stability of these 
polysaccharides and thus obtaining systems with slower dissolution rates in physiological conditions. 1 
When compared to other hydrogels with similar characteristics and applications, namely alginate, 
agarose, gellan gum and ulvan, several distinct properties are observed. Carrageenan is extracted from 
red algae, like agarose, while alginate is obtained from a brown algae and ulvan from green algae. 
Gellan gum is a polysaccharide manufactured by microbial fermentation of the Sphingomonas 
                                                             
1 Mihaila, S.M., et al., Photocrosslinkable Kappa-Carrageenan Hydrogels for Tissue Engineering Applications. Adv Healthcare 
Mater, 2012: p. n/a-n/a. 
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paucimobilis microorganism.2 Carrageenan and alginate are ionic hydrogels, and its gelling mechanism 
is temperature dependent, like agarose, although in a different manner.   
The registered values of the mechanical properties for κ-carrageenan based hydrogels are higher or 
within the range of the values found for other hydrogels used in similar cartilage regenerative 
approaches.3 Moreover, compared to human articular cartilage which has a compressive modulus of 
0.79 MPa, a shear modulus of 0.69 MPa, and a tensile modulus varying between 0.3 and 10.2 MPa, 
carrageenan hydrogels achieved up to 30–50% in strength and mechanical stiffness.4 
Another advantageous feature of carrageenan hydrogel is that it enables to obtain a chondrocyte typical 
phenotype once cells are embedded in it, even without any chondrogenic stimulation agents. Such 
accomplishment was owed not only because of the hydrogels matrix, which is adequate to retain the 
rounded shape specific of chondrocytes, likely to enhance chondrogenesis, but can be equally due to 
the interaction between the sulphated groups of carrageenan and the cells. Thus, future studies should 
address in more detail the influence of the chemical composition of κ-carrageenan in chondrogenic 
differentiation. Moreover, polysaccharides like carrageenan are thought to protect growth factors from 
degradation and seem to interact with stem cells due to the carbohydrate glycochemistry, mediating 
cellular behavior. 5  The host reaction issue is a serious concern in current TE approaches and 
monocytes/macrophages are known to the typically present immediately after the implantation of a 
construct. Carrageenan is thought to affect the innate immune response in ways not yet defined, with 
the molecular weight and the sulphate composition playing important roles in such particular behavior.6 
The inflammatory response is a key factor for tissue regeneration, thus targeting inflammation to 
support regeneration may be the solution. It is possible to sustain the concept that if understanding the 
signaling and activation pathways that regulate carrageenan inflammatory reaction may providing a 
rational for their use as therapeutic agents in treatment of inflammation-associated diseases.   
In summary, the success of engineering carrageenan hydrogel for cartilage application was granted by 
the use of stem cells, namely human adipose tissue derived stem cells. It can be hypothesized that this 
behavior could be related to the undifferentiated stage of the cells, providing a better cellular outcome 
as compared to the human primary chondrocytes. Moreover, in terms of accessibility, scarcity, 
                                                             
2 Oliveira, J.T., et al., Gellan gum: A new biomaterial for cartilage tissue engineering applications. J Biomed Mater Res A, 
2010. 93A(3): p. 852-863. 
3  C. Lee, et al., Topics in tissue engineering, in The Influence of Mechanical Stimuli on Articular Cartilage Tissue 
Engineering, N. Ashammakhi and R.L. Reis, Editors. 2006. 
4 Fisher, J.P., et al., Thermoreversible hydrogel scaffolds for articular cartilage engineering. J Biomed Mater Res A, 2004. 
71(2): p. 268-74. 
5 Vollmers, H.P. and S. Brandlein, Tumors: Too sweet to remember? Mol Cancer, 2007. 6(1): p. 78. 
6 Bhattacharyya, S., et al., Carrageenan-induced innate immune response is modified by enzymes that hydrolyze distinct 
galactosidic bonds. J Nutr Biochem, 2010. 21(10): p. 906-913. 
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harvesting procedures and cell number available, stem cells particularly those obtained from the 
adipose tissue are outrunning the primary cells. It is well recognize that exists a spatial-temporal 
modeling, meaning that cells communicate differently with the surrounding releasing distinct 
biomolecules at different stage inducing variations in the cellular response. Thus, variables such as cell 
number, cell culture media formulation, the stage of differentiation and the biological properties of the 
hydrogels should be investigated in detail to optimize therapies based on the cell–laden hydrogels.  
The option of using carrageenan natural hydrogels is relevant based on the gelling properties, the high 
chemical reactivity and the physical characteristics. The in situ gelation at physiological conditions is an 
important feature of carrageenan based hydrogels that may enable its application by injecting of the 
cell-laden systems directly into the tissue defect, in a minimally invasive manner. Such use of injectable 
hydrogels for cell delivery in cartilage regeneration therapies have attracted more and more attention, 
because of their promising advantages over pre-formed scaffolds. In any case, the chemical similarity 
to ECM may confer better biological performance and structural affinity, feature not yet fully exploited.  
As final remark, the herein proposed and studied carrageenan hydrogel proved to be suitable and 
represent a valid alternative to the existing/standard hydrogels options. Overall, the research presented 
in this thesis has provided a general comprehension of the possible applications of carrageenan 
hydrogel and stem cells in cartilage engineering as well as a starting point and motivation for further 
research on the use of red algae based polymers.  
 
 
